methotrexate has been researched along with Recrudescence in 895 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 151 (16.87) | 18.7374 |
1990's | 193 (21.56) | 18.2507 |
2000's | 247 (27.60) | 29.6817 |
2010's | 226 (25.25) | 24.3611 |
2020's | 78 (8.72) | 2.80 |
Authors | Studies |
---|---|
Aljurf, M; Ayala, E; Fernandez, A; Iqbal, M; Keller, K; Kharfan-Dabaja, MA; Kumar, A; Murthy, H; Reljic, T; Yassine, F | 1 |
Becker, J; Bley, TA; Hellmich, B; Kraemer, M; Minnerup, J; Steinbrecher, A | 1 |
Devine, SM; Geller, N; Giralt, S; Heslop, HE; Ho, VT; Horowitz, MM; Jones, RJ; Litzow, MR; Logan, B; Luznik, L; Mendizabal, A; Muffly, L; Nemecek, ER; O'Donnell, L; O'Reilly, RJ; Palencia, R; Pasquini, MC; Perales, MA; Schetelig, J; Shune, L; Soiffer, RJ; Solomon, SR; Vasu, S; Wu, J | 1 |
Aljurf, M; Bazarbachi, A; Bondarenko, S; Bourhis, JH; Brissot, E; Bug, G; Canaani, J; Choi, G; Ciceri, F; Cornelissen, JJ; Dholaria, B; Esteve, J; Gedde-Dahl, T; Giebel, S; Koc, Y; Labopin, M; Meijer, E; Mohty, M; Nagler, A; Niittyvuopio, R; Savani, B; Socié, G; Spyridonidis, A; Wu, D | 1 |
McNeer, JL; Schmiegelow, K | 1 |
Ito, Y; Kawakami, A; Kawasaki, R; Kawashiri, SY; Kawazoe, Y; Kuroda, S; Morimoto, S; Sato, S; Shimizu, T; Yamamoto, H | 1 |
Hilal, T; Jain, SP | 1 |
Kong, XY; Li, M; Wang, SM | 1 |
Jendoubi, F; Masson Regnault, M; Paul, C; Shourick, J; Tauber, M | 1 |
Aotsuka, N; Atsuta, Y; Eto, T; Hamamura, A; Hirayama, M; Ichinohe, T; Iemura, T; Kanaya, M; Kawakita, T; Kimura, T; Kondo, T; Kozai, Y; Morishima, S; Onizuka, M; Ozawa, Y; Sugio, Y; Takada, S; Takahashi, S; Tanaka, M; Uchida, N; Wake, A; Yamasaki, S; Yanada, M; Yokoyama, H | 1 |
Lee, SHR; Schmiegelow, K; Toksvang, LN; Yang, JJ | 1 |
Filippa, MG; Panopoulos, S; Sfikakis, PP; Spanos, E; Spanos, G; Tektonidou, MG; Yavropoulou, MP | 1 |
Angeles-Han, ST; Drews-Botsch, C; Jenkins, K; Lambert, SR; McCracken, C; Prahalad, S; Rouster-Stevens, KA; Shantha, JG; Yeh, S | 1 |
Faria, MJ; Fernanda, T; Rita, D; Rui, B | 1 |
Beeker, N; Bouaziz, JD; Chaigne, B; Dupin, N; Mouthon, L; Sène, D; Tieu, A; Zuelgaray, E | 1 |
Darrow, HJ; Raleigh, MF; Stoddard, J | 1 |
Gieling, J; Hoppenreijs, E; Schatorjé, E; van den Bemt, B | 1 |
Wu, Y; Yan, X; Yang, L; Zhang, Z; Zhao, J; Zhou, W | 1 |
Kato, M; Kikuchi, K; Sakamoto, K; Sako, M; Shioda, Y; Takimoto, T | 1 |
Brugarolas, E; Estrada, P; LLop, D; Maymó-Paituvi, P; Narváez, J; Nolla, JM; Palacios-Olid, J; Vidal-Montal, P | 1 |
Ceccato, J; Cinetto, F; Marcolongo, R; Romano Gargarella, L; Scarpa, R; Vianello, F | 1 |
Aouba, A; Boutemy, J; de Boysson, H; Deshayes, S; Dumont, A; Gallou, S; Lavergne, A; Maigné, G; Nguyen, A; Philip, R; Silva, NM | 1 |
Bai, W; He, X; Huang, C; Jiang, N; Li, M; Nie, Y; Niu, J; Peng, L; Qiao, L; Sun, B; Wang, L; Wu, D; Yang, Y; Zeng, X; Zhang, L; Zhang, W; Zhao, Y; Zheng, M; Zhou, J; Zhou, S | 1 |
Hashiramoto, A; Yamane, T | 1 |
Bagot, M; Bertolotti, A; Bouaziz, JD; Cambau, E; Chauveau, M; Duhamel, E; Hau, E; Jachiet, M; Jaume, L; Le, B; Mahé, A; Maisonobe, T; Monsel, G; Mougari, F; Petit, A | 1 |
Chan, A; Ciurea, SO; Doh, J; Griffin, SP; Jeyakumar, D; Kongtim, P; Lee, BJ; O'Brien, S | 1 |
Bozkurt, ZY; Coşkun, BN; Dalkılıç, E; Ekin, A; Lermi, N; Ocak, T; Ötegeçeli, MA; Pehlivan, Y; Yağız, B | 1 |
Huang, KH; Lin, CD; Lin, HC; Wu, PC | 1 |
Alousi, AM; Bashir, Q; Champlin, RE; Hosing, C; Joseph, J; Kebriaei, P; Milton, DR; Olson, AL; Oran, B; Popat, UR; Qazilbash, MH; Ramdial, JL; Saini, NY; Shpall, EJ; Srour, SA | 1 |
Keller, M; Sherban, A | 1 |
Bader-Meunier, B; Bodaghi, B; Grall-Lerosey, M; Gueudry, J; Monnet, D; Morelle, G; Quartier, P; Robert, MP; Uettwiller, F; Wouters, C | 1 |
Chen, Y; Cong, Y; Dong, L; Omar, D | 1 |
Benn, BS; De Marco, T; Gerstenfeld, EP; Hsia, HH; Janmohamed, M; Klein, L; Koth, LL; Lee, BK; Moss, JD; Murray, TO; Pampaloni, MH; Parwani, P; Petek, BJ; Rosenthal, DG; Scheinman, MM; Selby, V; Vedantham, V; Zikherman, J | 1 |
Goto, T; Julamanee, J; Kamoshita, S; Kiyoi, H; Koyama, D; Miyamura, K; Miyao, K; Murata, M; Nishida, T; Okuno, S; Ozawa, Y; Takagi, E; Terakura, S | 1 |
Ahuja, V; Aniwan, S; Chan, KH; Hartono, JL; Hilmi, I; Hui, AJ; Kumar, S; Lam, BCY; Leung, CM; Leung, WK; Li, MKK; Limsrivilai, J; Lo, FH; Mak, JWY; Ng, KM; Ng, SC; Ran, ZH; Sze, ASF; Tang, W; Tsang, SWC; Wei, SC; Yip, TCF | 1 |
Benvenuti, F; Doria, A; Gatto, M; Iaccarino, L; Larosa, M; Montesso, G; Saccon, F; Zen, M | 1 |
Fuji, S; Ishikawa, J; Kida, S; Koike, M; Masaie, H; Nakata, K; Nakata, R; Tada, Y; Tsutsumi, K; Yoshida, H | 1 |
Águeda, AF; Buttgereit, F; Cid, M; Dejaco, C; Hellmich, B; Luqmani, RA; Mahr, A; Monti, S; Ponte, C; Salvarani, C; Schmidt, W | 1 |
Aguiar, X; Fisher, RA; Frijstein, MM; Kaur, B; Lok, C; Massuger, L; Sarwar, N; Sebire, NJ; Seckl, MJ; Short, D; Ten Kate-Booij, MJ; van Trommel, NE; van Werkhoven, E | 1 |
Bian, W; Chen, D; Chen, J; Fu, J; Li, Y; Li, Z; Liu, Y; Sun, X; Zhang, W; Zhang, Y; Zhao, X | 1 |
Amigo, ML; Bravo-Perez, C; Escobar, H; Garcia, J; Garcia-Malo, MD; Muiña, B; Ortuño, FJ; Pajares, I; Piris, MA; Rodriguez-Pinilla, SM | 1 |
Casanova, MJ; Gisbert, JP; Rojo, E | 1 |
Bavaharan, B; Kawali, A; Mahendradas, P; Mohan, A; Sanjay, S; Shetty, B | 1 |
Cai, H; Cao, X; Chen, M; Duan, M; Feng, J; Li, J; Wang, W; Yang, C; Zhang, L; Zhang, W; Zhang, Y; Zhou, D; Zhu, T; Zhuang, J | 1 |
Honda, M; Kakimaru, H; Kondo, M; Moriyama, M; Murakawa, Y; Onoda, K; Sugiura, T; Watanabe, Y | 1 |
Chen, D; Gao, J; Li, ZG; Liu, Y; Shen, D; Wang, K; Wang, Y; Wang, Z; Xia, C; Yang, F; Yu, G; Zeng, Q; Zhang, S; Zhu, L | 1 |
Bachiller-Corral, J; Gorospe-Sarasúa, L; Larena-Grijalba, C; Morán-Álvarez, P; Morell-Hita, JL | 1 |
Fujino, Y; Hanami, K; Kubo, S; Miyagawa, I; Nakano, K; Nakayamada, S; Nawata, A; Saito, K; Tanaka, Y | 1 |
Bae, JH; Choi, H; Kim, HY; Kim, JH; Kim, TY; Kim, YS; Koh, SH; Kwon, HS; Lee, KY; Lee, YJ | 1 |
Çinar, M; Çolak, S; Tekgöz, E; Yilmaz, S | 1 |
Agazzi, A; Fadanelli, G; Martini, G; Meneghel, A; Vittadello, F; Zulian, F | 1 |
de la Torre, ML; Pisoni, CN; Rodríguez, AM | 1 |
Fang, C; Jing, X; Wang, N; Xu, Z; Zhang, Q | 1 |
Haapasaari, KM; Jantunen, E; Kaprio, E; Karihtala, P; Kauppila, S; Kuittinen, O; Kuitunen, H; Kuusisto, M; Makkonen, V; Turpeenniemi-Hujanen, T | 1 |
Adnan, IA; Biswas, J; Kharelo, SR | 1 |
Abe, A; Ishikawa, H; Ito, S; Kobayashi, D; Lee, H; Murasawa, A; Nakazono, K; Nemoto, T; Otani, H; Takai, C | 1 |
Cortazar, FB; Huizenga, NR; Laliberte, K; Niles, JL; Rhee, EP; Rosenthal, JM; Wallace, ZS; Zonozi, R | 1 |
Hijikata, Y; Hirata, Y; Kobayashi, M; Lim, LA; Matsubara, Y; Ota, Y; Tojo, A; Yotsuyanagi, H | 1 |
Chen, Y; Dai, Z; Han, L; Huang, RY; Liang, CL; Liu, H; Lu, C; Qiu, F; Yan, Y; Zhang, Q | 1 |
Gangopadhyay, D; Radhakrishnan, V | 1 |
Águeda, AF; Hellmich, B; Luqmani, R; Monti, S | 1 |
Bertsias, G; Boumpas, DT; Fanouriakis, A; Tziolos, N | 1 |
Cook, LB; Phillips, AA | 1 |
Leach, M; McKay, P; Oun, H; Wilson, M | 1 |
Carron, P; Colman, R; De Craemer, AS; Elewaut, D; Renson, T; Van den Bosch, F | 1 |
Goto, Y; Imamura, M; Kawahata, K; Nagafuchi, H; Sakurai, K; Shibata, T; Suzuki, S; Suzuki, T; Yamasaki, Y | 1 |
Haberstroh, WD; Lenka, A; Triano, MJ; Whelton, SA | 1 |
Friedman, M; Ringsted, S | 1 |
Hojo, H; Ikeda, S; Koyama, D; Ohta, M; Sukegawa, M; Suzuki, M; Tsunoda, S | 1 |
Hellmich, B | 1 |
Weibel, L | 1 |
Al-Shaibani, Z; Chen, C; Kim, DDH; Kumar, R; Lam, W; Law, AD; Lipton, JH; Loach, D; Mattsson, J; Michelis, FV; Nampoothiri, RV; Viswabandya, A | 1 |
Mete, B; Papila Kundaktepe, B; Velidedeoğlu, M | 1 |
Abrahamsson, J; Appell, ML; Grell, K; Hjalgrim, LL; Jónsson, ÓG; Kanerva, J; Lund, B; Nersting, J; Nielsen, SN; Pruunsild, K; Schmiegelow, K; Toksvang, LN; Vaitkeviciene, G | 1 |
Brunello, L; Bruno, B; Busca, A; Butera, S; Cerrano, M; Dellacasa, CM; Faraci, DG; Giaccone, L; Mordini, N; Sorasio, R; Vassallo, S; Zallio, F | 1 |
Balke-Want, H; Borchmann, P; Bröckelmann, PJ; Deckert, M; Gillessen, S; Gödel, P; Heger, JM; Kreissl, S; Naendrup, JH; Sieg, N; Simon, F; von Tresckow, B | 1 |
Batlevi, CL; Bobillo, S; Caron, PC; Dogan, A; Ghione, P; Hamilton, A; Hamlin, PA; Horwitz, SM; Joffe, E; Kumar, A; Matasar, MJ; Mondello, P; Moskowitz, A; Noy, A; Owens, CN; Palomba, ML; Sermer, D; Seshan, VE; Straus, D; von Keudell, G; Younes, A; Zelenetz, AD | 1 |
Bargagli, E; Bergantini, L; Cantarini, L; Conticini, E; d'Alessandro, M; Frediani, B; Gentili, F; Mazzei, MA | 1 |
Chen, H; Dai, X; Ji, Z; Jiang, L; Jin, X; Kong, X; Ma, L; Sun, Y; Wang, L | 1 |
Castillo-Vilella, M; Giménez, N; Modesto, C; Quintana, S; Tandaipan, JL | 1 |
Fujimoto-Hirakawa, Y; Fukuda, W; Iwai, T; Kobayashi, T; Kuriyama, K; Kuroda, J; Matsumoto, Y; Mizutani, S; Nagata, H; Nishikawa, R; Ohshiro, M; Shimura, Y; Tsukamoto, T; Uchiyama, H; Yamamoto-Sugitani, M | 1 |
Amano, K; Anan-Nemoto, T; Higashi, M; Kimura, Y; Kizaki, M; Momose, S; Okuyama, A; Tabayashi, T; Takahashi, Y; Tamaru, JI; Tanaka, Y; Tokuhira, M; Tomikawa, T; Watanabe, R | 1 |
Benseler, SM; Cabral, DA; Charuvanij, S; Dancey, P; Eberhard, BA; Elder, ME; Foell, D; Hersh, AO; Huber, AM; Klein-Gitelman, M; Kostik, MM; Lawson, EF; Lee, T; Li, SC; Lubieniecka, JM; Luqmani, RA; Moorthy, LN; Morishita, KA; Nielsen, SM; Ristic, G; Shenoi, S; Toth, MB; Twilt, M; Yeung, RSM | 1 |
Amengual, JE; Barta, SK; Bast, MA; Behdad, A; Blum, KA; Calzada, O; Cassaday, RD; Chavez, JC; Cohen, JB; Costa, C; Falkiewicz, MK; Feldman, T; Fenske, TS; Gerson, JN; Hernandez-Ilizaliturri, F; Hill, BT; Howlett, C; Kaplan, JB; Landsburg, DJ; Lansigan, F; Li, S; Lue, JK; Maly, J; Mato, AR; Medeiros, LJ; Nathan, S; Olszewski, AJ; Peace, DJ; Persky, DO; Petrich, AM; Reddy, NM; Rivera, X; Singavi, A; Torka, P; Vose, JM | 1 |
Jahnz-Różyk, K; Kucharczyk, A; Rutkowska, E; Świerkocka, K; Więsik-Szewczyk, E | 1 |
Baouendi, N; Belfeki, N; Ben Ghorbel, I; Ben Salem, T; Houman, MH | 1 |
Ikeda, S; Kawai, K; Kiriyama, M; Kobayashi, S; Kurumiya, Y; Mizuno, K; Mori, M; Nakashima, Y; Oiwa, T; Sekoguchi, E; Tominaga, K; Torii, N; Watanabe, H | 1 |
Chiang, BL; Su, Y; Yang, YH | 1 |
Baek, S; Choi, EJ; Choi, Y; Jeon, M; Jo, JC; Joo, YD; Kang, YA; Kang, YL; Kim, DY; Kim, H; Kim, SH; Ko, SH; Lee, JH; Lee, KH; Lee, YS; Lim, SN; Park, HS; Seol, M; Yun, SC | 1 |
Hara, A; Kizu, J; Matsumoto, K; Yokoyama, Y | 1 |
Castañeda, S; González-Gay, MA; Matteson, EL | 1 |
Braun, T; Choi, SW; Dinarello, CA; Gatza, E; Henig, I; Magenau, J; Parkin, B; Pawarode, A; Reddy, P; Riwes, M; Yanik, G | 1 |
Alberici, F; Andrulli, S; Buzio, C; Grasselli, C; Manenti, L; Maritati, F; Oliva, E; Palmisano, A; Pavone, L; Pesci, A; Santarsia, F; Santi, R; Tumiati, B; Urban, ML; Vaglio, A | 1 |
Gao, L; Tian, J; Zhang, P | 1 |
Du, L; Kijlstra, A; Liang, L; Qi, J; Wang, C; Wu, L; Yang, P; Ye, Z; Zhou, Q | 1 |
Chauhan, P; De, D; Handa, S; Narang, T; Saikia, UN | 1 |
Contreras-Yáñez, I; Ortiz-Haro, AB; Pascual-Ramos, V; Pérez-Román, DI; Ruiz-Medrano, E | 1 |
Alam, M; Lim, HW; Nahhas, AF | 1 |
Ikeda, K; Ito, M; Kikuta, A; Kobayashi, S; Mochizuki, K; Ohara, Y; Ohto, H; Sano, H; Takahashi, N; Waragai, T | 1 |
Arenas, CM; Chalela, JG; Ordóñez Rubiano, MF | 1 |
Browne, R; Stewart, L; Williams, HC | 1 |
Asgari, M; Jorizzo, J; Kesty, C; Kesty, KR; Subash, JJ | 1 |
Abraham, B; Anton, K; Barnes, EL; Cross, RK; Dryden, G; Fischer, M; Hanson, J; Harlan, W; Herfarth, H; Higgins, PDR; Isaacs, KL; Ivanova, A; Jackson, S; Levy, C; Lewis, JD; Long, MD; Martin, C; McCabe, R; Osterman, MT; Polyak, S; Saha, S; Sandler, RS; Sands, BE; Serrano, J; Valentine, JF; Williams, E; Yajnik, V | 1 |
Heiligenhaus, A; Heinz, C; Tappeiner, C; Walscheid, K; Zu Hoerste, MM; Zurek-Imhoff, B | 1 |
Affandi, AM; Bhullar, A; Kamal, WSA; Kamal, WSZ | 1 |
Bansie, RD; Karim, AF; Paridaens, D; Rombach, SM; van Hagen, PM; Van Laar, JAM; Verdijk, RM | 1 |
Driscoll, C; Elmore, S; Fehr, AE; Gilbert, UD; Hategekimana, V; Larrabee, K; Lehmann, L; May, L; Moore, M; Mpunga, T; Muhayimana, C; Rubagumya, F; Shulman, LN; Shyirambere, C; Uwizeye, FR; Xu, MJ | 1 |
Abdel-Razeq, S; Bahtiyar, MO; Deshmukh, U; Fan, L; Grechukhina, O; Kohari, K; Sfakianaki, AK | 1 |
Kurzinski, KL; Torok, KS; Zigler, CK | 1 |
Balci, S; Dogruel, D; Duyuler Ayçin, G; Miray Kisla Ekinci, R; Serbes, M; Ufuk Altintas, D; Yilmaz, M | 1 |
Castellino, A; Habermann, TM; Inwards, DJ; Johnston, PB; King, RL; Macon, WR; Micallef, INM; Nora Bennani, N; Nowakowski, GS; Pulido, JS; Ristow, KM; Salomao, DR; Witzig, TE | 1 |
Chen, J; Ngo, D; Rosenthal, J | 1 |
Fernandez, AP; Hu, JZ; Husni, ME; Mazloom, SE; Warren, CB; Ya, J; Yan, D | 1 |
Crowson, CS; Koster, MJ; Labarca, C; Muratore, F; Warrington, KJ; Yeruva, K | 1 |
Baran, R; Chiheb, S; Daniel, CR; Di Chiacchio, N; Gregoriou, S; Grover, C; Haneke, E; Iorizzo, M; Pasch, M; Piraccini, BM; Rich, P; Richert, B; Rigopoulos, D; Rompoti, N; Rubin, AI; Singal, A; Starace, M; Tosti, A; Triantafyllopoulou, I; Zaiac, M | 1 |
Batthish, M; Pai, N; Xie, ES | 1 |
Chander, S; Karim, MY; Wijetilleka, S | 1 |
Fukushima, M; Inokuma, T; Shimeno, N; Toyonaga, H | 1 |
Ahn, SE; Choi, HY; Lee, KM; Park, JE; You, MW | 1 |
Hong, JY; Huh, J; Kang, EH; Kim, S; Lee, K; Lee, SW; Park, CS; Suh, C; Yoon, DH | 1 |
Kantarjian, HM | 1 |
Akikusa, J; Alsaleem, A; Chiang, GPK; Laxer, RM; Lee, JJY; Limenis, E; Sontichai, W; Yeung, RSM | 1 |
Arcari, A; Centurioni, R; Evangelista, A; Freilone, R; Ladetto, M; Liberati, AM; Luminari, S; Massidda, S; Merli, F; Musuraca, G; Nassi, L; Patti, C; Pavone, V; Peli, A; Pulsoni, A; Re, A; Salvi, F; Spina, M; Stelitano, C; Tani, M; Tucci, A; Volpetti, S; Zanni, M | 1 |
Ayaz, NA; Çakan, M; Çakmak, F; Karadağ, ŞG; Sönmez, HE; Tanatar, A | 1 |
Benshushan, A; Dior, UP; Gilad, R; Levin, G; Rottenstreich, A; Shushan, A | 1 |
Jain, S; Jha, S; Kumar, RR; Sharma, A | 1 |
Mouthon, L | 1 |
Aricò, M; Astigarraga, I; Braier, J; Donadieu, J; Gadner, H; Grois, N; Henter, JI; Janka-Schaub, G; Ladisch, S; McClain, KL; Minkov, M; Pötschger, U; Thiem, E; Weitzman, S; Windebank, K | 1 |
Alberici, F; Buzio, C; Cobelli, R; Ferretti, S; Manenti, L; Maritati, F; Oliva, E; Palmisano, A; Urban, ML; Vaglio, A | 1 |
Eckert, C; Henze, G; v Stackelberg, A | 1 |
Aguilar-Lozano, L; Castillo-Ortiz, JD; Hernandez-Cuevas, C; Morales-Torres, J; Padilla-Ibarra, J; Ramos-Remus, C; Sanchez-Ortiz, A; Sandoval-Castro, C; Vargas-Serafin, C | 1 |
Escherich, G; Hagel, C; Hartz, B; Löbel, U | 1 |
Bielsa Marsol, I | 1 |
Huang, J; Jin, J; Lou, Y; Mai, W; Meng, H; Qian, W; Tong, H; Tong, Y | 1 |
Chen, WW; Cheng, AL; Hsu, CH; Huang, TC; Lin, CC; Yeh, KH | 1 |
Sumi, T | 1 |
Loke, YK; MacGregor, AJ; Watts, RA; Yates, M | 1 |
Baker, KS; Hingorani, SR; Hoffmeister, PA; Storer, BE | 1 |
Bertram, A; Ganser, A; Hafer, C; Ivanyi, P; Matthias, K; Peest, D; Schmidt, BM | 1 |
Benevolo, G; Chiappella, A; Vitolo, U | 1 |
Cherin, P; Diot, E; Dominique, S; Hachulla, E; Hatron, PY; Jouen, F; Marie, I; Menard, JF; Vittecoq, O | 1 |
Hong, EK; Huh, SY; Hyun, JW; Kim, HJ; Kim, SH; Yoo, H | 1 |
Cuthbertson, D; Hoffman, GS; Krischer, JP; Langford, CA; McAlear, CA; Merkel, PA; Monach, PA; Seo, P; Specks, U; Ytterberg, SR | 1 |
Araujo, EG; Englbrecht, M; Faustini, F; Finzel, S; Hueber, A; Nas, K; Rech, J; Schett, G; Schreiber, DA | 1 |
Luo, DQ | 1 |
Cao, XX; Duan, MH; Li, J; Shen, T; Zhang, W; Zhou, DB | 1 |
Ahlberg, L; Amini, RM; Åström, M; Bernell, P; Hägglund, H; Hallböök, H; Hulegårdh, E; Karlsson, K; Kozlowski, P; Markuszewska-Kuczymska, A; Smedmyr, B; Tomaszewska-Toporska, B | 1 |
Miyawaki, S | 1 |
Desalermos, AP; Farraye, FA; Frank, S | 1 |
Hoffman, GS; Langford, CA; Nutter, B; Springer, J; Villa-Forte, A | 1 |
Ghose, A; Kundu, R; Latif, T | 1 |
Fushimi, K; Takami, M; Tanabe, N | 1 |
Kim, HS; Kim, JY; Park, SH | 1 |
Bi, K; Chen, F; Fan, J; Hou, M; Liu, G; Ran, X; Wang, J; Wang, L; Wang, M; Wang, X; Wang, Z; Xu, R; Yang, E; Yang, S; Yu, W; Zhao, H | 1 |
Amiot, A; Bastuji-Garin, S; Belhassan, M; Chauvin, A; Delchier, JC; Le Baleur, Y; Le Thuaut, A; Mesli, F | 1 |
Brion, A; Chabin, M; Clavert, A; Colombat, P; Cumin, I; Delwail, V; Escoffre-Barbe, M; Gardembas, M; Ingrand, P; Lacotte-Thierry, L; Legouffe, E; Olivier, G; Solal-Celigny, P | 1 |
Matuzevičienė, R; Ragelienė, L; Schmiegelow, K; Stoškus, M; Vaitkevičienė, G; Žvirblis, T | 1 |
Djulbegovic, B; Kharfan-Dabaja, M; Kumar, A; Mhaskar, R; Perkins, JB; Pidala, J; Reljic, T | 1 |
Benton, CB; Borthakur, G; Dara, S; Franklin, AR; Garcia-Manero, G; Jabbour, E; Kantarjian, H; Kwari, M; O'Brien, S; Pierce, SR; Ravandi, F; Rytting, M; Thomas, DA; Yang, H | 1 |
Burbury, K; Carney, DA; Cheah, CY; Dickinson, M; Fedele, PL; George, A; Gilbertson, M; Harrison, SJ; Herbert, KE; Januszewicz, EH; Kennedy, GA; O'Rourke, K; Opat, SS; Prince, HM; Ritchie, DS; Seymour, JF; Tam, CS; Tan, SY; Westerman, DA; Wolf, M | 1 |
Antón, J; Bou, R; Calzada-Hernández, J; Giménez-Roca, C; Hernández, S; Iglesias, E; Ricart, S; Sánchez-Manubens, J; Torrente-Segarra, V | 1 |
Armuzzi, A; Bruzzese, V; Diamanti, AP; Gatta, L; Hassan, C; Laganà, B; Lorenzetti, R; Migliore, A; Ridola, L; Zullo, A | 1 |
Cho, HH; Jin, H; Kim, BS; Kim, HS; Kim, MB; Kim, WJ; Ko, HC; Mun, JH; Song, M | 1 |
Chang, CY; Meyer, RM; Reiff, AO | 1 |
Brown, N; Burns, A; Carr, S; Croft, AP; Hamilton, P; Harper, L; Morgan, MD; Pusey, CD; Salama, AD; Smith, SW; Venning, M; Youssouf, S | 1 |
Bruno-Ventre, M; Caligaris-Cappio, F; Citterio, G; Donadoni, G; Ferreri, AJ; Foppoli, M; Govi, S; Ponzoni, M; Sassone, M; Scarfò, L; Vignati, A | 1 |
Blumhardt, S; Finckh, A; Guerne, PA; Kyburz, D; Madigan, A; Mc Carthy, GM; Neto, D; Rappoport, G; Van Linthoudt, D; Weber, M | 1 |
Ashwal, E; From, A; Hiersch, L; Krissi, H; Peled, Y; Wiznitzer, A | 1 |
Abounader, D; Bolwell, B; Copelan, E; Dean, R; Duong, H; Haddad, H; Hamilton, BK; Hanna, R; Hill, BT; Kalaycio, M; Majhail, NS; Rybicki, L; Sobecks, R | 1 |
Borthakur, G; Brandt, M; Cortes, J; Daver, N; Estrov, Z; Garcia-Manero, G; Jabbour, E; Jain, P; Kadia, TM; Kantarjian, HM; O'Brien, S; Pemmaraju, N; Pierce, S; Ravandi, F; Thomas, DA; Wang, X | 1 |
Jiang, S; Lin, N; Liu, Y; Wang, Y; Xu, Y; Ye, Z | 1 |
Abril, A; Berianu, F; Cohen, MD; Ginsburg, WW | 1 |
Carlsen, N; Christensen, IJ; Dalhoff, K; Gréen, H; Gregers, J; Lausen, B; Peterson, C; Rosthoej, S; Schmiegelow, K; Schroeder, H | 1 |
Gupta, V; Hamad, N; Kim, DD; Kuruvilla, J; Lipton, JH; Messner, HA; Michelis, FV; Seftel, M; Shanavas, M; Uhm, J | 1 |
Anasetti, C; Ayala, E; Figueroa, J; Kharfan-Dabaja, MA; Kim, J; Locke, F; Nishihori, T; Perkins, J; Riches, M; Yue, B | 1 |
Alten, R; Demary, W; Englbrecht, M; Feuchtenberger, M; Finzel, S; Fleck, M; Haschka, J; Henes, J; Hueber, AJ; Kleinert, S; Kleyer, A; Lorenz, HM; Manger, B; Manger, K; Nuesslein, H; Ochs, W; Rech, J; Reiser, M; Ronneberger, M; Schett, G; Schmitt-Haendle, M; Schuch, F; Tony, HP; Wendler, J | 1 |
Gharib, M; Naderi, H; Sarvghad, M; Sheybani, F | 1 |
Eray, M; Haapasaari, KM; Haapasalo, H; Harjama, L; Jantunen, E; Karjalainen-Lindsberg, ML; Kuittinen, O; Kuitunen, H; Lehtinen, T; Leppä, S; Mannisto, S; Nousiainen, T; Soini, Y; Turpeenniemi-Hujanen, T; Vasala, K; Vornanen, M | 1 |
Gawroński, K; Kisiel, B; Rzepecki, P; Tłustochowicz, W | 1 |
Esiashvili, N; Flowers, CR; Jegadeesh, N; Khan, MK; Liu, Y; Okwan-Duodu, D; Rajpara, R; Shi, Z | 1 |
Brock, F; Franck-Larsson, K; Jansson, M; Larsson, E; Leirisalo-Repo, M; Uhlig, T; van Vollenhoven, RF; Østergaard, M | 1 |
Abou Chahla, W; Jissendi-Tchofo, P; Lolli, V; Pruvo, JP; Soto Ares, G | 1 |
Asano-Mori, Y; Hashimoto-Maeda, M; Izutsu, K; Kaji, D; Taniguchi, S; Uchida, N; Watanabe, M; Yamamoto, G | 1 |
Asal, M; El Desouky, F; Nofal, A; Nofal, E; Soliman, A | 1 |
Cao, Z; Gong, BF; Gong, XY; Gu, RX; Li, W; Li, Y; Lin, D; Liu, BC; Liu, KQ; Liu, YT; Mi, YC; Wang, JX; Wang, Y; Wei, H; Wei, SN; Zhang, GJ; Zhao, XL; Zhou, CL | 1 |
Arita, M; Furuta, K; Hotta, M; Ikeda, S; Ikeo, S; Ishida, T; Ito, A; Nishiyama, A | 1 |
Abe, S; Asashima, H; Ebe, H; Hagiwara, S; Hirota, T; Kondo, Y; Kurata, I; Matsumoto, I; Ogishima, H; Sumida, T; Suzuki, T; Takahashi, H; Tsuboi, H; Umeda, N; Yagishita, M | 1 |
Benseler, SM; Bichler, J; Haas, JP; Hügle, B; Krumrey-Langkammerer, M | 1 |
Hassanein, O; Moussa, E; Raafat, T; Rahman, HA; Sedky, MS; Taha, H | 1 |
Bae, SH; Chi, HS; Eom, HS; Hyun, MS; Jang, DY; Joo, YD; Jung, CW; Kim, DY; Kim, H; Kim, HJ; Kim, I; Kim, MK; Lee, GW; Lee, JH; Lee, KH; Lee, SM; Lee, WS; Lim, SN; Moon, JH; Park, S; Ryoo, HM; Shin, HJ; Sohn, SK; Won, JH; Yang, DH; Yun, SC | 1 |
Farah, RS; Ferguson, NN; Holahan, HM; Liu, V | 1 |
Flatø, B; Johnsson, A; Knudsen, PK; Lilleby, V | 1 |
Allaart, CF; Dirven, L; Gerards, AH; Huizinga, TW; Kerstens, PJ; Lems, WF; Markusse, IM; Ronday, HK; van Groenendael, JH | 1 |
Ahn, YC; Kim, SJ; Kim, WS; Ko, YH; Oh, D | 1 |
Ballet, V; Bollen, L; Ferrante, M; Gils, A; van Assche, G; Vande Casteele, N; Vermeire, S | 1 |
Gomollón, F | 1 |
Dankó, K; Farkas, F; Nagy-Vince, M; Szalmás, O | 1 |
Ise, T; Iwase, T; Kusunose, K; Sata, M; Soeki, T; Takagi, E; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K | 1 |
Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R | 1 |
Prior, JO; Pruvot, E; Rutz, T; Vionnet, J | 1 |
Andrew, NH; Kearney, D; McKelvie, P; McNab, A; Selva, D; Sladden, N; Sun, MT; Wu, A | 1 |
Bello, N; Carreño, L; De la Torre, I; González, CM; Hinojosa, M; Janta, I; López-Longo, J; Martínez-Barrio, J; Martínez-Estupiñán, L; Monteagudo, I; Montoro, M; Naredo, E; Nieto, JC; Ovalles-Bonilla, JG; Valor, L | 1 |
Fayad, A; González, G; Robaina Sindín, J; Smuclir Quevedo, A; Vazquez, V | 1 |
Abbas, F; Couder, F; Golfier, F; Hajri, T; Lotz, JP; Massardier, J; Schott, AM; You, B | 1 |
Ben-Neriah, S; Connors, JM; Ennishi, D; Farinha, P; Gascoyne, RD; Johnson, NA; Kansara, R; Kridel, R; Mottok, A; Savage, KJ; Scott, DW; Sehn, LH; Slack, GW; Steidl, C; Tan, KL; Villa, D | 1 |
Alivernini, S; Fedele, AL; Ferraccioli, G; Gremese, E; Peluso, G; Tolusso, B | 1 |
Feldman, J; Ogedegbe, C; Patel, C | 1 |
Begun, J | 1 |
Benagiano, G; Brosens, I; Gordts, S; Petraglia, F | 1 |
Andres, MP; Gonçalves, FC; Gonçalves, MO; Passman, LJ; Podgaec, S | 1 |
Gurion, R; Hamlin, P; Horwitz, S; Lunning, M; Mehta, N; Migliacci, JC; Moskowitz, A; Moskowitz, C; Zelenetz, A | 1 |
Bachta, A; Kisiel, B; Raczkiewicz, A; Rękas, M; Tłustochowicz, M; Tłustochowicz, W | 1 |
Dixit, A; Gupta, M; Madkaikar, M; Patil, V | 1 |
Feki, NB; Ghorbel, IB; Houman, MH; Khanfir, MS; Said, F | 1 |
Carey, JJ; Coughlan, R; Donnellan, S; Garrahy, A; Giblin, L; Griffin, MD; Griffin, TP; Lappin, D; McNicholas, BA; Reddan, D; Ryan, L | 1 |
Angeles-Han, ST; Rabinovich, CE | 1 |
Bakhritdinov, FSh; Suyumov, AS | 1 |
Brambilla, A; Caputo, R; Cimaz, R; Simonini, G | 1 |
Ahmed, I; Bahlas, S; El Gaafary, M; El Miedany, Y; Hegazi, M; Nasr, A; Youssef, S | 1 |
Bai, QX; Chen, JP; Chen, XQ; Dong, BX; Gao, GX; Gu, HT; Hao, CX; Liang, R; Shu, MM; Wang, JH; Wang, JS; Wang, XM; Yang, L; Zeng, Y; Zhang, N; Zhang, T | 1 |
Byun, JM; Kim, HL; Kim, I; Kim, JH; Koh, Y; Lee, YG; Park, SS; Seong, MW; Shin, DY; Yoon, SS | 1 |
Balzarotti, M; Cabrera, ME; Ceriani, L; Chiappella, A; Cunningham, D; Ferreri, AJ; Giovanella, L; Gospodarowicz, MK; Guarini, A; Johnson, PW; Martelli, M; Ricardi, U; Stelitano, C; Zinzani, PL; Zucca, E | 1 |
Amoura, Z; Bitoun, S; Borie, R; Boutin, DL; Bouvry, D; Cohen Aubart, F; Godeau, B; Haroche, J; Hie, M; Mahevas, M; Mathian, A; Nunes, H; Papo, T; Pottier, C; Psimaras, D; Sacre, K; Valeyre, D | 1 |
Aicart, M; Alcaín, G; Almela, P; Arguelles-Arias, F; Arias-Rivera, ML; Barreiro-de Acosta, M; Barrio, J; Beltrán, B; Benítez, JM; Bermejo, F; Botella, B; Bujanda, L; Busquets, D; Calvet, X; Casanova, MJ; Castaño-Milla, C; Castro, E; Castro, L; Ceballos, D; Chaparro, M; Cortés, X; Domènech, E; Domínguez, M; Domínguez-Antonaya, M; Dueñas, C; Esteve, M; Fernández-Salazar, L; García-Herola, A; García-López, S; García-Planella, E; García-Sánchez, V; García-Sepulcre, MF; Garrido, E; Gisbert, JP; Gómez-García, M; Gomollón, F; González-Lama, Y; Guardiola, J; Gutiérrez, A; Hernández-Martínez, A; Hervías, D; Hinojosa, J; Huguet, JM; Jauregui-Amezaga, A; Khorrami, S; Leo, E; Llaó, J; Lorente-Poyatos, R; Mañosa, M; Marín-Jiménez, I; Marrero, JM; Martín-Arranz, M; Martinez-Montiel, MP; Menacho, M; Merino, O; Monfort, D; Moraleja, I; Muñoz, C; Muñoz, F; Nantes, O; Navarro-Llavat, M; Novella, MT; Opio, V; Pajares, R; Pérez-Calle, JL; Pérez-Martínez, I; Pineda, JR; Ponferrada, A; Ramírez-de la Piscina, P; Ramos, L; Robles-Alonso, V; Rodríguez, C; Rodríguez, GE; Rodríguez-Pérez, A; Rojas-Feria, M; Roncedo, O; Sánchez-Torres, A; Sicilia, B; Taxonera, C; Tosca, J; Van Domselaar, M; Vázquez, JM; Vega-López, AB | 1 |
Madhumathi, J; Sridevi, S; Verma, RS | 1 |
Franzen, D; Greutmann, M; Kolios, A; Liebscher, F; Pfammatter, T | 1 |
Muratore, F; Pipitone, N; Salvarani, C | 1 |
Chong, JH; Koh, MJA | 1 |
Cortes, JE; Estrov, Z; Ferrajoli, A; Garcia-Manero, G; Jabbour, E; Kantarjian, HM; Khouri, M; Khoury, JD; Ko, H; O'Brien, SM; Pierce, S; Ravandi, F; Short, NJ; Thomas, DA; Thompson, PA; Verstovsek, S; Wierda, WG | 1 |
Meyer, V; Sachse, MM; Wagner, G | 1 |
Liozon, E; Ly, K | 1 |
Cravo, M; Figueiredo, A; Tellechea, O; Vieira, R | 1 |
Bardin, T; Chevalier, X; Doan, TH; Forestier, R; Leparc, JM; Richette, P | 1 |
Cohen, IJ | 1 |
Bang, YJ; Heo, DS; Im, SA; Kim, BK; Kim, BS; Kim, CW; Kim, DW; Kim, NK; Kim, TY; Park, S; Yoon, SS | 1 |
Au, WY; Fong, BM; Kwong, YL; Tam, S | 1 |
Ferreri, AJ; Foppoli, M; Mazzucchelli, L; Ponti, G; Ponzoni, M; Zucca, E | 1 |
Basso, G; Biondi, A; Fabbri, G; Locatelli, F; Paganin, M; Polato, K; Rizzari, C; Zecca, M | 1 |
Al-Ahmari, A; Al-Yamani, A; Dupuis, L; Hitzler, J; Shah, N; Stephens, D | 1 |
Chen, Y; Liu, FY; Liu, XD; Zhang, JL; Zheng, HG | 1 |
Brugnoletti, F; Inaba, H; Jeha, S; Laningham, FH; Morris, EB; Patay, Z; Pauley, JL; Pui, CH | 1 |
Fietz, T; Franke, A; Freund, M; Hänel, M; Knauf, WU; Thiel, E | 1 |
Annecke, K; Busch, R; Harbeck, N; Hoefler, H; Kiechle, M; Klein-Hitpass, L; Kruse, E; Langer, R; Mages, J; Naehrig, J; Reich, U; Schmitt, M; Smida, J; Specht, K | 1 |
Al-Hemidan, AI; Tabbara, KF | 1 |
Cabanillas, F; Fayad, L; Hagemeister, F; Kantarjian, H; Kwak, LW; McLaughlin, P; Rodriguez, MA; Romaguera, J; Wang, M; Zhou, Y | 1 |
Gafter-Gvili, A; Paul, M; Raanani, P; Ram, R; Shpilberg, O; Yeshurun, M | 1 |
Borowitz, MJ; Bowman, WP; Camitta, BM; Campana, D; Cao, X; Carroll, WL; Cheng, C; Davies, SM; Devidas, M; Downing, JR; Evans, WE; Fan, Y; French, D; Hunger, SP; Neale, G; Pei, D; Pounds, SB; Pui, CH; Relling, MV; Treviño, LR; Willman, CL; Yang, JJ; Yang, W | 1 |
Abali, H; Disel, U; Kose, F; Mertsoylu, H; Ozyilkan, O; Sezer, A | 1 |
Boezeman, JB; Creemers, MC; de Jong, EM; Kroft, EB; van den Hoogen, FH | 1 |
Agdi, M; Tulandi, T | 1 |
Berkhof, J; Boers, M; Knol, DL; Rijmen, F; Twisk, JW; Uitdehaag, BJ | 1 |
Hall, CP; Harutyunyan, N; Kang, MH; Lock, RB; Papa, RA | 1 |
Shah, N; Zambidis, ET | 1 |
Usui, J; Yamagata, K | 1 |
Bart, PA; Chakour, R; Leimgruber, A; Spertini, F | 1 |
Akiyoshi, K; Izumi, T; Kawano, T; Korematsu, S; Maeda, T; Miyahara, H; Sato, K; Suenobu, S; Yamada, H | 1 |
Cai, Y; Lin, L; Ling, JY; Sun, XF; Tong, GL; Xia, Y; Zhen, ZJ | 1 |
Oberoi, J; Radhakrishnan, N; Sachdeva, A; Yadav, SP | 1 |
Boucher, KM; Bunin, N; Goyal, RK; Grimley, M; Grupp, SA; Hankins, P; Pulsipher, MA; Wall, DA | 1 |
Bowen, GM; Florell, SF; Hadley, JC; Hadley, ML; Tristani-Firouzi, P | 1 |
Avery, S; McLean, C; Opat, S; Patil, S; Ritchie, D; Schwarer, A; Spencer, A; Wei, A | 1 |
Altmeyer, P; Gaifullina, R; Gambichler, T; Kirschke, J; Kreuter, A; Tigges, C | 1 |
Abdulghaffar, EE; Abou El Asrar, M; Adly, AA; El-Bostany, EA; El-Ghouroury, EA; Tantawy, AA | 1 |
Chalmers, RJ; Helbling, I; Yates, VM | 1 |
Alkhalifah, A; Alsantali, A; McElwee, KJ; Shapiro, J; Wang, E | 1 |
Alarcón-Romero, Ldel C; Gómez-Gómez, Y; Illades-Aguiar, B; Leyva-Vázquez, MA; Organista-Nava, J; Rivera-Ramírez, AB; Saavedra-Herrera, MV; Terán-Porcayo, MA | 1 |
Acholonu, S; Champlin, R; Dabaja, B; Donato, M; Duvic, M; Hosing, C; Khouri, I; Richmond, H; Singh, L; Wei, W | 1 |
Armbrust, W; Corona, F; Cuttica, R; Dolezalova, P; Ferriani, V; Foeldvari, I; Foell, D; Frosch, M; Gamir, ML; Garay, S; García-Consuegra, J; Gerss, J; Gonzalez, B; Khubchandani, R; Lepore, L; Martini, A; Mihaylova, D; Norambuena, X; Oliveira, S; Pistorio, A; Ravelli, A; Roth, J; Ruperto, N; Stanevicha, V; Susic, G; Tsakalidou, FK; Vojinovic, J; Wedderburn, LR; Wittkowski, H; Wulffraat, N | 1 |
DeAngelo, DJ; Stone, RM | 1 |
Boulinguez, S | 1 |
Baerlecken, N; Bange, FC; Ernst, D; Puls, F; Rana, A; Schmidt, RE; Stoll, M | 1 |
Blinder, R; Chang, P; Galinsky, I; Ho, VT; Housman, E; Kesari, S; Lane, SW; Mullally, A; Stone, RM | 1 |
Abramson, JS; Barnes, JA; Hammerman, P; Hellmann, M; Hochberg, EP; Muzikansky, A; Takvorian, T; Toomey, C | 1 |
Rheingold, SR; Seif, AE; Sutter, JA | 1 |
Behm, FG; Graham, K; Hale, GA; Howard, SC; Hudson, MM; Kaste, S; Krasin, MJ; Kun, LE; Lowe, E; Mahmoud, H; Metzger, ML; Onciu, M; Pui, CH; Razzouk, BI; Rencher, R; Ribeiro, RC; Sandlund, JT; Zhou, Y | 1 |
Abbenante, MC; Baccarani, M; Curti, A; Iacobucci, I; Martinelli, G; Paolini, S; Papayannidis, C; Parisi, S | 1 |
Arcangeli, G; Giannarelli, D; Giordano, C; Pinnarò, P; Rambone, R; Strigari, L | 1 |
Jacobe, HT; Saxton-Daniels, S | 1 |
Catalano, P; Chen, YH; Khimani, NB; Mauch, PM; Ng, AK; Silver, B | 1 |
Choi, CW; Kim, H; Kim, JS; Kim, SJ; Kim, WS; Lee, GW; Oh, SY; Park, J; Shin, HJ; Suh, C; Won, JH; Yang, DH | 1 |
Aublet-Cuvelier, B; Bourdel, N; Jaffeux, P; Larraín, D; Mage, G; Marengo, F; Pouly, JL; Rabischong, B | 1 |
Allaart, CF; Dijkmans, BA; Güler-Yüksel, M; Han, KH; Huizinga, TW; Kerstens, PJ; Klarenbeek, NB; van der Kooij, SM; van Groenendael, JH | 1 |
Colombel, JF; D'Hoore, A; Danese, S; Dignass, A; Gassull, M; Gomollón, F; Hommes, DW; Lémann, M; Lindsay, JO; Michetti, P; O'Morain, C; Oresland, T; Söderholm, J; Stange, EF; Travis, SP; Van Assche, G; Windsor, A | 1 |
Audrain, M; Bordessoule, D; de Leval, L; Devidas, A; Feuillard, J; Gachard, N; Gaulard, P; Hermine, O; Jaccard, A; Marin, B; Morschhauser, F; Petit, B; Rogez, S; Suarez, F; Thieblemont, C; Tilly, H; Ysebaert, L | 1 |
Ancliff, P; Darbyshire, P; Goulden, N; Green, N; Hancock, J; Leighton, C; Love, S; Masurekar, A; Moorman, AV; Morgan, M; Parker, C; Révész, T; Saha, V; Sutton, R; Waters, R | 1 |
Durrbach, A; Fermé, C; Hanna, C; Matta, C; Moise, L; Pilorge, S; Ribrag, V | 1 |
de Boer, JH; Kalinina Ayuso, V; Rothova, A; van de Winkel, EL | 1 |
Arraes, AE; Camargo, CZ; de Souza, AW; Freitas, DS; Mariz, HA | 1 |
Labalette, P | 1 |
Bozonnat, MC; Bressolle, F; Daurès, JP; Hillaire-Buys, D; Margueritte, G; Martelli, N; Mathieu, O; Peyrière, H | 1 |
Alaoui-Slimani, K; Biron, P; Blay, JY; Chassagne-Clement, C; de la Fouchardiere, A; de Prijck, B; Delannoy, A; Devidas, A; Ferlay, C; Ghesquières, H; Ketterer, N; Lepretre, S; Provencher, S; Sebban, C; Thyss, A; Tilly, H | 1 |
Abu El-Asrar, A; Amjadi, S; Chang, JH; Maconochie, Z; McCluskey, P; Wakefield, D | 1 |
Chosidow, O; Ingen-Housz-Oro, S; Ortonne, N; Roujeau, JC; Valeyrie-Allanore, L; Wolkenstein, P | 1 |
Bertz, H; Bethge, WA; Bornhäuser, M; Egger, M; Einsele, H; Finke, J; Grishina, O; Heim, DA; Holler, E; Kolb, HJ; Kolbe, K; Koza, V; Linkesch, W; Maertens, JA; Mayer, J; Ottinger, HD; Ruutu, T; Schmoor, C; Schwerdtfeger, R; Socié, G; Stelljes, M; Volin, L; Zander, AR | 1 |
Kim, YZ; Lee, EH; Sung, KH | 1 |
Barwick, SC; Brodlie, M; McKean, MC; Welch, A; Wood, KM | 1 |
Baldi, I; Balzarotti, M; Bottelli, C; Cavalli, F; Chiappella, A; Conconi, A; Ferreri, AJ; Gomez, H; Gospodarowicz, MK; Lopez-Guillermo, A; Martelli, M; Martinelli, G; Merli, F; Novero, D; Orsucci, L; Pavone, V; Ricardi, U; Sarris, AH; Storti, S; Vitolo, U; Zucca, E | 1 |
Antin, JH | 1 |
Brandão, M; Marinho, A | 1 |
Laskari, K; Moutsopoulos, HM; Tzioufas, AG | 1 |
Chakkittakandiyil, A; Laxer, RM; Mirsky, L; O'Brien, C; Pope, E | 1 |
Blasius, E; Glas, M; Herrlinger, U; Pels, H; Schlegel, U; Steinbeck, JA; Stuplich, M | 1 |
Clifford, R; Danby, R; Ellis, A; Hatton, C; Littlewood, T; Malladi, R; Medd, P; Monk, I; Peniket, A; Roberts, D; Vyas, P | 1 |
Koumas, S; Neokleous, N; Prokopiou, C; Seimeni, O | 1 |
Hidaka, T; Ishizaki, J; Katayose, K; Kawano, H; Kawano, N; Kubuki, Y; Maeda, K; Matsuoka, H; Ochiai, H; Oshima, K; Satou, S; Shide, K; Shimao, Y; Shimoda, H; Shimoda, K; Takenaka, K; Toyama, T; Ueda, A; Yamaguchi, K; Yamashita, K; Yano, T; Yoshida, S | 1 |
Matsuo, T; Miyata, Y; Ohba, K; Sagara, Y; Sakai, H; Takahashi, H; Watanabe, S | 1 |
Holodny, A; Omuro, A; Palomba, ML; Pentsova, E; Rosenblum, M | 1 |
Fujiki, Y; Hanafusa, T; Hata, K; Makino, S; Ozaki, T; Takeuchi, T; Yoshida, S; Yoshikawa, A | 1 |
Foell, D; Frosch, M; Hansmann, S; Holzinger, D; Hoppenreijs, EP; Kastrup, A; Moncrieffe, H; Otten, MH; Prince, FH; Roth, J; ten Cate, R; Ursu, S; Van Suijlekom-Smit, LW; Wedderburn, LR; Wittkowski, H | 1 |
Hwang, JM; Kim, MJ; Lee, YJ; Park, KH; Woo, SJ | 1 |
Berthelot, P; Carricajo, A; Lucht, F; Suy, F | 1 |
Brunet, P; Burtey, S; Dussol, B; Seck, SM | 1 |
Cheon, JH; Choi, CH; Jang, BI; Kim, YH; Lee, H; Lee, KM; Shin, SJ; Yang, SK; Ye, BD | 1 |
Agard, C; Aslangul, E; Aumaître, O; Bienvenu, B; Boutemy, J; Broussolle, C; Comoz, F; Cordier, JF; Decaux, O; Dubois, A; Dufour, JF; Guillevin, L; Le Gallou, T; Mahr, A; Marie, I; Pagnoux, C; Pinède, L; Puéchal, X; Sève, P | 1 |
Harvey, R; Lybol, C; Massuger, LF; Mitchell, H; Ottevanger, PB; Savage, PM; Seckl, MJ; Short, D; Sweep, FC; Thomas, CM | 1 |
Jindal, G; Rawat, A; Rohit, M; Singh, S; Suri, D | 1 |
Kobayashi, R; Matsumoto, Y; Nasu, T; Suzuki, D; Takanashi, K; Uetake, K | 1 |
Alp, H; Erdogan, T; Gursan, N; Karabag, K; Orbak, Z | 1 |
Huang, TS; Lin, HW; Shih, SR; Yao, M | 1 |
Al-Terkait, F; Blick, C; Chester, JD; Crew, J; Douglas, D; Hall, P; Kilbey, N; Macaulay, V; Munro, N; Powles, T; Protheroe, A; Pwint, T | 1 |
Sato, K; Uchiyama, M | 1 |
Kher, A; Kher, V | 1 |
Peña-Santos, G; Ruiz-Moreno, JL | 1 |
Aublet-Cuvelier, B; Belard, F; Bouyer, J; Canis, M; de Bennetot, M; Fernandez, H; Pouly, JL; Rabischong, B | 1 |
Andres, M; Pascual, E; Sivera, F | 1 |
Adde, M; Adeodou, O; Aken'Ova, Y; Brown, BJ; Durosinmi, M; Githang'a, J; Hurwitz, N; Kaijage, J; Leoncini, L; Magrath, I; Naresh, K; Ngoma, T; Rajab, J; Raphael, M; Rohatiner, A; Scanlan, P; Venzon, D | 1 |
Berinstein, N; Buckstein, R; Cheung, MC; Guirguis, HR; Imrie, KR; Mahrous, M; Piliotis, E; Zhang, L | 1 |
Geetha, D; Seo, P | 1 |
Kim, HS; Kim, YS; Lee, J | 1 |
Felstead, AM; Hughes, CW; Main, BG; Thomas, SJ | 1 |
Assanelli, A; Baldini, L; Caligaris-Cappio, F; Ferrari, A; Ferreri, AJ; Foppoli, M; Frezzato, M; Frungillo, N; Ilariucci, F; Licata, G; Mappa, S; Marturano, E; Proserpio, I; Reni, M; Sorarù, M; Stelitano, C; Vianello, F | 1 |
Ahn, HS; Kang, HJ; Kim, H; Lee, JW; Park, JD; Park, KD; Shin, HY; Yoon, JH | 1 |
Fukayama, M; Kurokawa, M; Nakamura, F; Takazawa, Y; Uni, M; Yoshimi, A | 1 |
Beppu, K; Kawano, N; Kuriyama, T; Marutsuka, K; Ono, N; Shimao, Y; Ueda, A; Ueda, Y; Yamashita, K; Yoshida, S | 1 |
Abramowsky, CR; Cooper, TM; Summers, RJ | 1 |
Benda, B; Blanco, R; Bradley, J; Burmester, GR; Charles-Schoeman, C; Gruben, D; Koncz, T; Krishnaswami, S; Mebus, C; Soma, K; Wallenstein, G; Wollenhaupt, J; Zerbini, C; Zwillich, SH | 1 |
Goulden, N; Hancock, J; Hough, R; Mitchell, C; Richards, S; Rowntree, C; Vora, A; Wade, R | 1 |
Barraco, D; Candoni, A; Fanin, R; Pirracchio, A; Simeone, E | 1 |
De Groot, K; Fink, CO; Gross, WL; Herlyn, K; Reinhold-Keller, E | 1 |
Baca, S; Bork, D; Calabrese, LH; Choi, HK; Cid, MC; Cohen, P; Dickler, H; Easley, KA; Ferland, D; Fessler, BJ; Flynn, JA; Fortin, P; Gross, W; Guillevin, L; Hellmann, DB; Hernández-Rodríguez, J; Hoffman, DB; Hoffman, GS; Hunder, GG; Kalunian, K; Klashman, D; Kosmorsky, G; Locker, GA; Lopez-Soto, A; Ludivico, C; Luqmani, RA; Mandell, BF; McRorie, E; Merkel, PA; Nuki, G; Prayson, R; Puechal, X; Scheetz, RJ; Schned, E; Schousboe, J; Segal, AM; Sherrer, Y; Sneller, MC; Soubrier, M; Stone, JH; Swanson, H; Tuggle, C; Walsh, B; Wilke, WS | 1 |
Balbir-Gurman, A; Braun-Moscovici, Y; Markovits, D; Militianu, D; Nahir, MA; Rozin, A; Schapira, D | 1 |
Antoni, C; Cursiefen, C; Dechant, C; Grunke, M; Holbach, LM; Jünemann, A | 1 |
Antonopoulos, MJ; Gregoriou, A; Kosmas, C; Malamos, NA; Rokana, S; Stamataki, M; Tsavaris, NB; Vartholomeou, M | 1 |
Chen, MG; Gastineau, DA; Gertz, MA; Inwards, DJ; Kumar, S; Lacy, MQ; Litzow, MR; Tefferi, A; Wolf, RC | 1 |
Nakaseko, C; Nishimura, M; Saito, Y; Uehara, T; Yokota, A | 1 |
Biggs, J; Brooks, P; Cannell, P; Handel, M; Joske, D; Langlands, B; Ma, D; McColl, G; Milliken, S; Moore, J; O'Callaghan, J; Passeullo, F; Rule, S; Snowden, J; Szer, J; Taylor, K; Wicks, I; Will, R | 1 |
Cohen, Y; Daas, N; Gillonb, D; Libster, D; Polliack, A | 1 |
Aschan, J; Barkholt, L; Eriksson, B; Hentschke, P; Holmberg, K; Myrbäck, KE; Remberger, M; Ringdén, O; Svahn, BM | 1 |
Hynan, L; Kamen, BA; Mantadakis, E; Smith, AK; Winick, NJ | 1 |
Chen, HR; Ji, SQ; Liu, J; Wang, HX; Xue, M; Xun, CQ; Yan, HM; Zhu, L | 1 |
Fleig, WE | 1 |
Hoffmann, J; Zeitz, M | 1 |
Encke, J; Erb, G; Flosdorff, P; Ganten, M; Grüber-Hoffmann, B; Hansmann, J | 1 |
Jacobsson, L; Mandl, T | 1 |
Aoki, K; Chiba, S; Goyama, S; Hirai, H; Kanda, Y; Kandabashi, K; Kawazu, M; Komeno, Y; Kurokawa, M; Motokura, T; Nakamoto, T; Nannya, Y; Niino, M; Ogawa, S; Takeshita, M; Tsujino, S | 1 |
Chan, GC; Cheung, AY; Chik, KW; Ha, SY; Lee, AC; Li, CK; Ling, SC; Luk, CW; Shing, MM; Yuen, HL | 1 |
Chang, SK; Hahn, JS; Kim, GE; Kim, YB; Koom, WS; Lee, KK; Park, W; Shim, SJ; Suh, CO; Yang, WI | 1 |
Björk, O; Glomstein, A; Gustafsson, G; Keiding, N; Kristinsson, J; Mäkipernaa, A; Rosthøj, S; Schmiegelow, K; Szumlanski, C; Sørensen, TM; Weinshilboum, R | 1 |
Corbacioglu, S; Eber, S; Gungor, T; Hummerjohann, J; Niggli, F | 1 |
Bañares, A; Fernandez-Gutierrez, B; Hernández-Garcia, C; Jover, JA; Morado, IC; Vargas, E | 2 |
Clarke, M; Gaynon, P; Hann, I; Harrison, G; Masera, G; Peto, R; Richards, S | 1 |
Barron, KS; Langford, CA; Sneller, MC; Talar-Williams, C | 1 |
Alyea, EP; Antin, JH; Cutler, C; Ho, VT; Hochberg, EP; Kim, HT; Lee, SJ; Miklos, DB; Soiffer, RJ; Wu, CJ | 1 |
Gupta, V; Keating, A; Tabak, D | 1 |
Amos Burke, GA; Gerrard, M; Hobson, R; Imeson, J | 1 |
Doolittle, ND; Kraemer, DF; Lacy, C; Neutwelt, EA; Siegal, T; Tyson, RM | 1 |
Kaye, DK | 1 |
Ring, J; Vocks, E; Worret, WI | 1 |
Pariente, A | 1 |
Konrad, A; Seibold, F | 1 |
Al-Meshari, AA; Faiz, SA; Sporrong, BG | 1 |
Fukui, H; Hisatome, I; Miyamoto, M; Ohtahara, A; Okamura, T; Shigamasa, C; Shimizu, H; Shimoyama, M; Taniguchi, S; Ueda, Y; Yamawaki, M | 1 |
Blazek, B; Cerná, Z; Dembická, D; Gajdos, P; Hak, J; Hrstková, H; Hrusák, O; Jabali, Y; Kopecná, L; Mihál, V; Mydlil, J; Pospísilová, D; Procházková, D; Ptoszková, H; Slavík, Z; Starý, J; Timr, P; Trka, J; Vávra, V; Zahálka, F | 1 |
Bahceci, E; Cooper, DL; Seropian, S | 1 |
Alinari, L; Baccarani, M; Stefoni, V; Vianelli, N; Zinzani, PL | 1 |
Lila, AM; Mazurov, VI; Raĭmuev, KV | 1 |
Dekker, AW; Mandigers, CM; Meijerink, JP; Raemaekers, JM; Schattenberg, AV; Verdonck, LF | 1 |
Cimino, L; Finzi, G; Gandolfi, SA; Mora, P; Orsoni, JG; Zavota, L | 1 |
Batinić, D; Bencić, D; Boras, Z; Potocki, K; Smojver, S | 1 |
Khoo, SK | 1 |
Foell, D; Frosch, M; Roth, J; Schulze zur Wiesch, A; Sorg, C; Vogl, T | 1 |
Käser, L; Kolyvanos Naumann, U; Vetter, W | 1 |
de Dios Luna, J; Hidalgo-Tenorio, C; Jiménez-Alonso, J; Martínez-Brocal, A; Sabio, JM; Tallada, M | 1 |
Atsuta, Y; Furukawa, T; Hamajima, N; Hirabayashi, N; Hirai, H; Hiraoka, A; Iseki, T; Iwato, K; Izutsu, K; Kanda, Y; Kasai, M; Kawa, K; Kodera, Y; Maruta, A; Mitsui, H; Okamoto, S; Sakamaki, H | 1 |
Foell, D; Frosch, M; Hammerschmidt, I; Horneff, G; Kuis, W; Roth, J; Schmeling, H; Sorg, C; Wittkowski, H; Wulffraat, N | 1 |
Kang, J; Laibl, V; Takacs, P | 1 |
Bujassoum, S; Lipton, JH; Rifkind, J | 1 |
Hachem, R; Hanna, H; Raad, I | 1 |
Bijlsma, JW; Blaauw, AA; Haanen, HC; Jacobs, JW; Schenk, Y; van Albada-Kuipers, GA; Verstappen, SM | 1 |
Harney, J; Pope, A; Short, SC | 1 |
Ferrero, S; Pretta, S; Ragni, N | 1 |
Job-Deslandre, C; Kahan, A; Sornay-Soares, C | 1 |
Tanaka, R; Yamanaka, R | 1 |
Choi, SJ; Kim, S; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Seol, M | 1 |
Lamb, SR | 1 |
Avramis, V; Douglas, JG; Felgenhauer, J; Geyer, JR; Hawkins, DS; Holcenberg, J; Loken, MR; Meshinchi, S; Park, JR; Thomson, B | 1 |
Acquatella, G; Carneiro, M; García, R; Gómez, R; Hernández, M; Insausti, CL; Nouel, A; Santos, S | 1 |
Dignass, AU; Herrlinger, K; Schölmerich, J | 1 |
Barbera-Guillem, E; Macivor, M; Sampsel, JW | 1 |
Alves, A; Bouhnik, Y; Joly, F; Lavergne-Slove, A; Panis, Y; Pocard, M; Valleur, P | 1 |
Gandhok, N; Sartor, O | 1 |
Berdel, WE; Diehl, V; Dörken, B; Engert, A; Glossmann, JP; Hossfeld, DK; Josting, A; Kirchner, HH; Kisro, J; Mapara, M; Metzner, B; Rudolph, C; Sieber, M; Sienawski, M; Sieniawski, M | 1 |
Chan, CC; Kim, SK; Wallace, DJ | 1 |
Chan, WM; Lam, DS; Liu, DT | 1 |
Beaugerie, L; Bouhnik, Y; Cosnes, J; Etienney, I; Gendre, JP; Lémann, M; Matuchansky, C; Modigliani, R; Rambaud, JC | 1 |
de Groot, K; Gause, A; Gross, WL; Hellmich, B; Metzler, C | 1 |
Barrette, S; Bernstein, ML; Champagne, J; Champagne, MA; Dalle, JH; David, M; Demers, J; Duval, M; Hume, H; Leclerc, JM; Meyer, P; Moghrabi, A; Rousseau, P | 1 |
Matsui, H; Mitsuhashi, A; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N; Yamazawa, K | 1 |
Hasegawa, J; Ichizuka, K; Matsuoka, R; Okai, T; Otsuki, K; Sekizawa, A | 1 |
Gomita, Y; Kawasaki, Y; Moriyama, M; Shibata, K | 1 |
Benchekroun, S; Benhmiddoune, L; Harif, M; Madani, A; Quessar, A; Zafad, S | 1 |
Diaconescu, R; Maloney, DG; Maris, MB; McSweeney, P; Parikh, CR; Sandmaier, BM; Schrier, RW; Sorror, ML; Storb, R; Storer, B | 1 |
Amal, S; Charioui, S; Hocar, O; Houass, S; Jalal, O; Laissaoui, K | 1 |
Balon, J; Bieniaszewska, M; Bieniaszewski, L; Hałaburda, K; Hellmann, A; Pawłowski, R; Piekarska, A; Reichert, M | 1 |
Fenk, R; Germing, U; Graef, T; Haas, R; Hinke, A; Kobbe, G; Neumann, F; Steidl, U; Tapprich, C; Vaupel, M | 1 |
Joseph, K; Kaplan, AP; Marsland, AM; Soundararajan, S | 1 |
Bader, P; Heckl, S; Herrlinger, U; Küker, W; Nägele, T | 1 |
Bonadonna, G; Demicheli, R; Hrushesky, WJ; Miceli, R; Moliterni, A; Retsky, MW; Valagussa, P; Zambetti, M | 1 |
Bacon, PA; De Groot, K; Feighery, C; Gregorini, G; Gross, WL; Jayne, DR; Luqmani, R; Rasmussen, N; Tervaert, JW | 1 |
Karsdorp, VH; van der Weiden, RM | 1 |
Harris, AW; Hayee, BH | 1 |
Barthel, HR; Gille, T; Halbsguth, A; Kramer, M | 1 |
Aries, PM; Reinhold-Keller, E | 1 |
Dienes, HP; Kruis, W; Lanyi, B | 1 |
Dahl, GV; Donaldson, SS; Dvorak, CC; Razzouk, BI; Sanders, RP | 1 |
Danilatou, V; Kalmanti, M; Mantadakis, E; Papadhimitriou, S; Paterakis, G; Stiakaki, E | 1 |
Im, YH; Jung, CW; Kang, JH; Kang, WK; Kim, K; Kim, WS; Ko, YH; Lee, J; Lee, MH; Lee, SH; Park, BB; Park, JO; Park, K; Park, KW; Park, YS | 1 |
McClain, KL; Shah, MD | 1 |
Barfield, RC; Behm, FG; Burnette, K; Eldridge, P; Hale, GA; Handgretinger, R; Knapp, K | 1 |
Coombes, RC; Ford, HT; Gazet, JC; Gray, R; Lowndes, S; McConkey, CC; Quilliam, J; Sutcliffe, R | 1 |
Gross, WL; Hellmich, B; Lamprecht, P | 1 |
Androutsos, G; Athanassiadou, F; Papadhimitriou, SI; Paterakis, GS; Polychronopoulou, S; Tsakiridou, AA | 1 |
Armendariz, H; Creutzig, U; Fleischhack, G; Kaspers, GJ; Reinhardt, D; Stark, B; Zimmermann, M; Zwaan, CM | 1 |
Carter, TB; Dansby, LM; Diskin, C; Graves, A; Graves, E; Radcliff, L | 1 |
Lange, B | 1 |
Au, WY; Cheng, VC; Hon, C | 1 |
Martin, P; Potter, JD; Robien, K; Schubert, MM; Storb, R; Ulrich, CM; Yasui, Y | 1 |
Doyle, JJ; Marshall, GA | 1 |
Abreu, MT; Cohen, R; Lichtenstein, GR; Tremaine, W | 1 |
Fayers, PM; Groenvold, M; Mouridsen, HT; Petersen, MA | 1 |
Blake, M; Broxson, E; Gaynon, PS; Heerema, NA; Hutchinson, R; Kelleher, JF; La, M; Lindemulder, S; Masterson, M; Matloub, Y; Nachman, J; Sather, H; Sorrell, AD; Stork, LC; Wells, LM; Yanofsky, R | 1 |
Alessandrino, PE; Bacigalupo, A; Barisione, G; Bosi, A; Bruno, B; Bruzzi, P; di Bartolomeo, P; Guidi, S; Lamparelli, T; Oneto, R; Sacchi, N; van Lint, MT | 1 |
Bo, J; DA, WM; Li, HH; Wang, QS; Wang, SH; Wu, XX; Yu, L; Zhao, Y | 1 |
Bouhala, M; Dukic, R; Hueber, M; Kieffer, C; Kieffer, P; Riegel, P; Wilhelm, JM | 1 |
Chan, GC; Cheuk, DK; Chiang, AK; Ha, SY; Lau, YL; Shek, TW | 1 |
Iida, H; Kitaori, K; Kohno, A; Matsuo, K; Morishita, Y; Ozeki, K; Sakamaki, H; Sao, H; Yokozawa, T | 1 |
Anderlini, P; Champlin, RE; Couriel, D; de Lima, M; Giralt, S; Hosing, C; Khouri, IF; Korbling, M; Lekakis, L; Martin, T; Shpall, EJ | 1 |
Bensinger, W | 1 |
Alonso Ojembarrena, A; Contra Gómez, T; Díaz Pérez, MA; García Castro, J; González-Vicent, M; Madero López, L; Pérez Martínez, A; Ramírez Orellana, M | 1 |
Barde, C; Saurat, JH; Thielen, AM | 1 |
Harper, JI; Howell, KJ; Sampaio, MC; Visentin, MT; Weibel, L; Woo, P | 1 |
Papp, KA; Rosoph, L; Toth, D | 1 |
Agrawal, RK; Bathers, S; Brunt, AM; Crawford, SM; Dunn, JA; Earl, HM; Fernando, IN; Foster, L; Grieve, RJ; Harvey, P; Hiller, L; Leonard, RC; Mansi, JL; McAdam, K; O'Reilly, SM; Poole, CJ; Rea, DW; Simmonds, P; Spooner, DA; Stanley, A; Twelves, CJ | 1 |
Evans, WE; Pui, CH; Relling, MV | 1 |
Chuma, M; Harabayashi, T; Higashiyama, H; Hige, S; Nonomura, K; Shinohara, N | 1 |
Clarke, LE; Goldfeder, KL; James, WD; Katz, KA; Levin, JM; Loren, AW | 1 |
Inamura, K; Kakuta, K; Matano, S; Munemoto, S; Nishijima, H; Okamura, T; Satoh, S; Sugimoto, T | 1 |
Herring, RA; Lee, DA; McClain, KL; Tatevian, N | 1 |
Devidas, M; Ge, Y; Haska, CL; LaFiura, K; Linda, SB; Liu, M; Matherly, LH; Taub, JW; Thomas, R | 1 |
Anagnostopoulos, I; Kiewe, P; Korfel, A; Loddenkemper, C; Reinwald, M; Thiel, E | 1 |
Degée, S; Dricot, JF; Dubois, M; Foidart, JM; Lamborelle, S; Nisolle, M | 1 |
Chen, H; Han, W; Huang, XJ; Liu, DH; Liu, KY; Xu, LP | 1 |
Guillevin, L; Guilpain, P; Pagnoux, C | 1 |
Kiilholma, P; Kortekangas-Savolainen, O | 1 |
Jayne, D | 1 |
Cardot, N; Italiano, A; Peyrade, F; Soler, C; Thyss, A | 1 |
Bergamaschi, R; Bogdanov, EI; Mikhaylov, IM; Moglia, A; Pichiecchio, A; Ravaglia, S | 1 |
Digumarti, R; Rajappa, SJ; Uppin, SG | 1 |
Chiusolo, P; Farina, G; Fianchi, L; Fiorini, A; La Torre, G; Laurenti, L; Leone, G; Mannocci, A; Palladino, M; Reddiconto, G; Sica, S; Sorà, F | 1 |
Fujishima, M; Fujishima, N; Hirokawa, M; Inomata, M; Kameoka, Y; Saitoh, H; Saitoh, K; Sawada, K; Takahashi, N; Yamanaka, Y; Yoshioka, T | 1 |
de Groot, K; Gross, WL; Hellmich, B; Iking-Konert, C; Manger, K; Metzler, C; Miehle, N; Reinhold-Keller, E | 1 |
Ardern-Jones, M; Bateman, EA; Ogg, GS | 1 |
Brackstone, M; Chambers, AF; Townson, JL | 1 |
Alonso, C; Altés, A; Baiget, M; Barnadas, A; Del Rio, E; Paré, L; Ramón y Cajal, T; Sedano, L | 1 |
Ansell, W; Asterling, S; Berney, D; Joel, SP; Liu, S; Mutsvangwa, K; Oliver, RT; Powles, T; Shamash, J; Stebbing, J; Wilson, P; Wyatt, P | 1 |
Fernández-Gutiérrez, B; Hernández-García, C; Jover, JA; Lavalley, MP; Mahr, AD; Merkel, PA; Spiera, RF | 1 |
Blanche, S; de Saint Basile, G; Fischer, A; Mahlaoui, N; Neven, B; Ouachée-Chardin, M; Picard, C | 1 |
Cole, PD; Drachtman, RA; Drapala, DA; Glod, J; Kamen, BA; Lisi, S; Masterson, M; Smith, AK; Zebala, JA | 1 |
Bacon, P; Carruthers, D; Chakravarty, K; D'Cruz, D; Guillevin, L; Harper, L; Jayne, D; Lapraik, C; Luqmani, R; Mooney, J; Scott, D; Watts, R | 1 |
Chaperon, J; Coustans, M; Edan, G; Le Page, E; Leray, E; Morrissey, SP; Taurin, G | 1 |
Gupta, R; Gupta, S | 1 |
Carey, J; Clark, TM; Gomes, M; Hoffman, GS; Karafa, MT; Langford, CA; Mascha, E; Roberson, G; Villa-Forte, A | 1 |
Dyer, JA; Guitart, J; Klein-Gitelman, M; Mancini, AJ | 1 |
Ardoin, SP; Jaffe, GJ; Kredich, D; Rabinovich, E; Schanberg, LE | 1 |
Fibbe, WE; Huijgens, PC; Lugtenburg, PJ; van 't Veer, MB; van Imhoff, GW; van Oers, MH; van Putten, WL; Vellenga, E; Verdonck, LF; Wijermans, PW; Zijlstra, JM | 1 |
Joseph, M; Layden, BT; Platanias, LC; Tallman, MS | 1 |
Bührer, C; Fengler, R; Hartmann, R; Henze, G; Janka-Schaub, G; Klingebiel, T; Mann, G; Ratei, R; Reiter, A; Ritter, J; Schmiegelow, K; von Stackelberg, A | 1 |
Gaynon, PS; La, MK; Malempati, S; Sather, H; Stork, LC | 1 |
Avilés, A; Castañeda, C; Cleto, S; Gonzalez, M; Huerta-Guzmán, J; Nambo, MJ; Neri, N | 1 |
Baleydier, A; Baron, G; Breban, M; Chary-Valckenaere, I; Claudepierre, P; Combe, B; Dougados, M; Euller-Ziegler, L; Fautrel, B; Fournié, B; Gaudin, P; Henry, YD; Hudry, C; Jousse, S; Le Loët, X; Marcelli, C; Mariette, X; Perdriger, A; Pham, T; Ravaud, P; Solau-Gervais, E; Trape, G; Wendling, D | 1 |
Anal, O; Durak, I; Gunes, D; Makay, B; Ozbek, Z; Ozer, E; Unsal, E | 1 |
Depla, JA; Van Calster, J | 1 |
Hasegawa, Y; Izutsu, K; Kawa, K; Kim, WS; Kwong, YL; Nakamura, S; Okamura, T; Oshimi, K; Suzuki, R; Suzumiya, J; Yamaguchi, M | 1 |
Alegre de Miguel, V; Martínez Casimiro, L; Sánchez Carazo, JL | 1 |
Dietze, O; Filipits, M; Gnant, MF; Greil, R; Grill, R; Huynh, A; Jakesz, R; Kwasny, W; Lax, S; Lehnert, M; Rudas, M; Schippinger, W; Singer, C; Stierer, M; Stiglbauer, W | 1 |
Fujimoto, J; Kikuchi, A; Kumagai, M; Mori, T; Okimoto, Y; Sunami, S; Tsuchida, M | 1 |
Abromowitch, M; Bowman, WP; Chen, CH; Crom, WR; Evans, WE; Simone, JV; Stewart, CF | 1 |
Jacobs, C; Mead, GM | 1 |
Bleehen, NM | 1 |
Bertino, J; Cadman, E; Farber, L; Fischer, D; Spiro, P; Todd, M; Waldron, J | 1 |
Helbig, W; Kubel, M; Schultze, W; Schwenke, H | 1 |
Jansen, J; Zwaan, FE | 1 |
Goodyear, MD; Mackay, IR; Penschow, J; Riglar, C | 1 |
Barnwell, R; Berard, CW; Edwards, BK; Jaffe, ES; Janus, C; Magrath, IT; Miliauskas, J; Morris, K; Spiegel, R | 1 |
Cadman, EC; Cross, J; Glick, JH; Horton, J; Taylor, SG | 1 |
Dörffel, W; Grulich, M; Reuter, G | 1 |
Tricot, G; Van Hoof, A; Verwilghen, RL | 1 |
Barber, SW; Camitta, BM; Casper, JT; Kamen, BA; Kaplan, BM; Kline, RW; Kun, LE; Lauer, SJ; Mulhern, RK | 1 |
Bidlingmaier, F; Haas, RJ; Helmig, M; Janka, GE; Mack, R | 1 |
Chessells, J; Leiper, A; Rogers, D | 1 |
Abbrederis, K; Grünewald, K | 1 |
Chessells, JM; Sandland, RM; Tiedemann, J | 1 |
Creutzig, U; Schellong, G | 1 |
Herson, J; Kimball, JC; Sullivan, MP | 1 |
Freeman, AI; Sinks, LF; Wang, JJ | 1 |
Aherne, W; Craft, AW; Rankin, A | 1 |
Bodey, GP; Freireich, EJ; Keating, MJ; McCredie, KB; Yap, BS | 1 |
Baba, Y; Hoshizaki, H; Niki, Y | 1 |
Bates, TS; Brinkley, D; Edelstyn, GA; Evans, RG; Kitchen, G; MacRae, KD; Nicol, NT; Spittle, M; Wheeler, TK | 1 |
Debanne, SM; Eckert, C; Flynn, WJ; Hermann, RE; Hubay, CA; Jones, JC; Mansour, EG; Marshall, JS; McGuire, WL; Pearson, OH; Rhodes, RS | 1 |
Armstrong, RB; Poh-Fitzpatrick, MB | 1 |
Barnes, S; Bleyer, WA; Poplack, DG; Riccardi, R; Vigersky, RA | 1 |
Bodey, GP; Cabanillas, F; Freireich, EJ; Hagemeister, FB | 1 |
Clark, GM; Knight, WA; McGuire, WL; Osborne, CK | 1 |
Grundsell, H; Johnsson, JE; Mattsson, W; Tropé, C | 1 |
Kuboyama, K; Maruo, K; Shido, T; Yokoe, K; Yoshikawa, H | 1 |
Aramini, L; Martini, A; Ramenghi, B; Ravelli, A; Ruperto, N; Viola, S | 1 |
Bernard, JP; Lécuru, F; Taurelle, R; Vildé, F | 1 |
Callen, JP; Roth, DJ; Williams, BJ | 1 |
Eiermann, W; Harbeck, N; Pache, L; Untch, M | 1 |
Battin, M; Chessells, J; Christie, D; Leiper, AD; Neville, BG; Vargha-Khadem, F | 1 |
Demetri, GD; Kaplan, WD; Salgia, R | 1 |
Glomstein, A; Gustafsson, G; Kristinsson, J; Salmi, T; Schmiegelow, K; Schrøder, H; Wranne, L | 1 |
Anteby, SO; Meirow, D; Reubinoff, BE; Tanos, V | 1 |
Heinz, R; Hopfinger, G; Koller, E; Pittermann, E; Schneider, B | 1 |
Bleyer, A | 1 |
Aricò, M; Basso, G; Colella, R; Conter, V; Messina, C; Miniero, R; Mori, PG; Rizzari, C; Testi, AM; Valsecchi, MG | 1 |
Chan, GL; Vijayanagar, RR; Weinstein, SS | 1 |
Eviatar, L; Grossman, R; Karayalycin, G; Lanzkowsky, P; Maytal, J; Schaul, N; Shende, AC; Yusuf, FH | 1 |
Arnold, R; Bunjes, D; Duncker, C; Heimpel, H; Heit, W; Hertenstein, B; Novotny, J; Stefanic, M; Wiesneth, M | 1 |
Abromowitch, M; Ayers, GD; Behm, FG; Pui, CH; Roberson, PK; Sandlund, JT; Santana, VM | 1 |
Hagemeister, FB | 1 |
Hattori, N; Kaya, H; Matano, S; Mochizuki, Y; Nakamura, S; Okabe, Y; Okumura, H; Otake, S; Takeshima, M; Yoshida, T | 1 |
Andersson, BS; Bellare, N; Gajewski, JL; Giralt, SA; Khouri, IF; McCarthy, P; Mehra, R; Nath, R; Przepiorka, D; van Besien, KW | 1 |
Hołowiecki, J; Kachel, L; Krawczyk, M; Krzemień, S; Rudzka, E; Wojnar, J | 1 |
Fauci, AS; Hallahan, CW; Hoffman, GS; Kerr, GS; Sneller, MC; Talar-Williams, C | 1 |
Kadin, M; Kersey, JH; King, D; Krailo, MD; Meadows, AT; Morse, M; Rosenstock, J; Steinherz, PG; Tubergen, DG | 1 |
Fenaux, P | 1 |
Crist, WM; Hancock, ML; Hudson, M; Kun, L; Mahmoud, H; Mulhern, RK; Pui, CH; Ribeiro, RC; Rivera, GK; Sandlund, JT | 1 |
Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW | 1 |
Barraclough, B; Boyages, J; Langlands, AO; Ung, O | 1 |
Stark, ME; Tremaine, WJ | 1 |
Aglietta, M; Bondesan, P; Caracciolo, D; Falda, M; Gallo, E; Gavarotti, P; Locatelli, F; Novarino, A; Paolino, F; Sanavio, F | 1 |
Fauci, AS; Hoffman, GS; Kerr, GS; Leavitt, RY; Rottem, M; Sneller, MC | 1 |
Welborn, JL | 1 |
Abla, O; Arcese, W; Boni, L; Di Bartolomeo, P; Dini, G; Iori, AP; Locatelli, F; Polchi, P; Rossetti, F; Uderzo, C | 1 |
Fujii, K; Fukuda, A; Imamura, S; Matsuyoshi, N; Mizuno, K; Okamoto, H | 1 |
Favre, H; Lemoine, R; Miescher, PA | 1 |
Aschan, J; Ljungman, P; Lönnqvist, B; Markling, L; Remberger, M; Ringden, O | 1 |
Kamen, BA; Weitman, SD; Winick, NJ | 1 |
Khalil, AM; Mroueh, AM; Salem, ZM; Tabbal, SD; Yamout, BI | 1 |
Ito, H; Kimura, Y; Nakamura, H; Nomura, N; Otaka, M; Sakai, N; Shirota, T; Suzuki, A; Toyama, K; Uchida, H | 1 |
Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Parker, PM; Smith, EP; Snyder, DS; Stein, AS | 1 |
Hirose, M; Kuroda, Y; Ninomiya, T; Okamoto, Y; Sano, T; Takahashi, Y; Ushiroguchi, Y; Watanabe, T | 1 |
Baxter, JD; DiNubile, MJ | 1 |
Almeida, MT; Britto, JL; Cristofani, LM; Maksoud, JG; Maluf, PT; Manissadjian, A; Odone Filho, V; Pontes, E | 1 |
Chan, LC; Chan, TK; Chiu, EK; Kwong, YL; Liang, R; Lie, A; Todd, D | 1 |
Berretty, PJ; Ideler, AH; Schoon-Blaauw, GH; Tan-Go, I | 1 |
Abe, A; Kato, H; Matsuoka, A; Matsushita, T; Tahara, T; Takeo, T; Towatari, M; Toyozumi, H; Yamamoto, K; Yamazaki, T | 1 |
Gadner, H; Gatterer-Menz, I; Grois, N; Heitger, A; Ladisch, S | 1 |
Arlt, I; Bührer, C; Fengler, R; Hartmann, R; Henze, G; Loewke, M; Schober, S | 1 |
Beck, O; Björk, O; Hayder, S; Peterson, C; Skoglund, KA; Söderhäll, S; Wennberg, M | 1 |
Arcese, W; Bandini, G; Bosi, A; Carreras, E; Frassoni, F; Gahrton, G; Gratwohl, A; Hermans, J; Niederwieser, D; Vernant, JP | 1 |
Champagne, J; Dresse, MF; Infante-Rivard, C; Leclerc, JM; Rivard, GE | 1 |
Chardonnens, E; De Grandi, P; Delaloye, JF; Spuhler, S | 1 |
Ashida, T; Ayabe, T; Maekawa, I; Namiki, M; Shibata, Y; Taruishi, M | 1 |
Bari, M; Bruscagnin, G; Gatti, C; Gion, M; Leon, AE; Mione, R; Nascimben, O; Pappagallo, GL; Vinante, O | 1 |
Helmchen, C; Samtleben, W; Terjung, B | 1 |
Goldman, J; Morleda, J; Mughal, T | 1 |
Barnett, MJ; Dhaliwal, HS; Gallagher, CJ; Ganesan, TS; Gregory, W; Johnson, PW; Matthews, J; Richards, MA; Rohatiner, AZ; Whelan, JS | 1 |
Appelbaum, FR; Bakke, L; Bensinger, WI; Bianco, JA; Bowden, RA; Buckner, CD; Clift, RA; McDonald, GB; Schubert, M; Singer, JW | 1 |
Amylon, MD; Chao, NJ; Dagis, AC; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Schmidt, GM | 1 |
Aurer, I; Bogdanić, V; Kovacević-Metelko, J; Labar, B; Maravić, N; Mrsić, M; Nemet, D; Radman, I; Zupancić-Salek, S | 1 |
Clavell, LA; Cohen, HJ; Dalton, V; Donnelly, M; Gelber, RD; Sallan, SE; Tarbell, NJ; Tobia, F | 1 |
Anderson, JR; Armitage, JO; Bierman, P; Bishop, MR; Cowles, MK; Kessinger, A; Martin-Algarra, S; Reed, E; Tarantolo, S; Vose, JM | 1 |
Guzzo, C; Kaidby, K | 1 |
Anasetti, C; Anderson, JE; Appelbaum, FR; Bensinger, WI; Bryant, E; Buckner, CD; Chauncey, T; Clift, RA; Gooley, T; Schoch, G | 1 |
Huikuri, HV; Kettunen, R; Oikarinen, A; Takkunen, JT | 1 |
Kuijpers, AL; Termorshuizen, F; van de Kerkhof, PC; van Dooren-Greebe, RJ | 1 |
Annino, L; Mandelli, F; Rotoli, B | 1 |
De Vaan, GA; Hählen, K; Kamps, WA; Solbu, G; Suciu, S; Van der Does-Van der Berg, A; Van Leeuwen, EF; Van Wering, ER; Veerman, AJ | 1 |
Amadori, S; Bendandi, M; Falini, B; Gherlinzoni, F; Mandelli, F; Martelli, M; Martelli, MF; Pileri, SA; Sabattini, E; Tura, S; Zinzani, PL | 1 |
Bessell, EM; Firth, JL; Graus, F; Hope, DT; Lopez-Guillermo, A; Moloney, AJ; Punt, JA; Villa, S | 1 |
Blakley, RL; Chunduru, SK; Pui, CH; Sleep, SE; Sorrentino, BP; Spencer, HT | 1 |
Bohrer, MK; Kemmann, E; Qasim, SM | 1 |
Okamura, J; Tsuruchi, N | 1 |
Morland, BJ; Shaw, PJ | 1 |
Horton, C; Mehta, J; Meller, S; Pinkerton, CR; Powles, R; Singhal, S; Tait, D; Treleaven, J | 1 |
Teitel, AD | 1 |
Bijlsma, JW; Dinant, HJ; van Albada-Kuipers, GA; van Booma-Frankfort, C; van der Veen, MJ | 1 |
Atkinson, K; Downs, K | 1 |
Chamiot-Prieur, C; Colombel, JF; Gendre, JP; Halphen, M; Lémann, M; Mesnard, B; Messing, B; Modigliani, R; Rambaud, JC | 1 |
Borowitz, M; Bowman, WP; Buchanan, GR; Farrow, A; Jacaruso, D; Kamen, BA; Shuster, JJ; Winick, N | 1 |
Raez, LE; Saldana, M; Temple, JD | 1 |
Kramer, N; Leitner, SP; Michaelson, RA; Rosenstein, ED | 1 |
Hicke, A; Sońta-Jakimczyk, D; Tomaszewska, R; Wieczorek, M | 1 |
Bacigalupo, A; Fiere, D; Frassoni, F; Gluckman, E; Gorin, NC; Harrousseau, JL; Jouet, JP; Labopin, M; Reiffers, J; Ringdén, O; Vernant, JP | 1 |
Cher, L; Glass, J; Gruber, ML; Hochberg, FH; Shustik, C | 1 |
Graczykowski, JW; Mishell, DR | 1 |
Lerner, JP; Monteagudo, A; Tarricone, NJ; Timor-Tritsch, IE | 1 |
Beck, L; Marwaha, S; Morison, WL | 1 |
Behringer, D; Fetscher, S; Finke, J; Kanz, L; Lange, W; Lübbert, M; Mertelsmann, R | 1 |
Gomi, K; Izuno, I; Oguchi, M; Sasaki, S; Shikama, N; Sone, S; Takei, K | 1 |
Costanzo, MR; Fisher, SG; Heroux, AL; Johnson, MR; Kao, WG; Koch, DM | 1 |
Gullestad, L; Hunt, SA; Pak, J; Ross, HJ; Slauson, S; Valantine, HA | 1 |
Ariad, S; Flusser, D; Sukenik, S | 1 |
Hanada, R; Hongo, T; Horikoshi, Y; Sakurai, M; Yajima, S | 1 |
Connors, JM; Gascoyne, RD; Klimo, P; Lee, AY; O'Reilly, SE | 1 |
Breedveld, FC; Dijkmans, BA; Hermans, J; ten Wolde, S | 1 |
Beller, U; Ben-Chetrit, A; Neuman, M; Rabinowitz, R; Ravhon, A | 1 |
Hausen, B; Morris, RE | 1 |
Adams, PT; Jacobson, P; Ratanatharathorn, V; Scalzo, A; Silver, SM; Uberti, JP | 1 |
Jacobsen, G; Lindqvist, B; Moe, PJ; Nygaard, R; Seidel, H; Slørdal, L | 1 |
Boyett, JM; Evans, WE; Pui, CH; Relling, MV | 1 |
Amylon, M; Buck, S; Camitta, B; Ekizian, R; Matherly, LH; Pullen, J; Ravindranath, Y; Simpson, PM; Taub, JW; Williamson, M; Wong, SC | 1 |
Jonas, A; Padeh, S; Passwell, JH; Theodor, R | 1 |
Aricó, M; Basso, G; Conter, V; Dördelmann, M; Ludwig, WD; Masera, G; Reiter, A; Riehm, H; Rizzari, C; Schrappe, M; Valsecchi, MG; Zimmermann, M | 1 |
Hallahan, D; Mundt, AJ; Williams, SF | 1 |
Becker, W; Göbel, D; Gratz, S; von Rothkirch, T; Willert, HG | 1 |
Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Chauncey, T; Clift, R; Deeg, HJ; Doney, K; Flowers, ME; Hansen, JA; Leisenring, W; Martin, P; Pepe, M; Pettinger, M; Sanders, J; Storb, R; Sullivan, KM; Thomas, ED; Witherspoon, R | 1 |
Jaffe, IA | 1 |
Gottlieb, BS; Ilowite, NT; Keenan, GF; Lu, T | 1 |
Azuma, E; Higashigawa, M; Hirayama, M; Hori, H; Ido, M; Kawasaki, H; Sakurai, M | 1 |
Arber, N; Becker, S; Broide, E; Eliakim, R; Fich, A; Gilat, T; Keter, D; Lavy, A; Moshkowitz, M; Odes, S; Oren, R; Patz, J; Pomeranz, I; Reisfeld, I; Shirin, C; Shirin, H; Villa, Y | 1 |
Connors, JM; Gascoyne, RD; Hoskins, PJ; Klasa, R; Le, N; O'Reilly, S; Shenkier, T | 1 |
Bleyer, WA; Breneman, JC; Cherlow, JM; Gaynon, PS; Grossman, NJ; Johnstone, HS; Kersey, JH; Sather, HN; Steinherz, PG; Trigg, ME; Uckun, FM | 1 |
Bitran, JD; Grad, G; Grinblatt, DL; Laport, GF; Williams, SF | 1 |
Hirabayashi, N; Ikeda, Y; Ishida, A; Matsuoka, S; Moriki, T; Okamoto, S; Wakui, M; Watanabe, R | 1 |
Bacigalupo, A; Berisso, G; Bregante, S; De Stefano, F; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Occhini, D; Soracco, M; Van Lint, MT; Vitale, V; Zikos, P | 1 |
Chan, GC; Chan, LC; Chiu, DC; Ha, SY; Lau, YL; Ma, SK | 1 |
Kaufman, SS; Mack, DR; Ramey, L; Vanderhoof, JA; Young, R | 1 |
Karokis, D; Kitas, GD; Raza, K | 1 |
Behm, FG; Evans, WE; Hancock, ML; Head, DR; Kun, LE; Mahmoud, HH; Pui, CH; Relling, MV; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sandlund, JT | 1 |
Behm, FG; Borowitz, MJ; Carroll, AJ; Harris, MB; Land, VJ; Pullen, DJ; Shuster, JJ | 1 |
Antin, JH; Avalos, B; Buell, DN; Christiansen, NP; Devine, SM; Fay, JW; Fitzsimmons, WE; Herzig, RH; Karanes, C; Klein, JL; Litzow, MR; Longo, WL; Maher, RM; Nademanee, A; Nash, RA; Petersen, FB; Przepiorka, D; Ratanatharathorn, V; Storb, R; van der Jagt, R; Weisdorf, D; Wingard, JR; Wolff, SN | 1 |
Bessell, EM; Byrne, JL; Haynes, AP; Hyde, H; Miflin, G; Russell, NH; Stainer, C | 1 |
Dubost, JJ; Sauvezie, B; Soubrier, M | 1 |
Ames, MM; Balis, FM; Bleyer, WA; Ge, J; Gilchrist, GS; Holcenberg, JS; Murphy, RF; Poplack, DG; Sather, HN; Tubergen, DG; Waskerwitz, MJ; Zimm, S | 1 |
Adam, Z; Hájek, R; Hejlová, N; Klabusay, M; Korístek, Z; Krahulcová, E; Král, Z; Mayer, J; Müllerová, I; Navrátil, M; Penka, M; Tomíska, M; Vásová, I; Vodvárka, P; Vorlícek, J | 1 |
Furness, M; Pachulicz, M; Petrucco, O; Wilkinson, C | 1 |
Sungurtekin, U; Uyar, Y | 1 |
Blom, J; Kaplan, SS; Rybka, WB; Shekhter-Levin, S | 1 |
Adamson, PC; Balis, FM; Gillespie, AJ; Moser, AM; Poplack, DG | 1 |
Bauters, F; Detourmignies, L; Dupriez, B; Fenaux, P; Jouet, JP; Morel, P; Plantier-Colcher, I; Simon, M | 1 |
Baert, F; D'Haens, G; Rutgeerts, P; Vandeputte, L | 1 |
Bailey, CC; Gattamaneni, HR; Lashford, LS; Lewis, IJ; Michelagnoli, MP | 1 |
Chellam, VG; James, FV; Kusumakumary, P; Nair, MK; Ratheesan, K | 1 |
Bock, E; Herborn, G; Rau, R; Sander, O | 1 |
Bonadonna, G; Brambilla, C; Demicheli, R; Ferrari, L; Miceli, R; Moliterni, A; Valagussa, P; Zambetti, M | 1 |
Hanauer, SB; Stein, RB | 1 |
Basara, N; Basu, O; Beelen, DW; Blau, IW; Bornhäuser, M; Ehninger, G; Fauser, AA; Hägglund, H; Hölig, K; Remberger, M; Ringdén, O; Runde, V | 1 |
Carter, JL; Cohen, JA; Kinkel, RP; Schwid, SR | 1 |
Algara, P; Díaz, MA; Madero, L; Martínez, P; Tutor-Ureta, O | 1 |
Martini, A; Migliavacca, D; Pistorio, A; Ravelli, A; Ruperto, N; Viola, S | 1 |
Aguayo, A; Cortes, J; Kantarjian, H; Keating, M; Pierce, S; Thomas, D | 1 |
Matherly, LH; Taub, JW | 1 |
Anderlini, P; Andersson, BS; Braunschweig, I; Champlin, R; Chan, KW; Claxton, D; Cleary, K; Donato, M; Fischer, H; Gajewski, J; Giralt, S; Ippoliti, C; Khouri, I; Körbling, M; Mehra, R; Przepiorka, D; Ueno, NT; van Besien, K | 1 |
Amylon, MD; Blume, KG; Chao, NJ; Dagis, AC; Forman, SJ; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Ross, M; Schmidt, GM; Smith, EP; Snyder, DS; Stein, AS; Wong, RM | 1 |
Fridrik, M; Gnant, M; Haider, K; Hausmaninger, H; Jakesz, R; Kolb, R; Kubista, E; Manfreda, D; Mittlböck, M; Mlineritsch, B; Samonigg, H; Steger, G; Steindorfer, P; Stierer, M; Tschurtschenthaler, G | 1 |
Bonadonna, G; Ferreri, AJ; Giardini, R; Rampinelli, I; Siracusano, L; Tondini, C; Valagussa, P | 1 |
Antonello, RM; Bragadin, LM; Cazzato, G; De Masi, R; Moretti, R; Nasuelli, D; Torre, P; Zivadinov, R; Zorzon, M | 1 |
Barenbrock, M; Berdel, WE; Dietrich, M; Kisters, K; Matzkies, FK; Rahn, KH; Schaefer, RM; Tombach, B | 1 |
Hibi, S; Hojo, M; Imashuku, S; Kajimoto, H; Naya, M | 1 |
Feldman, BM; Krafchik, BR; Laxer, RM; Uziel, Y; Yeung, RS | 1 |
Cobellis, L; De Lucia, E | 1 |
Bergeron, C; Brugières, L; Delsol, G; Hartmann, O; Landmann, J; Le Deley, MC; Pacquement, H; Patte, C; Perel, Y; Quartier, P; Schmitt, C; Terrier-Lacombe, MJ | 1 |
Ascari, E; Avanzini, P; Baldini, L; Broglia, C; Ghirardelli, ML; Gobbi, PG; Loni, C; Quarta, G; Silingardi, V; Stelitano, C | 1 |
Bessho, F; Hanada, R; Hoshi, Y; Hosoya, R; Ikuta, K; Ishimoto, K; Kaneko, T; Koike, Ki; Maeda, M; Manabe, A; Mori, T; Nakazawa, S; Ohara, A; Ohkawa, Y; Okimoto, Y; Saito, T; Sato, T; Shitara, T; Toyoda, Y; Tsuchida, M; Tsunematsu, Y | 1 |
Ansaloni, L; Bazzocchi, R; Bini, A; Grazia, M; Stella, F; Zompatori, M | 1 |
Feagan, BG; Fedorak, RN; Greenberg, GR; Hanauer, SB; Hopkins, M; Irvine, EJ; Koval, J; McDonald, JW; Steinhart, AH; Sutherland, L; Wild, G; Wong, CJ | 1 |
al-Ghamdi, H; Martin, J; Patay, Z; Sabbah, R | 1 |
Henze, G; Janka-Schaub, GE; Jansen, G; Noordhuis, P; Peters, GJ; Pieters, R; Rots, MG; Van Zantwijk, CH; Veerman, AJ | 1 |
Lémann, M | 1 |
Bacal, F; Bellotti, G; Bocchi, EA; Fiorelli, AI; Ramires, JA; Stolf, NA; Veiga, VC | 1 |
Cazals-Hatem, D; Chevret, S; Clauvel, JP; Dubreuil, ML; Gerard, L; Levy, Y; Matheron, S; Oksenhendler, E | 1 |
Elonen, E; Juvonen, E; Parkkali, T; Ruutu, T; Volin, L | 1 |
Chakrabarti, S; Chakraverty, RK; Chopra, R; de Elvira, MC; Devereux, S; Goldstone, AH; Hale, G; Kottaridis, PD; Linch, DC; Mackinnon, S; Mahendra, P; Marsh, JC; Milligan, DW; Morgan, GJ; Peggs, K; Pettengell, R; Robinson, S; Schey, S; Verfuerth, S; Waldmann, H; Williams, CD | 1 |
Jansen, G; Kaspers, GJ; Peters, GJ; Pieters, R; Rots, MG; Veerman, AJ | 1 |
Anami, K; Asami, K; Fujimoto, T; Horikoshi, Y; Iwai, A; Katano, N; Kawano, Y; Kikuchi, M; Kikuta, A; Koizumi, S; Matsushita, T; Miyake, M; Mugishima, H; Sekine, I; Tsurusawa, M; Watanabe, A; Yamamura, Y | 1 |
Roseau, E | 1 |
Khan, AJ; Marghoob, AA; Prestia, AE; Spector, IJ | 1 |
Egan, LJ; Lipsky, JJ; Mays, DC; Sandborn, WJ; Tremaine, WJ | 1 |
Dinney, CP; Inoue, K; Karashima, T; Millikan, R; Shuin, T; Slaton, JW; Sweeney, P; Yoshikawa, C | 1 |
Arbel-Alon, S; Glezerman, M; Golan, A; Sagiv, R | 1 |
Cortes, J | 1 |
Carmichael, AJ; Griffiths, CE; Kirby, B; Marsland, AM | 1 |
Cantú, OG; Gómez-Almaguer, D; González-Llano, O; Jaime-Pérez, JC; Ruiz-Argüelles, A; Ruiz-Argüelles, GJ | 1 |
Binymin, K; Cooper, RG | 1 |
Kaklamani, VG; Kaklamanis, PG | 1 |
Dignass, A; Roznowski, AB | 1 |
Auperin, A; Behrendt, H; Coze, C; Frappaz, D; Leverger, G; Lutz, P; Michon, J; Patte, C; Perel, Y; Raphaël, M; Terrier-Lacombe, MJ | 1 |
Basara, N; Bischoff, M; Blau, W; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Römer, E; Schmetzer, B | 1 |
Rutgeerts, PJ | 1 |
Dallay, D; Hopirtean, V; Jourdain, O; Saint-Amand, H | 1 |
Go, RS; Li, CY; Phyliky, RL; Tefferi, A | 1 |
Aurlien, E; Holte, H; Jakobsen, E; Kvalheim, G; Kvaløy, S; Rusten, LS | 1 |
Daniel, M; Demetriou, L; Göbel, U; Kolotas, C; Kurek, R; Martin, T; Schnabel, T; Tonus, C; Zamboglou, N | 1 |
Hellebostad, M; Landaas, S; Toverud, EL | 1 |
Croockewit, AJ; Fibbe, WE; Kingma, T; Uyl-de Groot, CA; van Agthoven, M; van Imhoff, GW; van Oers, MH; Vellenga, E; Verdonck, LF; Volkers, CP; Wijermans, PJ | 1 |
Barbui, T; Benedetti, F; Cavalli, F; Cortelazzo, S; Di Nicola, M; Ghielmini, M; Gianni, AM; Oldani, E; Pogliani, E; Rambaldi, A; Rossi, A; Tarella, C; Vitolo, U; Zaglio, F | 1 |
Hudson, GV; Lamont, A; Moody, AM; Pratt, J; Smith, P; Williams, MV | 1 |
Kabisch, H; Kröger, N; Krüger, W; Renges, H; Schetelig, J; Schrum, J; Siegert, W; Stute, N; Zabelina, T; Zander, AR | 1 |
Batchelor, T; Kaufman, D; Leahy, N | 1 |
Anderlini, P; Cabanillas, FF; Champlin, RE; Donato, ML; Gajewski, JL; Giralt, SA; Hagemeister, FB; Ippoliti, C; Khouri, IF; Korbling, M; Lee, MS; McLaughlin, P; Okoroji, GJ; Saliba, RM; Younes, A | 1 |
Chilcote, RR; Kadin, ME; Kjeldsberg, C; Krailo, MD; Meadows, AT; Morse, M; Siegel, SE; Sposto, R; Steinherz, PG; Termuhlen, AM | 1 |
Aizawa, Y; Aoki, S; Hashimoto, S; Takahashi, H; Takahashi, M; Toba, K; Tsuchiyama, J; Tsukada, N | 1 |
Benedetti, F; Bordignon, C; Bregni, M; Ciceri, F; Corradini, P; Dodero, A; Falda, M; Gianni, AM; Ladetto, M; Lucesole, M; Olivieri, A; Pileri, A; Rambaldi, A; Sajeva, MR; Tarella, C; Tresoldi, M; Voena, C; Zallio, F | 1 |
Chao, TY; Chen, YC; Ho, CL; Hwang, JM; Kao, WY; Sheu, LF | 1 |
Akiba, M; Bessho, M; Hirashima, K; Itoh, K; Itoh, Y; Kashimura, T; Kawai, N; Kishimoto, K; Matsuda, A; Murohashi, I; Sakata, T; Suzuki, T; Takahashi, T; Tominaga, K; Wakao, D; Yagasaki, F; Yoshida, K | 1 |
Cleary, AG; McDowell, H; Sills, JA | 1 |
Botsonis, A; Moschovi, M; Papadopoulou, AL; Tsangaris, GT; Tzortzatou-Stathopoulou, F | 1 |
Harris, E; Jackson, N; Jones, L; Mahendra, P; Paneesha, S | 1 |
Advani, SH; Banavali, SD; Bhatia, KG; Magrath, I; Naresh, KN; Soman, CS | 1 |
Bokstein, F; Lossos, A; Lossos, IS; Siegal, T | 1 |
Balmaceda, C; Mansukhani, M; Mears, JG; Orazi, A; Rescigno, J; Savage, DG; Shendrik, I | 1 |
Gerrard, M; Hobson, R; Imeson, J; McCarthy, K; Pinkerton, CR; Williams, DM | 1 |
Graham, TC; Sale, GE; Storb, R; Thomas, ED; Weiden, PL | 1 |
Bertino, JR; Boston, B; Capizzi, RL | 1 |
Kyalwazi, SK; McIntire, KR; Primack, A; Vogel, CL; Waldmann, TA | 1 |
Burgess, MA; Einhorn, LH; Gottlieb, JA; Livingston, RB | 1 |
Davis, S; Kessler, W | 1 |
Kogelnik, HD; Krepler, P; Pichler, E; Reinartz, G; Schmidmeier, W | 1 |
Cohen, MH; Kane, RC | 1 |
Einhorn, LH; Greco, FA; Oldham, RK; Richardson, RL | 1 |
Blom, J; Law, IP | 1 |
Dzherieva, AV | 1 |
Holland, JF | 1 |
Maekawa, T; Moteki, M; Omine, M; Shimano, S; Shinonome, S; Suda, T; Tsuchiya, J | 1 |
Armata, J; Borkowski, W; Cyklis, R | 1 |
Aur, RJ; Dahl, GV; Mauer, AM; Murphy, SB; Rivera, G; Verzosa, MS | 1 |
Aur, RJ; George, SL; Mauer, AM; Simone, JV | 1 |
Yoshikawa, H | 1 |
Okamoto, K; Yoshikawa, H | 1 |
Falletta, JM; Shepherd, DA; Starling, KA; Steuber, CP; Stewart, SJ | 1 |
Graham-Pole, J; Malpas, JS; Parker, D; Paxton, A | 1 |
Breiter, DN; Diasio, RB; Neifeld, JP; Rosenberg, SA; Roush, ML | 1 |
Barlow, JJ; Lele, SB; Piver, MS | 1 |
deKernion, JB | 1 |
Fisher, B | 1 |
Donaldson, MH; Meadows, AT; Morgan, E | 1 |
Berd, D; Bertino, J; Cadman, E; Farber, L | 1 |
Bonadonna, G; Rossi, A; Valagussa, P | 1 |
Frei, E; Sallan, SE | 1 |
Amgwerd, R; Bigler, R; Enderlin, F; Engelhart, G; Heinz, C; Hochuli, E; Jungi, WF; Lanz, R; Senn, HJ; Simeon, B; Sprenger, F; Wick, A | 1 |
Mayr, AC; Senn, HJ | 1 |
Bacci, G; Campanacci, M; Pagani, P; Picci, P | 1 |
Friedman-Birnbaum, R; Haim, S | 1 |
Cebrian-Bonesana, A; Kvicala, R; Lein, JM; Ojeda, FG; Pavlovsky, S; Penchansky, L; Pependieck, C; Roca-Garcia, C; Sackmann-Muriel, S; Schvartzman, E | 1 |
Baker, AR; Brennan, MF; Chabner, B; Chretien, PB; Cohen, MH; Costa, J; deMoss, EV; Kent, H; Rosenberg, SA; Sears, HF; Seipp, C; Simon, R; Webber, BL; Young, R | 1 |
Deisseroth, AB; Glaubiger, DL; Kent, HC; Levine, AS; Magrath, IT; Pizzo, PA; Poplack, DG; Ziegler, JL | 1 |
Priestman, TJ; Salaman, PF | 1 |
Cohen, ME; Duffner, PK; Freeman, AI; Sinks, LF; Thomas, PR | 1 |
Tormey, DC; Waalkes, TP | 1 |
Willoughby, ML | 1 |
Ziegler, JL | 1 |
Cheng, FC; Lee, CM; Ong, GB | 1 |
Lever, WF; Schaumburg-Lever, G | 1 |
Iavorskiĭ, VV; Kadagidze, ZG; Kupin, VI; Malaev, SG; Trapeznikov, NN | 1 |
Pochedly, C | 1 |
DeVita, VT; Graw, RG; Herzig, G; Leventhal, BG; Levine, AS; Pomeroy, TC; Ziegler, JL | 1 |
Smith, B | 1 |
Javier, G; Ortega, JJ; Sáenz, A; Tusell, J | 1 |
Bajetta, E; Bonadonna, G; Brambilla, C; Brugnatelli, L; Brusamolino, E; De Lena, M; Musumeci, R; Rossi, A; Tancini, G; Valagussa, P; Veronesi, U | 1 |
Nkrumah, FK; Perkins, IV | 1 |
Mead, GM; Sweetenham, JW; Whitehouse, JM | 1 |
Ahlgren, JD; Schulof, RS; Wampler, GL | 1 |
Abrams, GD; Ellis, SG; Gallagher, KP; Muller, DW; Topol, EJ | 1 |
Apperley, J; Barrett, AJ; Cullis, JO; Hows, JM; Hughes, TP; Kelly, S; Mackinnon, S; Marks, DI; Schwarer, AP; Szydlo, R | 1 |
DeNardo, BA; Miller, LC; Schaller, JG; Sisson, BA; Tucker, LB | 1 |
Gadner, H; Harbott, J; Henze, G; Lampert, F; Ludwig, WD; Müller-Weihrich, S; Niemeyer, CM; Reiter, A; Ritter, J; Schrappe, M | 1 |
Cámara, R; Fernández-Villalta, MJ; Ferro, T; Figuera, A; Kassack, JJ; Lamana, M; López, J; Serrano, F; Steegmann, JL; Vázquez, L | 1 |
Arya, LS; Choudhry, VP; Krishnamurthy, L; Pati, H; Rath, GK; Saraya, AK | 1 |
Hunter, T | 1 |
Fauci, AS; Hoffman, GS; Kerr, GS; Leavitt, RY | 1 |
Chisa, M; Hasegawa, S; Katoh, M; Koike, M; Kubomatsu, Y; Kunika, N; Nakamura, K; Sano, F; Takahashi, M; Wakayama, T | 1 |
Bessell, EM; Hunter, AE; Russell, NH | 1 |
Appelbaum, F; Bianco, J; Buckner, CD; Clift, R; Petersen, F | 1 |
Bancillon, A; Baruchel, A; Bergeron, C; Leblanc, T; Lejars, O; Lepage, E; Leverger, G; Perel, Y; Schaison, G; Sommelet, D | 1 |
Bailey, CC; Chessells, JM; Richards, S | 1 |
Alessandrino, EP; Bacigalupo, A; Bernasconi, C; Carella, AM; Ficarra, F; Lazzarino, M; Locatelli, F; Morra, E; Pagnucco, G; Resegotti, L | 1 |
Goldman, JM | 1 |
Borowitz, MJ; Crist, WM; Falletta, JM; Foreman, E; Patterson, R; Pullen, DJ; Shuster, JJ; Vietti, TJ; Wharam, M | 1 |
Andersen, JW; Anderson, KC; Bosserman, LD; Klatt, MM; Licht, JD; Martel, JK; Pinkus, G; Rosenthal, DS; Skarin, AT; Yeap, BY | 1 |
DeCherney, AH; Diamond, MP; Doyle, MB; Gutmann, JN; Jones, EE; Seifer, DB | 1 |
Amadori, S; Gherlinzoni, F; Guglielmi, C; Mandelli, F; Mazza, P; Tura, S | 1 |
Abuchaibe, O; Antillon, F; Azinovic, I; Calvo, FA; Cañadell, J; Ortiz de Urbina, D; Santos, M; Sierrasesúmaga, L | 1 |
Espinoza, LR; Jara, LJ; Levin, RW; Martínez-Osuna, P; Seleznick, MJ; Silveira, LH; Wallach, PM | 1 |
Bender-Götze, C; Dopfer, R; Ebell, W; Ehninger, G; Friedrich, W; Gadner, H; Henze, G; Klingebiel, T; Peters, C; Riehm, H | 1 |
Borsi, JD; Moe, PJ; Stokland, T; Wesenberg, F | 1 |
Holowiecki, J; Kachel, L; Lawniczek, T; Pajak, J; Rudzka, E | 1 |
Dombernowsky, P; Hansen, HH; Hansen, M; Hirsch, FR; Osterlind, K; Pedersen, AG; Sörenson, S | 1 |
Fengler, R; Hartmann, R; Henze, G; Janka-Schaub, G; Kornhuber, B; Niethammer, D; Riehm, H | 1 |
Behrendt, H; Dufillot, D; Gentet, JC; Lamagnère, JP; Otten, J; Patte, C; Pein, F; Philip, T; Rodary, C; Zucker, JM | 1 |
Abromowitch, M; Harris, M; Kavanagh, R; Ochs, J; Rivera, GK; Rodman, J; Yalowich, J | 1 |
Brecher, M; Crist, W; Harris, MB; Krance, RA; Land, VJ; Newman, EM; Pullen, J; Ravindranath, Y; Shuster, JJ; Wimmer, R | 1 |
Carpenter, JT; Levine, EG; Raczynski, JM | 1 |
Falliers, CJ | 1 |
Bleyer, WA; Coccia, PF; Finklestein, JZ; Hammond, GD; Littman, PS; Lukens, JN; Miller, DR; Nickerson, HJ; Sather, HN; Siegel, SE | 1 |
Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH | 1 |
de Andrea, ML; de Camargo, B; Melaragno, R | 1 |
Espinola, TE; White, JA | 1 |
Bigler, RD; Griffin, TD; Kadin, M; Kang, CA; Rogers, TJ; Vonderheid, EC | 1 |
Belasco, JB; Luery, N; Scher, C | 1 |
Ash, R; Beatty, P; Hows, JM; McGlave, PB | 1 |
Ferrazini, G; Giesbrecht, E; Greenberg, M; Kapelushnik, J; Klein, J; Koren, G; Langevin, AM; Soldin, S; Sulh, H | 1 |
Phay, KL; Ratnam, KV; Tan, CK | 1 |
Enblad, G; Glimelius, B; Hagberg, H; Lindemalm, C | 1 |
Pandurski, F; Slavov, N; Stambolov, B | 1 |
Dinçol, D; Içli, F; Isikman, E; Unal, M | 1 |
Bartoli, C; Bonadonna, G; Brambilla, C; Coopmans de Yoldi, G; Ferrari, L; Greco, M; Luini, A; Rilke, F; Veronesi, U; Zucali, R | 1 |
Cockerill, FR; Rosenow, EC; Wilson, WR | 1 |
Krusinski, PA; Nunnink, JC; Yates, JW | 1 |
Buster, JE; Bustillo, M; Gorrill, MJ; Greenberg, LH; Gunning, JE; Rodi, IA; Sauer, MV; Yeko, TR | 1 |
Eifel, PJ; McClure, S | 1 |
Kanamaru, A; Kato, S; Kodera, Y; Masaoka, T; Moriyama, Y; Nakamura, H; Shibata, H; Shimosaka, A; Takaku, F | 1 |
Fukutani, H; Hirano, A; Horikoshi, N; Inoue, K; Mizunuma, N; Mukaiyama, T; Ogawa, M; Shinagawa, K; Tabata, M | 1 |
Bosl, GJ; Nanus, DM | 1 |
Bates, SE; Cohen, S; McKeever, P; Poplack, DG; Price, RA; Raphaelson, MI | 1 |
Janka, GE | 1 |
Andres, P; Fornes, G; Garcia-Castellano, JM; Gomez, P; Gomez-Villagran, JL; Herrera, C; Martinez, F; Rojas, R; Torres, A; Velasco, F | 1 |
Appelbaum, FR; Banaji, M; Buckner, CD; Fefer, A; Fisher, L; Hansen, J; Storb, R; Sullivan, KM; Weiden, PL; Witherspoon, RP | 1 |
Bäckman, L; Janossy, G; Lönnqvist, B; Markling, L; Philstedt, P; Ringdén, O; Sundberg, B; Tollemar, J | 1 |
Gordon, DS; Heffner, LT; Reynolds, RC; Vogler, WR; Winton, EF | 1 |
Appelbaum, FR; Buckner, CD; Cheever, MA; Clift, RA; Deeg, HJ; Doney, KC; Flournoy, N; Kennedy, MS; Storb, R; Thomas, ED | 1 |
Kock, HC; Kooi, GS | 1 |
Camaggi, CM; Cilenti, G; Fruet, F; Martoni, A; Pannuti, F | 1 |
Ford, D; Kwan, YL; Lam-Po-Tang, PR; Mameghan, H; O'Gorman-Hughes, DW; Vowels, MR; White, L; Ziegler, JB | 1 |
Costanzo-Nordin, MR; Grusk, BB; O'Connell, JB; Pifarré, R; Robinson, JA; Silver, MA; Sobotka, PA; Winters, GL | 1 |
Arnold, R; Bunjes, D; Heimpel, H; Heit, W; Hertenstein, B; Schmeiser, T; Wiesneth, M | 1 |
Pulczynska, MK; Schmiegelow, K; Seip, M | 1 |
Taher, AA | 1 |
Begel', NI; Tynterov, AI | 1 |
Choudhary, AJ; Koppikar, SB; Kurkure, PA; Pai, SK; Pai, VR; Sanchetee, SC; Shetty, PA | 1 |
Eady, RA; Logan, RA; McFadden, JP | 1 |
Allegra, C; Chabner, B; Inghirami, G; Klippel, JH; Shiroky, J; Yarboro, C | 1 |
al-Jilaihawi, AN; Bullimore, J; Mott, M; Wisheart, JD | 1 |
Bäckman, L; Bolme, P; Gahrton, G; Heimdahl, A; Lindholm, A; Lönnqvist, B; Ringdén, O | 1 |
Cascinelli, N; Greco, M; Leo, E | 1 |
Abromowitch, M; Bowman, WP; Crom, WR; Dodge, R; Evans, WE; George, SL; Look, AT; Pui, CH | 1 |
Chessells, JM; Mills, S; Pinkerton, CR | 1 |
Balis, FM; Poplack, DG; Zimm, S | 1 |
Buckner, CD; Flournoy, N; Sanders, JE; Thomas, ED; Thompson, CB | 1 |
Bleyer, A; Evans, RG; Finklestein, J; Gaynon, P; Meyers, P; Miller, DR; Reaman, G; Sather, H; Steinherz, LJ; Steinherz, PG | 1 |
Brecher, ML | 1 |
Armitage, JO; Aunan, SB; Burns, CP; Dick, FR; Edwards, RW; Gingrich, RD; Leimert, JT; Maguire, LC | 1 |
Aur, RJ; Berg, R; Hustu, HO; Ochs, JJ; Rivera, G; Simone, JV | 1 |
Galicich, J; Jereb, B; Steinherz, P | 1 |
Appelbaum, FR; Buckner, CD; Clift, RA; Deeg, HJ; Flournoy, N; Lum, LG; Sanders, JE; Stewart, P; Sullivan, KM; Thomas, ED | 1 |
Lee, YT | 1 |
Appelbaum, FR; Beatty, P; Bensinger, W; Buckner, CD; Clift, R; Deeg, HJ; Doney, K; Irle, C; Kennedy, M; Storb, R | 1 |
Cavallin-Ståhl, E; Hagberg, H; Lind, J | 1 |
Achurra Castillo, AF; Benítez, R; Bulgín, O; Llerena, JM; López, RI; Sandoval, E; Villarreal, V | 1 |
Dovzhanskiĭ, SI; Miasnikova, TD; Samoteĭkina, IuM; Sherstneva, VN | 1 |
Amadori, S; Anselmo, AP; Biagini, C; Cimino, G; Guglielmi, C; Mandelli, F; Papa, G; Ruco, LP | 1 |
Lurati, M; Mertens, HG | 1 |
Baethke, R; Kampf, D | 1 |
Simone, JV | 1 |
Buckner, CD; Fefer, A; Glucksberg, H; Lerner, KG; Neiman, P; Storb, R; Thomas, ED | 1 |
Richardson, KT | 1 |
Byland, W; Nagel, G; Senn, HJ | 1 |
Aztarain, E; Giralt, M; Raichs, A; Torres, A | 1 |
Aur, RJ; Hustu, HO; Simone, JV; Verzosa, MS; Wood, A | 1 |
Eppinger-Helft, M; Pavlovsky, S; Sackmann Muriel, F | 1 |
Benöhr, HC; Frommhold, W; Oehmichen, M; Peiffer, J; Rückle, H; Waller, HD; Wilmans, W; Wilms, K | 1 |
Armata, J; Wyszkowski, J | 1 |
Hansen, NE; Karle, H; Killmann, SA | 1 |
O'Gorman Hughes, DW | 1 |
Aur, RJ; Hustu, HO; Simone, JV; Verzosa, MS | 1 |
Blatt, PM; Cathey, WJ; Miller, HL; Rothstein, G | 1 |
Lever, WF | 1 |
Benveniste, M; Blanchet, P; Civatie, J; Saurat, JH | 1 |
Brilliant, MD | 1 |
Buckner, CD; Chard, RL; Clift, RA; Fefer, A; Funk, DD; Johnson, FL; Neiman, P; Storb, R; Thomas, ED | 1 |
Buckner, CD; Clift, RA; Fefer, A; Lerner, KG; Neiman, PE; Storb, R; Thomas, ED | 1 |
Swierzowa, J | 1 |
Arcangeli, G; Casale, C; Friedman, M; Nervi, C; Page, G; Starace, G; Ziparo, E | 1 |
Amitan, BIa; Ashmarin, IuIa; Kreinin, VM; Shatova, LI | 1 |
Goldstein, DP; Pastorfide, GB | 1 |
Ezhov, NIa; Romanenko, GF; Verbenko, EV | 1 |
Hardisty, RM; Norman, PM | 1 |
Ahlendorf, W; Aurich, G; Kob, D; Zintl, F | 1 |
Armata, J | 1 |
Farber, EM; Watson, W | 1 |
107 review(s) available for methotrexate and Recrudescence
Article | Year |
---|---|
Omission of day +11 methotrexate dose and allogeneic hematopoietic cell transplantation outcomes: results of a systematic review/meta-analysis.
Topics: Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Prospective Studies; Recurrence; Transplantation Conditioning | 2022 |
[Diagnostics and treatment of giant cell arteritis].
Topics: Drug Therapy, Combination; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Middle Aged; Recurrence | 2022 |
Management of CNS Disease in Pediatric Acute Lymphoblastic Leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Central Nervous System Neoplasms; Child; Humans; Injections, Spinal; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies | 2022 |
Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review.
Topics: Chronic Disease; Cyclosporine; Humans; Interleukin-17; Interleukin-23; Methotrexate; Psoriasis; Recurrence; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor Inhibitors | 2022 |
Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations.
Topics: Humans; Mercaptopurine; Methotrexate; Methyltransferases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Thioguanine | 2022 |
Optimum Methotrexate Exposure in Patients With Suspected or Confirmed CNS Invasive Hematological Malignancies: A Systematic Critical Review.
Topics: Adult; Central Nervous System Neoplasms; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 2023 |
Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Chronic Disease; Humans; Male; Methotrexate; Recurrence; Treatment Outcome | 2022 |
Efficacy and safety of leflunomide in the management of large vessel vasculitis: A systematic review and metaanalysis of cohort studies.
Topics: Antirheumatic Agents; Cohort Studies; Giant Cell Arteritis; Glucocorticoids; Humans; Leflunomide; Methotrexate; Recurrence; Takayasu Arteritis | 2023 |
Relapsing autoimmune inner ear disease with significant response to methotrexate and azathioprine combination therapy: A case report and mini literature review.
Topics: Adrenal Cortex Hormones; Adult; Autoimmune Diseases; Azathioprine; Female; Hearing Loss, Sensorineural; Humans; Immunosuppressive Agents; Labyrinth Diseases; Methotrexate; Methylprednisolone; Recurrence | 2023 |
Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis.
Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Mycophenolic Acid; Network Meta-Analysis; Odds Ratio; Recurrence; Remission Induction; Rituximab; Tacrolimus | 2020 |
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Biomarkers; Blindness; Drug Therapy, Combination; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Methotrexate; Observational Studies as Topic; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Recurrence; Risk Management; Systemic Vasculitis; Takayasu Arteritis | 2019 |
Treatment of microscopic colitis: the role of budesonide and new alternatives for refractory patients.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antidiarrheals; Antimetabolites; Azathioprine; Biological Products; Budesonide; Colitis, Collagenous; Colitis, Lymphocytic; Colitis, Microscopic; Diarrhea; Humans; Loperamide; Malabsorption Syndromes; Mesalamine; Methotrexate; Prednisolone; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors | 2020 |
Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Recurrence; Takayasu Arteritis | 2020 |
Update οn the diagnosis and management of systemic lupus erythematosus.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Autoantibodies; Azathioprine; Calcineurin Inhibitors; Cardiovascular Diseases; Cyclophosphamide; Disease Management; Female; Glucocorticoids; Heart Valve Diseases; Humans; Hydroxychloroquine; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Macrophage Activation Syndrome; Methotrexate; Mycophenolic Acid; Myocarditis; Outcome Assessment, Health Care; Pericarditis; Phenotype; Pregnancy; Pregnancy Complications; Prognosis; Purpura, Thrombocytopenic, Idiopathic; Quality of Life; Recurrence; Rituximab; Severity of Illness Index; Survival Rate; Uterine Cervical Neoplasms | 2021 |
A rheumatologic approach to granulomatous mastitis: A case series and review of the literature.
Topics: Adolescent; Adult; Female; Granulomatous Mastitis; Humans; Immunosuppressive Agents; Methotrexate; Recurrence; Remission Induction; Retrospective Studies; Steroids; Time Factors; Treatment Outcome; Young Adult | 2021 |
[Glucocorticoids in the treatment of giant cell arteritis : How much, how long and how to spare?]
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Osteoporosis; Recurrence | 2021 |
Diagnosis and management of morphoea in children: an overview.
Topics: Abatacept; Adrenal Cortex Hormones; Child; Dermatologic Agents; Early Diagnosis; Humans; Methotrexate; Mycophenolic Acid; Recurrence; Scleroderma, Localized | 2021 |
Recurrent infections in a patient with psoriatic arthritis and hypogammaglobulinemia, treated with conventional and biologic disease-modifying anti-rheumatic drugs-a primary or secondary entity?
Topics: Agammaglobulinemia; Antirheumatic Agents; Arthritis, Psoriatic; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Male; Methotrexate; Middle Aged; Recurrence; Respiratory Tract Infections; Treatment Outcome | 2017 |
Polymyalgia rheumatica.
Topics: Diagnosis, Differential; Dose-Response Relationship, Drug; Humans; Interleukin-6; Methotrexate; Polymyalgia Rheumatica; Positron-Emission Tomography; Prednisolone; Prognosis; Recurrence | 2017 |
Rituximab as a therapeutic consideration for refractory eosinophilic fasciitis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Arm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Eosinophilia; Fasciitis; Follow-Up Studies; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methotrexate; Recurrence; Rituximab; Severity of Illness Index; Treatment Outcome | 2018 |
Is methotrexate an effective and safe treatment for maintaining hair regrowth in people with alopecia totalis? A Critically Appraised Topic.
Topics: Administration, Oral; Administration, Topical; Alopecia; Alopecia Areata; Glucocorticoids; Hair; Humans; Induction Chemotherapy; Maintenance Chemotherapy; Methotrexate; Quality of Life; Recurrence; Severity of Illness Index; Treatment Outcome | 2018 |
Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus.
Topics: Acitretin; Administration, Oral; Administration, Topical; Adult; Aged; Biological Products; Consensus; Cyclosporine; Dermatologic Agents; Disease Management; Expert Testimony; Female; Humans; Injections, Intralesional; Male; Methotrexate; Middle Aged; Nail Diseases; Practice Guidelines as Topic; Psoriasis; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |
Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
Topics: Adult; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Child; Churg-Strauss Syndrome; Cyclophosphamide; Drug Substitution; Drug Therapy, Combination; Forecasting; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Leflunomide; Methotrexate; Mycophenolic Acid; Plasma Exchange; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Rituximab; Severity of Illness Index | 2019 |
L44. Management of relapses in vasculitis.
Topics: Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Glucocorticoids; Humans; Immunization, Passive; Immunosuppressive Agents; Methotrexate; Plasma Exchange; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Rituximab; Tumor Necrosis Factor-alpha | 2013 |
Update on the classification and treatment of localized scleroderma.
Topics: Algorithms; Aminoquinolines; Clinical Trials as Topic; Eosinophilia; Fasciitis; Glucocorticoids; Humans; Imiquimod; Immunosuppressive Agents; Methotrexate; Photochemotherapy; Physical Therapy Modalities; Recurrence; Scleroderma, Localized; Severity of Illness Index | 2013 |
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dapsone; Female; Giant Cell Arteritis; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Prednisolone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Treatment Outcome; Vasculitis | 2014 |
[Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Drug Discovery; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Molecular Targeted Therapy; Mutation; Recurrence; Tretinoin; Vincristine | 2014 |
Prophylactic CNS directed therapy in systemic diffuse large B cell lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Rituximab; Survival Analysis; Vincristine | 2014 |
Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
Topics: Allografts; Calcineurin Inhibitors; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Randomized Controlled Trials as Topic; Recurrence; Tacrolimus | 2014 |
Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Certolizumab Pegol; Drug Therapy, Combination; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Polyethylene Glycols; Psoriasis; Randomized Controlled Trials as Topic; Recurrence; Rheumatic Diseases; Risk Factors; Tuberculosis; Tumor Necrosis Factor-alpha | 2014 |
Treatment for and clinical characteristics of granulomatous mastitis.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Breast; Drug Therapy, Combination; Female; Granulomatous Mastitis; Humans; Immunosuppressive Agents; Lymphatic Diseases; Methotrexate; Middle Aged; Prednisone; Recurrence; Young Adult | 2015 |
[Treatment of inflammatory bowel diseases].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Clinical Trials as Topic; Fecal Microbiota Transplantation; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Multicenter Studies as Topic; Oligonucleotides, Antisense; Recurrence; Therapies, Investigational; Transplantation, Autologous | 2015 |
A new approach to the management of ovarian endometrioma to prevent tissue damage and recurrence.
Topics: Adolescent; Adult; Animals; Apoptosis; Aromatase Inhibitors; Endometriosis; Endometrium; Estrogens; Ethanol; Female; Fertility Preservation; Free Radicals; Humans; Interleukin-2; Methotrexate; Ovarian Diseases; Ovary; Progestins; Receptors, Progesterone; Recombinant Proteins; Recurrence; Sclerotherapy; Young Adult | 2016 |
A systematic review of ultrasonography-guided transvaginal aspiration of recurrent ovarian endometrioma.
Topics: Endometriosis; Ethanol; Female; Humans; Methotrexate; Observational Studies as Topic; Ovarian Cysts; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Tetracycline; Ultrasonography, Interventional | 2016 |
Uveitis in children.
Topics: Adolescent; Adrenal Cortex Hormones; Antirheumatic Agents; Aqueous Humor; Arthritis, Juvenile; Autoimmune Diseases; Black or African American; Blood Sedimentation; Child; HLA-B27 Antigen; HLA-DR1 Antigen; HLA-DRB1 Chains; Humans; Methotrexate; Recurrence; Risk Factors; S100 Proteins; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Visual Acuity | 2016 |
Standard and biological treatment in large vessel vasculitis: guidelines and current approaches.
Topics: Animals; Antibodies, Monoclonal; Azathioprine; Biological Therapy; Clinical Trials as Topic; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphotoxin-alpha; Methotrexate; Practice Guidelines as Topic; Recurrence; Remission Induction; Takayasu Arteritis | 2017 |
Non-topical management of recalcitrant paediatric atopic dermatitis.
Topics: Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressive Agents; Medicine, Chinese Traditional; Methotrexate; Mycophenolic Acid; Phototherapy; Prebiotics; Probiotics; Recurrence; Ultraviolet Therapy | 2017 |
[Giant cell arteritis].
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Anti-Infective Agents; Biopsy; Blood Sedimentation; C-Reactive Protein; Dapsone; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography; Recurrence; Temporal Arteries; Time Factors; Ultrasonography, Doppler, Duplex | 2008 |
Prophylaxis regimens for GVHD: systematic review and meta-analysis.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Risk; Tacrolimus; Treatment Outcome | 2009 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropanes; Cyclosporine; Hair; Haptens; Humans; Immunotherapy; Injections, Intralesional; Laser Therapy; Methotrexate; Minoxidil; Photochemotherapy; Randomized Controlled Trials as Topic; Rats; Recurrence; Research Design; Social Support; Sulfasalazine; Treatment Outcome; Triamcinolone Acetonide | 2010 |
[Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].
Topics: Biological Products; Contraindications; Cyclosporine; Drug Administration Routes; Drug Monitoring; Female; Folic Acid; Humans; Immunosuppressive Agents; Kidney Diseases; Latent Tuberculosis; Liver Cirrhosis; Medical History Taking; Methotrexate; Pregnancy; Pregnancy Complications; Psoriasis; Pulmonary Fibrosis; Recurrence; Tumor Necrosis Factor-alpha; Vaccination | 2010 |
[Refractory anterior uveitis].
Topics: Adrenal Cortex Hormones; Adult; Child; Chronic Disease; Diagnosis, Differential; Humans; Immunosuppressive Agents; Iridocorneal Endothelial Syndrome; Methotrexate; Mydriatics; Ophthalmic Solutions; Recurrence; Tumor Necrosis Factor-alpha; Uveitis, Anterior | 2011 |
What is new HLA-B27 acute anterior uveitis?
Topics: Acute Disease; Administration, Topical; Adrenal Cortex Hormones; Animals; Arthritis; Bacterial Infections; HLA-B27 Antigen; Humans; Immunity, Innate; Incidence; Methotrexate; Multifactorial Inheritance; Mydriatics; Recurrence; Sulfasalazine; Uveitis, Anterior | 2011 |
Idiopathic inflammatory myopathies: definition and management of refractory disease.
Topics: Biomarkers, Pharmacological; Disease Progression; Drug Resistance; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Methotrexate; Myositis; Prognosis; Recurrence | 2011 |
Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature.
Topics: Adult; Aged; Constriction, Pathologic; Cystostomy; Follow-Up Studies; Genital Diseases, Male; Glucocorticoids; Granuloma, Plasma Cell; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Nephrectomy; Prednisone; Prostatectomy; Recurrence; Retrospective Studies; Skin Ulcer; Stents; Transurethral Resection of Prostate; Ureteral Diseases; Young Adult | 2012 |
Relapse of acute myeloid leukemia at the pituitary gland: a case report and review of literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Diabetes Insipidus; Etoposide; Female; Humans; Hypopituitarism; Idarubicin; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Methotrexate; Pituitary Neoplasms; Radiotherapy; Recurrence; Remission Induction; Vision Disorders | 2012 |
Immunotherapy in renal diseases.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Diseases; Methotrexate; Plasmapheresis; Prognosis; Recurrence; Rituximab | 2012 |
Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Incidence; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Risk Factors; Rituximab; Vincristine; Young Adult | 2012 |
Advances in therapy for ANCA-associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Cyclophosphamide; Glucocorticoids; Humans; Methotrexate; Plasma Exchange; Recurrence; Remission Induction; Rituximab | 2012 |
Primary NK/T cell lymphoma of the testis. A case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Doxorubicin; Fatal Outcome; Herpesvirus 4, Human; Humans; Immunohistochemistry; Immunophenotyping; In Situ Hybridization; Killer Cells, Natural; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Necrosis; Neoplasm Metastasis; Orchiectomy; Prednisone; Radiotherapy; Recurrence; RNA, Viral; Skin; Testicular Neoplasms; Thoracic Wall; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 2003 |
CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials.
Topics: Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Spinal; Male; Methotrexate; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2003 |
Acute promyelocytic leukemia: a case-based review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Case Management; Evidence-Based Medicine; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Methotrexate; Neoplasm Proteins; Oncogene Proteins, Fusion; Prognosis; Recurrence; Remission Induction; Salvage Therapy; Syndrome; Tretinoin | 2003 |
[Auto-immune hepatitis: therapeutic management].
Topics: Anti-Inflammatory Agents; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mycophenolic Acid; Recurrence; Remission Induction; Risk Factors; Steroids; Tacrolimus; Treatment Outcome | 2003 |
Clinical aspects of gestational trophoblastic disease: a review based partly on 25-year experience of a statewide registry.
Topics: Brain Neoplasms; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Leucovorin; Liver Neoplasms; Methotrexate; Neoplasms, Second Primary; Pregnancy; Queensland; Recurrence; Registries | 2003 |
[Wegener's granulomatosis (morbus Wegener)].
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone Hemisuccinate; Prednisone; Prognosis; Radiography, Thoracic; Recurrence; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
Multiple sclerosis: management issues during pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Animals; Breast Feeding; Cyclophosphamide; Delivery, Obstetric; Female; Humans; Labor, Obstetric; Methotrexate; Multiple Sclerosis; Postpartum Period; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prognosis; Recurrence | 2004 |
Advances for the treatment of primary central nervous system lymphoma (review).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Quality of Life; Recurrence; Time Factors; Treatment Outcome | 2004 |
Management of primary intraocular lymphoma.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Eye Neoplasms; Humans; Lymphoma, Non-Hodgkin; Medical Oncology; Methotrexate; Radiotherapy; Recurrence; Retina; Stem Cell Transplantation; Treatment Outcome | 2005 |
Limitations of conservative treatment for repeat Cesarean scar pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Cesarean Section; Cicatrix; Female; Humans; Methotrexate; Pregnancy; Pregnancy Trimester, First; Pregnancy, Ectopic; Recurrence; Treatment Failure; Ultrasonography; Uterus | 2005 |
Advances in the therapy of Wegener's granulomatosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Etanercept; Granulomatosis with Polyangiitis; Guanidines; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Plasmapheresis; Receptors, Tumor Necrosis Factor; Recurrence; Rituximab | 2006 |
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid; Recurrence | 2006 |
Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia.
Topics: Adenoma, Sweat Gland; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carcinoma, Acinar Cell; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Parotid Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Survivors; Sweat Gland Neoplasms; Vincristine; Whole-Body Irradiation | 2008 |
Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration.
Topics: Bone Marrow Transplantation; Disease Management; Dose-Response Relationship, Drug; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Methotrexate; Odds Ratio; Peripheral Blood Stem Cell Transplantation; Randomized Controlled Trials as Topic; Recurrence; Survival Analysis; Time Factors; Transplantation, Homologous | 2006 |
[Microscopic polyangiitis].
Topics: Adrenal Cortex Hormones; Age Factors; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Biological Therapy; Clinical Trials as Topic; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis; Humans; Immunosuppressive Agents; Infant, Newborn; Lung Diseases; Male; Methotrexate; Middle Aged; Plasma Exchange; Polyarteritis Nodosa; Prognosis; Recurrence; Remission Induction; Skin Diseases; Time Factors; Vasculitis | 2007 |
Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.
Topics: Administration, Oral; Aged; Chemotherapy, Adjuvant; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Male; MEDLINE; Methotrexate; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2007 |
[Long-term control of psoriasis is necessary].
Topics: Acitretin; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Combined Modality Therapy; Comorbidity; Cyclosporine; Cytokines; Dermatologic Agents; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Quality of Life; Recurrence | 2008 |
Changing role of chemotherapy in treatment of head and neck cancer.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Methotrexate; Recurrence | 1982 |
Management of small cell cancer: radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Radiation; Humans; Lomustine; Lung Neoplasms; Methotrexate; Palliative Care; Recurrence; Whole-Body Irradiation | 1984 |
Bone marrow transplantation in acute nonlymphoblastic leukemia.
Topics: Acute Disease; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporins; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia; Methotrexate; Piperazines; Prognosis; Recurrence; Whole-Body Irradiation | 1984 |
Maintenance of symptomatic remission in patients with Crohn's disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Recurrence; Remission Induction; Sulfasalazine | 1993 |
"Above all do no harm:" horizons in pediatric oncology.
Topics: Bone Marrow Transplantation; Child; Combined Modality Therapy; Growth Substances; Humans; Leukemia, Myeloid, Acute; Medical Oncology; Mercaptopurine; Methotrexate; Pediatrics; Phenotype; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quality of Life; Recurrence; Survival Rate | 1994 |
Case report and review of literature: leptomeningeal relapse in epithelial ovarian cancer.
Topics: Adult; Aged; Brain; Combined Modality Therapy; Female; Humans; Meningeal Neoplasms; Methotrexate; Middle Aged; Ovarian Neoplasms; Recurrence | 1994 |
[Review of methotrexate treatment of persistent extrauterine pregnancy].
Topics: Chorionic Gonadotropin; Drug Administration Schedule; Female; Humans; Methotrexate; Pregnancy; Pregnancy, Ectopic; Recurrence | 1993 |
Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies.
Topics: Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lung Transplantation; Lymphatic Irradiation; Methotrexate; Mycophenolic Acid; Photopheresis; Polyenes; Recurrence; Sirolimus; Tacrolimus | 1997 |
Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: what can we learn from small studies?
Topics: Antimetabolites, Antineoplastic; Child; Disease-Free Survival; Dose-Response Relationship, Drug; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Risk Assessment | 1997 |
Wegener's granulomatosis and ANCA syndromes.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Anti-Infective Agents; Antibodies, Antineutrophil Cytoplasmic; Antimetabolites, Antineoplastic; Cyclophosphamide; Granulomatosis with Polyangiitis; Humans; Methotrexate; Prognosis; Recurrence; Sulfamethoxazole | 1997 |
Clinical presentation, hematologic features and treatment outcome of childhood acute lymphoblastic leukemia: a review of 73 cases in Hong Kong.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cranial Irradiation; Disease-Free Survival; Female; Hemorrhage; Hepatomegaly; Hong Kong; Humans; Immunophenotyping; Infant; Karyotyping; Life Tables; Male; Methotrexate; Pain; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Retrospective Studies; Splenomegaly; Survival Analysis; Treatment Outcome | 1997 |
[Treatment of refractory spondylarthropathies].
Topics: Acquired Immunodeficiency Syndrome; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Humans; Methotrexate; Methylprednisolone; Recurrence; Spondylitis, Ankylosing; Sulfasalazine | 1998 |
Medical therapy for inflammatory bowel disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Recurrence; Salicylates; Severity of Illness Index; Steroids | 1999 |
Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders.
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Multiple Sclerosis; Recurrence; Treatment Failure; Treatment Outcome | 1999 |
Molecular and cellular correlates of methotrexate response in childhood acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Child; Disease Progression; Folic Acid; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Risk Factors | 1999 |
[Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Azathioprine; Clinical Trials as Topic; Forecasting; Glatiramer Acetate; Humans; Hydroxyquinolines; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferons; Methotrexate; Multiple Sclerosis; Peptides; Polymers; Recurrence; Retrospective Studies | 1999 |
[Relapse of acute lymphoblastic leukemia as a retro-orbital mass].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Methotrexate; Orbital Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence | 1999 |
Bilateral recurrent pneumothorax complicating chemotherapy for pulmonary metastatic breast ductal carcinoma: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Drainage; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Pneumothorax; Recurrence; Treatment Outcome | 2000 |
[Use of immunosuppressors in chronic inflammatory intestinal diseases].
Topics: Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Recurrence; Severity of Illness Index; Time Factors | 1999 |
Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia.
Topics: Acute Disease; Animals; Child; Drug Administration Schedule; Drug Resistance, Neoplasm; Folic Acid Antagonists; Humans; Leukemia, B-Cell; Leukemia, Myeloid; Leukemia, T-Cell; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 2000 |
Central nervous system involvement in adult acute lymphocytic leukemia.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Child; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Humans; Injections, Spinal; Leukemic Infiltration; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Risk Factors; Salvage Therapy; Survival Analysis; Treatment Outcome | 2001 |
Conventional treatment of Crohn's disease: objectives and outcomes.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Methotrexate; Prednisone; Quality of Life; Recurrence; Sulfasalazine; Treatment Outcome | 2001 |
Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Juvenile; Child; Epstein-Barr Virus Infections; Humans; Lymphoma, B-Cell; Male; Methotrexate; Recurrence; Sentinel Lymph Node Biopsy; Treatment Outcome | 2002 |
Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Disease-Free Survival; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Humans; Immunoglobulin Heavy Chains; Infant; Leukemia-Lymphoma, Adult T-Cell; Life Tables; Male; Methotrexate; Neoplasm, Residual; Polymerase Chain Reaction; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Retrospective Studies; Risk; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine | 2001 |
Leptomeningeal relapse of multiple myeloma following allogeneic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Combined Modality Therapy; Dexamethasone; Diphosphonates; Doxorubicin; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Interleukin-2; Melphalan; Meninges; Methotrexate; Multiple Myeloma; Neoplastic Stem Cells; Osteolysis; Pamidronate; Paraparesis; Recurrence; Salvage Therapy; Seizures; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2002 |
Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Prednisolone; Recurrence; Risk; Thioguanine; United Kingdom; Vincristine | 2002 |
Small cell lung cancer: progress and perspectives.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Recurrence; Remission, Spontaneous; Research Design; Time Factors; Transplantation, Autologous | 1978 |
The chemotherapy of advanced bladder carcinoma.
Topics: Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Injections, Intra-Arterial; Methotrexate; Mitomycins; Neoplasm Metastasis; Recurrence; Research Design; Urinary Bladder Neoplasms | 1977 |
Acute lymphoblastic leukemia: treatment.
Topics: Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunotherapy; Injections, Spinal; Leukemia, Lymphoid; Male; Meningeal Neoplasms; Methotrexate; Prognosis; Recurrence; Remission, Spontaneous; Spinal Cord Neoplasms | 1978 |
Biochemical markers in cancer of the breast.
Topics: Breast Neoplasms; Cadaverine; Carcinoembryonic Antigen; Chorionic Gonadotropin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Guanosine; Humans; Inosine; Methotrexate; Neoplasm Metastasis; Prognosis; Putrescine; Recurrence; Spermidine; Spermine | 1976 |
Bone marrow transplantation for chronic myeloid leukaemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Methotrexate; Recurrence; Time Factors; Transplantation, Homologous | 1992 |
Persistent ectopic pregnancy following laparoscopic linear salpingostomy.
Topics: Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Laparoscopy; Methotrexate; Peptide Fragments; Pregnancy; Pregnancy, Ectopic; Recurrence; Regression Analysis; Reoperation; Salpingostomy | 1990 |
Chemotherapy for squamous cell carcinoma of the head and neck: an overview.
Topics: Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Methotrexate; Recurrence | 1990 |
Pulmonary disease in the immunocompromised host. 1.
Topics: Acquired Immunodeficiency Syndrome; Biopsy; Bleomycin; Bone Marrow Transplantation; Connective Tissue Diseases; Graft vs Host Disease; Hemorrhage; Humans; Immune Tolerance; Kidney Failure, Chronic; Kidney Transplantation; Leukemia; Leukocyte Count; Lung Diseases; Lung Neoplasms; Lymphoma; Methotrexate; Pulmonary Fibrosis; Radiography; Recurrence; Sarcoma, Kaposi; Transplantation Immunology | 1985 |
Systemic chemotherapy in the management of bladder cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Humans; Methotrexate; Recurrence; Urinary Bladder Neoplasms; Vinblastine | 1989 |
Treatment of acute lymphoid leukemia in children: current regimens and future prospects.
Topics: Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Central Nervous System Diseases; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Lymphoid; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Mice; Prognosis; Recurrence; T-Lymphocytes | 1986 |
Patterns of metastasis and natural courses of breast carcinoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptors, Estrogen; Recurrence | 1985 |
[Therapy of lupus-nephritis using corticosteroids and immunosuppressive agents].
Topics: Adrenal Cortex Hormones; Antibodies, Antinuclear; Azathioprine; Beta-Globulins; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Germany, West; Glomerulonephritis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Nephritis; Recurrence | 1974 |
Management of childhood leukemia.
Topics: Alkanesulfonates; Amidines; Bone Marrow Examination; Chickenpox; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; gamma-Globulins; Humans; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Nervous System Diseases; Phenyl Ethers; Physician-Patient Relations; Pneumonia, Pneumocystis; Prednisone; Pseudomonas Infections; Recurrence; Testicular Neoplasms; Vincristine | 1974 |
Pharmacology and pathophysiology of inflammation.
Topics: Antibody Formation; Antigen-Antibody Reactions; Antilymphocyte Serum; Colchicine; Humans; Hydrocortisone; Hypersensitivity, Delayed; Immunity, Cellular; Immunoglobulin A; Immunoglobulin D; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Lymphocytes; Lysosomes; Methotrexate; Microbial Collagenase; Nitrogen Mustard Compounds; Phagocytosis; Recurrence; Transplantation Immunology | 1971 |
[Treatment of acute leukemias].
Topics: Acute Disease; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Child; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methods; Methotrexate; Prednisolone; Recurrence; Remission, Spontaneous; Vincristine | 1973 |
192 trial(s) available for methotrexate and Recrudescence
Article | Year |
---|---|
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.
Topics: Adolescent; Adult; Aged; Calcineurin Inhibitors; Chronic Disease; Cyclophosphamide; Disease-Free Survival; Drug Therapy, Combination; Female; Germany; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Recurrence; Tacrolimus; Time Factors; Transplantation Conditioning; United States; Young Adult | 2022 |
Discontinuation of methotrexate in rheumatoid arthritis patients achieving clinical remission by treatment with upadacitinib plus methotrexate (DOPPLER study): A study protocol for an interventional, multicenter, open-label and single-arm clinical trial w
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; C-Reactive Protein; Double-Blind Method; Drug Therapy, Combination; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase Inhibitors; Methotrexate; Multicenter Studies as Topic; Recurrence; Remission Induction; Treatment Outcome | 2022 |
Efficacy, safety, and cost-effectiveness of triple therapy in preventing relapse in rheumatoid arthritis: A randomized controlled trial (ESCoRT study).
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Methotrexate; Recurrence; Treatment Outcome | 2022 |
Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Incidence; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Rituximab; Vincristine | 2020 |
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Prospective Studies; Recurrence; Remission Induction; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Haploidentical; Unrelated Donors; Vidarabine | 2017 |
Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT.
Topics: Acetylation; Acute Disease; Adolescent; Adult; Aged; Demography; Feasibility Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Incidence; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis; Tacrolimus; Transplantation Conditioning; Unrelated Donors; Vorinostat; Young Adult | 2017 |
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Topics: Adolescent; Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Churg-Strauss Syndrome; Cyclophosphamide; Female; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Methotrexate; Microscopic Polyangiitis; Middle Aged; Patient Safety; Patient Selection; Peripheral Nervous System Diseases; Proteinuria; Random Allocation; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome | 2017 |
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Colitis, Ulcerative; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Steroids; Time Factors; Treatment Outcome; United States | 2018 |
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL).
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Carmustine; Combined Modality Therapy; Female; Heart Diseases; Hodgkin Disease; Humans; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Prognosis; Recurrence; Remission Induction; Survival Analysis; Teniposide; Treatment Outcome | 2019 |
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Vinblastine | 2013 |
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Italy; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Remission Induction; Retroperitoneal Fibrosis; Survival Rate; Young Adult | 2013 |
Sustained clinical remission and rate of relapse after tocilizumab withdrawal in patients with rheumatoid arthritis.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |
[Prospective multicentre study of chemotherapeutic regimen containing pirarubicin on the treatment of relapsed or refractory acute myeloid leukemia in adults].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Recurrence; Remission Induction | 2014 |
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Immunocompetence; Infections; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Palliative Care; Prednisolone; Recurrence; Remission Induction; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Vindesine | 2014 |
Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Decitabine; Dexamethasone; DNA Methylation; DNA, Neoplasm; Doxorubicin; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Hyperglycemia; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Vincristine; Young Adult | 2014 |
Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Risk Factors; Rituximab; Vincristine | 2015 |
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Chondrocalcinosis; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Methotrexate; Middle Aged; Recurrence; Treatment Outcome | 2014 |
Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Bilirubin; Dexamethasone; Female; Humans; Male; Methotrexate; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Recurrence; Rituximab; Survival Analysis; T-Lymphocytes; Transaminases; Treatment Outcome; Vincristine | 2015 |
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.
Topics: Adult; Aged; Antibodies; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Humans; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Predictive Value of Tests; Prospective Studies; Recurrence; Withholding Treatment | 2016 |
Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Etanercept; Female; Humans; Male; Methotrexate; Middle Aged; Recurrence; Severity of Illness Index; Treatment Outcome; Withholding Treatment | 2016 |
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Induction Chemotherapy; Male; Methotrexate; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Survival Analysis; Transplantation, Homologous; Vincristine | 2015 |
Optimizing therapy in inflammatory arthritis: prediction of relapse after tapering or stopping treatment for rheumatoid arthritis patients achieving clinical and radiological remission.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Biological Products; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Inflammation; Male; Methotrexate; Proportional Hazards Models; Prospective Studies; Recurrence; Remission Induction; Rheumatology; ROC Curve; Synovitis; Treatment Outcome; Ultrasonography | 2016 |
A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; China; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Immunophenotyping; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Polyethylene Glycols; Prognosis; Recurrence; Retreatment; Treatment Outcome; Young Adult | 2017 |
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Prednisolone; Recurrence; Survival Analysis; Treatment Outcome; Young Adult | 2009 |
Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prednisone; Prognosis; Prospective Studies; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2008 |
[Clinical randomized study of bee-sting therapy for rheumatoid arthritis].
Topics: Acupuncture Points; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Bee Venoms; Female; Humans; Male; Meloxicam; Methotrexate; Middle Aged; Recurrence; Sulfasalazine; Thiazines; Thiazoles | 2008 |
Treatment of primary mediastinal large B cell lymphoma with an alternating chemotherapy regimen based on high-dose methotrexate.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Recurrence; Survival Rate; Treatment Outcome; Young Adult | 2009 |
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Recurrence; Rituximab; Salvage Therapy; Vincristine | 2008 |
Relapse-remission and remission-relapse switches in rheumatoid arthritis patients were modeled by random effects.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Methotrexate; Models, Statistical; Prednisolone; Recurrence; Remission Induction; Sulfasalazine; Treatment Outcome | 2009 |
A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL).
Topics: Adolescent; Child; Child, Preschool; Epidemiologic Methods; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Sirolimus; Tacrolimus; Treatment Outcome; Young Adult | 2009 |
Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Disease Progression; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Melphalan; Methotrexate; Middle Aged; Mycosis Fungoides; Myeloablative Agonists; Recurrence; Sezary Syndrome; Tacrolimus; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation; Young Adult | 2010 |
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; ATP-Binding Cassette Transporters; Calgranulin B; Child; Child, Preschool; Female; Humans; Infant; Male; Methotrexate; Predictive Value of Tests; Prospective Studies; Recurrence; Remission Induction | 2010 |
Long-term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Recurrence; Risk Assessment; Risk Factors; Survival Analysis; Time Factors; Treatment Outcome | 2011 |
Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Biomarkers; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infliximab; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Prednisone; Recurrence; Remission Induction; Severity of Illness Index; Treatment Outcome | 2011 |
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study.
Topics: Aged; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Disease-Free Survival; DNA, Viral; Female; France; Herpesvirus 4, Human; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy | 2011 |
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Assessment; Treatment Outcome; United Kingdom; Vidarabine; Vincristine | 2010 |
Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Feasibility Studies; Follow-Up Studies; Humans; Immunosuppression Therapy; Lymphoma; Methotrexate; Middle Aged; Organ Transplantation; Recurrence; Remission Induction; Transplantation; Treatment Outcome | 2011 |
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Recurrence; Rituximab; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vincristine | 2011 |
Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.
Topics: Adolescent; Adult; Africa South of the Sahara; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cause of Death; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Methotrexate; Middle Aged; Neoplasm Staging; Recurrence; Remission Induction; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2012 |
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial.
Topics: Adult; Aged; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Janus Kinases; Male; Maximum Tolerated Dose; Methotrexate; Middle Aged; Pain Measurement; Piperidines; Pyrimidines; Pyrroles; Recurrence; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Humans; Infant; Ireland; Male; Methotrexate; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Factors; Treatment Outcome; United Kingdom; Vincristine | 2013 |
High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Child; Drug Therapy, Combination; Female; Glomerulonephritis; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction | 2002 |
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Blood Sedimentation; Double-Blind Method; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Recurrence; Treatment Failure | 2002 |
Isolated leptomeningeal carcinomatosis (carcinomatous meningitis) after taxane-induced major remission in patients with advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Disease Progression; Docetaxel; Female; Humans; Incidence; Meningeal Neoplasms; Meningitis; Methotrexate; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Recurrence; Remission Induction; Survival Rate; Taxoids | 2002 |
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.
Topics: Antigens, CD34; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Dose-Response Relationship, Drug; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Methotrexate; Pilot Projects; Recurrence; Retreatment; Rheumatoid Factor; Safety; Severity of Illness Index; Time Factors; Treatment Outcome | 2002 |
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.
Topics: Adolescent; Adult; Analgesics; Cause of Death; Costs and Cost Analysis; Cyclosporine; Drug Utilization; Erythrocyte Transfusion; Female; Fever; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Home Nursing; Hospitalization; Humans; Immunosuppressive Agents; Infection Control; Male; Methotrexate; Middle Aged; Pancytopenia; Parenteral Nutrition, Total; Patient Care Team; Patient Isolation; Prednisolone; Quality of Life; Recurrence; Survival Rate; Sweden; Transplantation Conditioning; Treatment Outcome | 2002 |
Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Erythrocytes; Female; Humans; Infant; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Sex Factors; Thioguanine | 2003 |
Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse.
Topics: Adolescent; Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Female; Follow-Up Studies; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Male; Methotrexate; Prednisone; Prospective Studies; Recurrence; Remission Induction | 2003 |
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation.
Topics: Adult; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Sirolimus; Survival Rate; Tacrolimus; Tissue Donors | 2003 |
[Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Vincristine | 2003 |
Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma.
Topics: Adult; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Risk Factors; Survival Rate; Tacrolimus; Transplantation, Homologous | 2003 |
Relationship between myalgias/arthralgias occurring in patients receiving quinupristin/dalfopristin and biliary dysfunction.
Topics: Aged; Alkaline Phosphatase; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Arthralgia; Biliary Tract Diseases; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Immunosuppressive Agents; Liver Function Tests; Male; Methotrexate; Middle Aged; Muscular Diseases; Neoplasms; Pain; Recurrence; Risk Factors; Tacrolimus; Virginiamycin | 2004 |
A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Organogold Compounds; Pain Measurement; Prognosis; Proportional Hazards Models; Recurrence; Remission Induction; Severity of Illness Index; Treatment Outcome | 2005 |
Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Siblings; Survival Rate; Tissue Donors | 2004 |
Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacteremia; Bone Marrow Neoplasms; Child; Child, Preschool; Cytarabine; Dexamethasone; Etoposide; Female; Flow Cytometry; Humans; Idarubicin; Ifosfamide; Infant; Infusions, Intravenous; Leucovorin; Male; Mesna; Methotrexate; Mouth Mucosa; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stomatitis; Thioguanine; Treatment Outcome; Vincristine | 2004 |
Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B Vaccines; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Treatment Outcome; Venezuela; Vincristine | 2004 |
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Treatment Outcome; Vincristine | 2005 |
Churg Strauss syndrome--successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment.
Topics: Adolescent; Adult; Aged; Churg-Strauss Syndrome; Drug Therapy, Combination; Female; Heart Diseases; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Remission Induction; Respiratory Tract Infections | 2004 |
Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Infusions, Intravenous; Injections, Intramuscular; Leucovorin; Methotrexate; Recurrence; Remission Induction; Risk Factors; Treatment Outcome | 2005 |
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Fluorouracil; Humans; Mastectomy; Methotrexate; Neoplasm Metastasis; Recurrence | 2005 |
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Remission Induction; Treatment Outcome; Vasculitis | 2005 |
Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Mastectomy, Segmental; Methotrexate; Middle Aged; Receptors, Estrogen; Recurrence | 2006 |
Low efficacy of methotrexate in childhood acute myeloid leukemia (AML): single-agent therapeutic window study in relapsed AML.
Topics: Adolescent; Adult; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Methotrexate; Recurrence; Treatment Outcome | 2006 |
Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Ovary; Quality of Life; Recurrence; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2006 |
Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemi
Topics: Age Factors; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Central Nervous System; Central Nervous System Neoplasms; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Female; Humans; Hydrocortisone; Injections, Spinal; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Sex Factors; T-Lymphocytes; Testicular Neoplasms; Time Factors | 2006 |
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Forced Expiratory Volume; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Karnofsky Performance Status; Leukemia; Life Tables; Lung Diseases; Male; Methotrexate; Middle Aged; Neural Tube Defects; Premedication; Prospective Studies; Recurrence; Survival Analysis; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome; Vital Capacity | 2006 |
Low-dose cyclosporin A with short-term methotrexate for graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation from human leukocyte antigen-identical siblings: a prospective phase II study in Japanese patients.
Topics: Adolescent; Adult; Asian People; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; HLA Antigens; Humans; Immunosuppressive Agents; Japan; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Siblings; Transplantation, Homologous | 2006 |
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
Topics: Adult; Antilymphocyte Serum; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Melphalan; Methotrexate; Middle Aged; Myeloablative Agonists; Recurrence; Risk Factors; Tacrolimus; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2006 |
Approaches to discontinuing efalizumab: an open-label study of therapies for managing inflammatory recurrence.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pilot Projects; Prospective Studies; Psoriasis; Recurrence; Retinoids; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Withholding Treatment | 2006 |
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Quality of Life; Recurrence; Survival Analysis | 2006 |
Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Agents; Benzamides; Child; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Haplotypes; Histocompatibility; HLA Antigens; Humans; Imatinib Mesylate; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia; Lymphocyte Transfusion; Male; Methotrexate; Mitoxantrone; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Piperazines; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Tissue Donors; Treatment Outcome | 2007 |
Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
Topics: Administration, Oral; Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; C-Reactive Protein; Cyclophosphamide; Drug Administration Schedule; Female; Glomerulonephritis; Granulomatosis with Polyangiitis; Hemoptysis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leukopenia; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Treatment Outcome | 2007 |
GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Humans; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Recurrence; Treatment Outcome | 2007 |
Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia.
Topics: Adolescent; Aminopterin; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Child; Child, Preschool; Drug Overdose; Erythrocytes; Female; Fever; Folic Acid Antagonists; Gastrointestinal Diseases; Humans; Leucovorin; Male; Methotrexate; Neurotoxicity Syndromes; Pilot Projects; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Treatment Outcome | 2008 |
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Azathioprine; Brain; Demography; Disability Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Observation; Peptides; Prevalence; Recurrence | 2008 |
Methotrexate-betamethasone weekly oral pulse in psoriasis.
Topics: Administration, Oral; Adolescent; Adult; Betamethasone; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Severity of Illness Index; Treatment Outcome | 2007 |
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2008 |
High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 2008 |
Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Female; Humans; Hydrocortisone; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stem Cell Transplantation; Survival Analysis; Thioguanine; Treatment Outcome | 2007 |
Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides/Sézary syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Methotrexate; Middle Aged; Mycosis Fungoides; Recombinant Proteins; Recurrence; Sezary Syndrome; Skin Neoplasms; Survival Analysis; Treatment Outcome | 2007 |
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Recurrence; Spondylitis, Ankylosing; Treatment Outcome | 2008 |
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Humans; Ifosfamide; Leukemia, Lymphoid; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Middle Aged; Recurrence | 2008 |
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclin D1; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Goserelin; Humans; Methotrexate; Middle Aged; Prognosis; Receptors, Cytoplasmic and Nuclear; Recurrence; Tamoxifen; Treatment Outcome | 2008 |
Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Infant; Lymphoma, B-Cell; Methotrexate; Neoplasms, Second Primary; Recurrence; Survival Analysis; Treatment Outcome | 2008 |
Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia.
Topics: Bone Marrow Examination; Central Nervous System Diseases; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Kinetics; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Probability; Random Allocation; Recurrence; Testicular Neoplasms | 1984 |
A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Random Allocation; Recurrence; Time Factors; Vincristine | 1984 |
Adjuvant chemotherapy with four drugs for stage 2 breast cancer.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Random Allocation; Recurrence; Vincristine | 1980 |
Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
Topics: Aged; BCG Vaccine; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Random Allocation; Receptors, Estrogen; Recurrence; Tamoxifen | 1980 |
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana d
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Injections, Spinal; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Regression Analysis; Remission Induction; Survival Analysis; Vincristine | 1995 |
In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/methotrexate.
Topics: Acute Disease; Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome | 1995 |
MACOP-B treatment in children and adolescents with advanced diffuse large-cell non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Staging; Pilot Projects; Prednisolone; Recurrence; Remission Induction; Vincristine | 1993 |
[MMIP chemotherapy for the treatment of the relapsed and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Recurrence | 1995 |
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Male; Methotrexate; Middle Aged; Opportunistic Infections; Prednisone; Prospective Studies; Recurrence; Remission Induction; Time Factors | 1995 |
Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cause of Death; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Thioguanine; Treatment Failure; Vincristine | 1995 |
Results of APL 91 European trial combining ATRA and chemotherapy: presentation of APL 1993 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Europe; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Mercaptopurine; Methotrexate; Recurrence; Remission Induction; Treatment Outcome; Tretinoin | 1994 |
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors | 1995 |
Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Postoperative Care; Radiotherapy Dosage; Recurrence; Retrospective Studies; Time Factors | 1995 |
High-dose sequential (HDS) chemotherapy with blood and marrow cell autograft as salvage treatment in very poor prognosis, relapsed non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Prognosis; Recurrence; Transplantation, Autologous | 1993 |
Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).
Topics: Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia, Myeloid, Acute; Leukocytes; Male; Methotrexate; Multivariate Analysis; Recurrence; Remission Induction; Risk Factors; Transplantation, Homologous; Whole-Body Irradiation | 1994 |
Use of cyclosporine in the treatment of autoimmune disorders.
Topics: Adult; Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence | 1994 |
Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Topics: Adult; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Methotrexate; Recurrence; Survival Analysis; T-Lymphocytes; Time Factors | 1994 |
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Chromosome Aberrations; Chromosome Disorders; Cyclosporine; Cytogenetics; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence; Survival Rate; Whole-Body Irradiation | 1994 |
Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Diabetes Insipidus; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Male; Mercaptopurine; Methotrexate; Prednisone; Prognosis; Prospective Studies; Recurrence; Remission Induction; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vinblastine | 1994 |
Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. BFM (Berlin-Frankfurt-Münster) Relapse Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Rate | 1994 |
Plasma and urine levels of methotrexate and 7-hydroxymethotrexate in children with ALL during maintenance therapy with weekly oral methotrexate.
Topics: Administration, Oral; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Administration Schedule; Humans; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Regression Analysis; Remission Induction | 1994 |
Circadian time-dependent response of childhood lymphoblastic leukemia to chemotherapy: a long-term follow-up study of survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Circadian Rhythm; Drug Administration Schedule; Follow-Up Studies; Humans; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proportional Hazards Models; Recurrence; Regression Analysis; Survival Analysis; Time Factors; Vincristine | 1993 |
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Cytomegalovirus Infections; Double-Blind Method; Fever; Graft vs Host Disease; Humans; Methotrexate; Middle Aged; Pentoxifylline; Placebos; Probability; Recurrence; Survival Analysis; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Humans; Infant; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Regression Analysis; Treatment Outcome | 1993 |
Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Analysis; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infections; Karyotyping; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Regression Analysis; Survival Rate; Treatment Outcome; Whole-Body Irradiation | 1996 |
The GIMEMA ALL 0183 trial: analysis of 10-year follow-up. GIMEMA Cooperative Group, Italy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Follow-Up Studies; Humans; Idarubicin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Analysis; Survival Rate | 1996 |
Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Phenotype; Prednisone; Prospective Studies; Recurrence; Survival Rate; Vincristine | 1996 |
Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carmustine; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Vincristine | 1996 |
Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antirheumatic Agents; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone; Recurrence | 1996 |
Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Female; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis | 1995 |
Methotrexate for the treatment of refractory Crohn's disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antimetabolites; Crohn Disease; Drug Resistance; Female; Humans; Injections, Intramuscular; Male; Methotrexate; Recurrence | 1996 |
Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis; Vincristine | 1996 |
Methotrexate prophylaxis for persistent ectopic pregnancy after conservative treatment by salpingostomy.
Topics: Adult; Female; Follow-Up Studies; Humans; Methotrexate; Pregnancy; Pregnancy, Ectopic; Recurrence; Salpingostomy | 1997 |
Radiosynoviorthesis with rhenium-186 in rheumatoid arthritis: a prospective study of three treatment regimens.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Child; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Injections, Intra-Articular; Male; Methotrexate; Pain Measurement; Patient Selection; Prednisolone; Prospective Studies; Radioisotopes; Range of Motion, Articular; Recurrence; Rhenium; Synovitis; Treatment Outcome; Triamcinolone Acetonide | 1997 |
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Karnofsky Performance Status; Methotrexate; Multivariate Analysis; Recurrence; Risk Factors; Time Factors; Transplantation Conditioning; Treatment Failure | 1997 |
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
Topics: Abdominal Pain; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chronic Disease; Crohn Disease; Double-Blind Method; Evaluation Studies as Topic; Female; Follow-Up Studies; Health Status; Humans; Immunosuppressive Agents; Israel; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Placebos; Recurrence; Remission Induction; Treatment Outcome | 1997 |
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Humans; Infant; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Prednisone; Prognosis; Recurrence; Remission Induction; Thioguanine; Vincristine | 1998 |
High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Methotrexate; Middle Aged; Mitoxantrone; Recurrence; Survival Rate; Thiotepa; Time Factors; Transplantation, Autologous; Vincristine | 1998 |
Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexate.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis; Time Factors | 1998 |
Methotrexate in patients with Crohn's disease after 6-mercaptopurine.
Topics: Adolescent; Child; Child, Preschool; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Mercaptopurine; Methotrexate; Prospective Studies; Recurrence; Remission Induction; Risk Factors; Treatment Outcome | 1998 |
Consolidation therapy with antimetabolite-based therapy in standard-risk acute lymphocytic leukemia of childhood: a Pediatric Oncology Group Study.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child, Preschool; Cytarabine; Female; Humans; Leucovorin; Male; Methotrexate; Recurrence; Remission Induction | 1998 |
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Nuclear Family; Recurrence; Survival Analysis; Tacrolimus; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 1998 |
[Chemotherapy of resistant and recurrent lymphoma based on a combination of ifosfamide and etoposide. Antitumor effects, toxicity and stimulation of peripheral stem cells].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Mitoxantrone; Recurrence; Salvage Therapy; Transplantation Conditioning | 1998 |
The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisolone; Prospective Studies; Recurrence; Repressor Proteins; Transplantation, Autologous | 1999 |
Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Female; Follow-Up Studies; Gold Sodium Thiomalate; Humans; Injections, Intramuscular; Male; Methotrexate; Recurrence; Treatment Outcome | 1999 |
Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cause of Death; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukocyte Count; Male; Methotrexate; Middle Aged; Neutrophils; Prospective Studies; Recurrence; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1999 |
Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Drug Administration Schedule; Enzymes, Immobilized; Female; Humans; L-Lactate Dehydrogenase; Male; Methotrexate; Middle Aged; Philadelphia Chromosome; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Treatment Outcome; Vincristine | 1999 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Chronic Disease; Communicable Diseases; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Transplantation, Homologous | 1999 |
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Survival Rate; Tamoxifen; Vincristine | 1999 |
Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Factors; Treatment Outcome | 2000 |
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
Topics: Adult; Crohn Disease; Double-Blind Method; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intramuscular; Male; Methotrexate; Prednisone; Recurrence; Remission Induction | 2000 |
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Bone and Bones; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Hospitalization; Humans; Infections; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Nuclear Family; Prospective Studies; Recurrence; Survival Rate | 2000 |
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Melphalan; Methotrexate; Microsatellite Repeats; Middle Aged; Nuclear Family; Polymerase Chain Reaction; Recurrence; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2000 |
[Crohn's disease: prevention of relapse with methotrexate or growth hormone].
Topics: Adult; Aged; Crohn Disease; Female; Growth Hormone; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Treatment Outcome | 2000 |
Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.
Topics: Adrenal Cortex Hormones; Aged; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Male; Methotrexate; Placebos; Prednisone; Recurrence; Sensitivity and Specificity; Statistics, Nonparametric | 2001 |
[Sustaining remission in Crohn disease with methotrexate--a placebo controlled study].
Topics: Crohn Disease; Double-Blind Method; Humans; Injections, Intramuscular; Methotrexate; Recurrence | 2001 |
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Remission Induction; Survival Rate; Vincristine | 2001 |
Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Etoposide; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Mitoguazone; Premedication; Recurrence; Transplantation, Autologous | 2001 |
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chi-Square Distribution; Cisplatin; Cost-Benefit Analysis; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Recurrence; Statistics, Nonparametric; Survival Rate; Transplantation, Autologous | 2001 |
British National Lymphoma Investigation: pilot studies of neoadjuvant chemotherapy in clinical stage Ia and IIa Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Female; Hodgkin Disease; Humans; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Recurrence; Survival Rate; Vinblastine | 2001 |
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Female; Graft Survival; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Immunotherapy, Adoptive; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Male; Methotrexate; Middle Aged; Platelet Transfusion; Recurrence; Remission Induction; Rituximab; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Heart Diseases; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Prednisone; Recurrence; Stomatitis; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2001 |
Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisone; Recurrence; Survival Rate; Time Factors; Vincristine | 2002 |
Central nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Feasibility Studies; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis; Treatment Outcome | 2002 |
Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Recurrence | 1979 |
Small cell lung cancer: progress and perspectives.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Recurrence; Remission, Spontaneous; Research Design; Time Factors; Transplantation, Autologous | 1978 |
Adjuvant chemotherapy in the primary management of breast cancer.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Survival; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Melphalan; Methotrexate; Middle Aged; Neoplasm Metastasis; Recurrence; Research Design | 1977 |
The value of maintenance therapy following treatment of central nervous system leukemia.
Topics: Antineoplastic Agents; Bone Marrow Diseases; Brain Neoplasms; Child; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Male; Methotrexate; Recurrence; Remission, Spontaneous; Retrospective Studies; Spinal Cord Neoplasms; Time Factors | 1977 |
Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Recurrence; Remission, Spontaneous; Time Factors; Vincristine | 1977 |
Surgery and adjuvant chemotherapy in the treatment of operable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Recurrence | 1977 |
Adjuvant chemotherapy in breast cancer--Swiss co-operative studies.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prednisone; Recurrence; Time Factors | 1979 |
Adjuvant multiple drug chemotherapy for osteosarcoma of the extremity: a 6 year report.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Extremities; Female; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Recurrence; Vincristine | 1979 |
Non-Hodgkin's lymphoma in children: an analysis of 122 cases from Argentina.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Infant; Leukemia; Lymphoma; Male; Methotrexate; Prednisone; Procarbazine; Recurrence; Remission, Spontaneous; Time Factors; Vincristine | 1978 |
Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas.
Topics: Adult; Aged; Amputation, Surgical; Arm; Cyclophosphamide; Doxorubicin; Female; Humans; Leg; Male; Methotrexate; Middle Aged; Propionibacterium acnes; Prospective Studies; Recurrence; Sarcoma; Soft Tissue Neoplasms | 1978 |
Treatment of overt meningeal leukaemia in children: results of second MRC meningeal leukaemia trial.
Topics: Brain; Cerebrospinal Fluid; Child; Humans; Leukemia, Lymphoid; Leukocyte Count; Meninges; Methotrexate; Radiotherapy, High-Energy; Recurrence; Spinal Cord | 1976 |
Adult lymphoblastic lymphoma: high incidence of central nervous system relapse in patients treated with the Stanford University protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Treatment Outcome | 1992 |
Fractionated TBI and methotrexate-cyclosporin do not seem to increase relapses in BMT for first chronic phase CML patients: results of a single centre study.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Pulmonary Fibrosis; Recurrence; Whole-Body Irradiation | 1992 |
Efficacy of intrathecal methotrexate with and without cranial radiotherapy in preventing central nervous system relapses in acute lymphocytic leukemia.
Topics: Adolescent; Brain; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Infant; Injections, Spinal; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Treatment Outcome | 1992 |
Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Female; France; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Risk Factors; Vincristine; Vindesine | 1992 |
MRC UKALL X. The UK protocol for childhood ALL: 1985-1990. The Medical Research Council Working Party on Childhood Leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Cranial Irradiation; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; United Kingdom | 1992 |
Early intensification followed by allo-BMT or auto-BMT or a second intensification in adult ALL: a randomized multicenter study.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Feasibility Studies; Humans; Italy; Methotrexate; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vincristine | 1992 |
Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Erythrocytes; Female; Humans; Hydrocortisone; Infant; Injections, Spinal; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Prednisone; Recurrence; Remission Induction; Rosette Formation; Thioguanine; Treatment Outcome; Vincristine | 1992 |
Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II to IV non-Hodgkin's lymphomas with intermediate- or high-grade histology.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leucovorin; Leukopenia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Mouth Mucosa; Neoplasm Staging; Neutropenia; Recurrence; Remission Induction; Stomatitis; Stroke Volume; Survival Rate; Vincristine | 1990 |
Intraoperative radiotherapy in the multidisciplinary treatment of bone sarcomas in children and adolescents.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Intraoperative Period; Male; Methotrexate; Osteosarcoma; Prospective Studies; Recurrence; Remission Induction; Sarcoma, Ewing; Vincristine | 1991 |
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Daunorubicin; Etoposide; Follow-Up Studies; Graft vs Host Disease; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Time Factors; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 1991 |
How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Humans; Infant; Leucovorin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Retrospective Studies; Risk Factors | 1991 |
Combination chemotherapy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prospective Studies; Recurrence; Remission Induction; Survival Rate; Vincristine | 1991 |
Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Testicular Neoplasms | 1991 |
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Follow-Up Studies; Humans; Infant; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Survival Rate; Vincristine | 1991 |
A phase II study of combined methotrexate and teniposide infusions prior to reinduction therapy in relapsed childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Evaluation; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Teniposide | 1991 |
A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Female; Fever; Humans; Infant; Infections; Length of Stay; Leukocyte Count; Male; Methotrexate; Neutropenia; Pilot Projects; Platelet Count; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Survival Rate | 1991 |
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Random Allocation; Recurrence; Remission Induction; Survival Rate; Testicular Neoplasms; Vincristine | 1991 |
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Survival Analysis; Tamoxifen | 1990 |
A new treatment protocol for childhood non-Hodgkin's lymphoma: preliminary evaluation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Premedication; Randomized Controlled Trials as Topic; Recurrence; Survival Rate; Vincristine | 1990 |
Pemphigus therapy with oral prednisolone regimens. A 5-year study.
Topics: Administration, Oral; Adolescent; Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Pemphigus; Prednisolone; Random Allocation; Recurrence | 1990 |
Nonsurgical management of unruptured ectopic pregnancy: an extended clinical trial.
Topics: Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leucovorin; Methotrexate; Peptide Fragments; Pregnancy; Pregnancy, Ectopic; Recurrence | 1987 |
Cyclosporin A versus methotrexate, followed by rescue with folinic acid as prophylaxis of acute graft-versus-host disease after bone marrow transplantation.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Blood Transfusion; Bone Marrow Transplantation; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leucovorin; Leukemia; Male; Methotrexate; Middle Aged; Postoperative Complications; Prospective Studies; Random Allocation; Recurrence | 1989 |
Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunotherapy; Infant; Leukemia; Leukocytes; Lymphoma; Male; Methotrexate; Pulmonary Fibrosis; Recurrence | 1989 |
Results of four different protocols for prophylaxis against graft-versus-host disease.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Lymphoma; Methotrexate; Postoperative Complications; Random Allocation; Recurrence; T-Lymphocytes | 1989 |
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Cyclosporins; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Prospective Studies; Random Allocation; Recurrence | 1985 |
Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Methotrexate; Middle Aged; Prospective Studies; Recurrence | 1988 |
A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Cyclosporins; Female; Graft Survival; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Middle Aged; Mouth Diseases; Random Allocation; Recurrence | 1986 |
Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect.
Topics: Adolescent; Analysis of Variance; Child; Child, Preschool; DNA, Neoplasm; Dose-Response Relationship, Drug; Female; Flow Cytometry; Hemoglobins; Humans; Infant; Infusions, Parenteral; Leukemia, Lymphoid; Leukocyte Count; Male; Metabolic Clearance Rate; Methotrexate; Prospective Studies; Random Allocation; Recurrence | 1986 |
Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukemia, Lymphoid; Male; Methotrexate; Prednisone; Prognosis; Radiotherapy Dosage; Recurrence; Risk; Thioguanine; Time Factors; Vincristine | 1986 |
Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine.
Topics: Adult; Bone Marrow Transplantation; Cyclosporins; Graft vs Host Disease; Humans; Kidney Diseases; Leukemia; Liver Diseases; Methotrexate; Middle Aged; Recurrence; Vascular Diseases; Whole-Body Irradiation | 1985 |
Comparison of two methods of preventing central nervous system leukemia.
Topics: Adolescent; Central Nervous System; Central Nervous System Diseases; Child; Child, Preschool; Cobalt Isotopes; Cyclophosphamide; Humans; Injections, Spinal; Leukemia, Lymphoid; Leukocyte Count; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Vincristine | 1973 |
597 other study(ies) available for methotrexate and Recrudescence
Article | Year |
---|---|
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation.
Topics: Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Recurrence; Siblings; Transplantation Conditioning; United States | 2022 |
Isolated CNS relapse of blastic plasmacytoid dendritic cell neoplasm.
Topics: Adult; Central Nervous System Neoplasms; Dendritic Cells; Hematologic Neoplasms; Humans; Injections, Spinal; Male; Methotrexate; Myeloproliferative Disorders; Recurrence | 2022 |
Analysis of the frequency distribution of five single-nucleotide polymorphisms of the MTRRgene in a Chinese pediatric population with acute lymphoblastic leukemia.
Topics: Child; Ferredoxin-NADP Reductase; Gene Frequency; Genotype; Humans; Methotrexate; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies | 2022 |
Improved outcomes of single-unit cord blood transplantation for acute myeloid leukemia by killer immunoglobulin-like receptor 2DL1-ligand mismatch.
Topics: Calcineurin Inhibitors; Cord Blood Stem Cell Transplantation; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Ligands; Methotrexate; Mycophenolic Acid; Receptors, KIR; Recurrence; Retrospective Studies | 2022 |
Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Insufficiency; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Cosyntropin; Glucocorticoids; Humans; Hydrocortisone; Hydroxychloroquine; Leflunomide; Methotrexate; Prednisolone; Recurrence; Tumor Necrosis Factor Inhibitors | 2022 |
Relapse and Remission in Children With Chronic Noninfectious Uveitis Treated With Methotrexate.
Topics: Child; Humans; Immunosuppressive Agents; Methotrexate; Recurrence; Retrospective Studies; Treatment Outcome; Uveitis | 2022 |
Cluster analysis reveals eosinophilia and fibrosis as poor prognostic markers in 128 patients with eosinophilic fasciitis.
Topics: Cluster Analysis; Eosinophilia; Fasciitis; Fibrosis; Glucocorticoids; Humans; Methotrexate; Prognosis; Recurrence; Retrospective Studies | 2022 |
Polymyalgia Rheumatica and Giant Cell Arteritis: Rapid Evidence Review.
Topics: C-Reactive Protein; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Myalgia; Polymyalgia Rheumatica; Recurrence | 2022 |
Pilot study to estimate the safety and effectiveness of hydroxyurea and methotrexate recurrent langerhans cell histiocytosis (LCH-HU-pilot).
Topics: Histiocytosis, Langerhans-Cell; Humans; Hydroxyurea; Methotrexate; Pilot Projects; Recurrence | 2022 |
Usefulness of methotrexate in relapsing idiopathic retroperitoneal fibrosis.
Topics: Humans; Methotrexate; Recurrence; Retroperitoneal Fibrosis; Retrospective Studies; Steroids; Treatment Outcome | 2023 |
Efficacy and tolerance of methotrexate in a real-life monocentric cohort of patients with giant cell arteritis.
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Recurrence; Retrospective Studies | 2023 |
The influence of intrathecal injection of methotrexate and dexamethasone on neuropsychiatric systemic lupus erythematosus (NPSLE): a retrospective cohort study of 386 patients with NPSLE.
Topics: Adult; Dexamethasone; Female; Humans; Injections, Spinal; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Male; Methotrexate; Recurrence; Retrospective Studies; Young Adult | 2023 |
A case of chronic eosinophilic pneumonia associated with rheumatoid arthritis in glucocorticoid-free remission with JAK inhibitor: A case report.
Topics: Adult; Arthritis, Rheumatoid; Asthma; Female; Glucocorticoids; Humans; Janus Kinase Inhibitors; Methotrexate; Middle Aged; Prednisolone; Pulmonary Eosinophilia; Recurrence; Young Adult | 2023 |
Methotrexate as a corticosteroid-sparing agent in leprosy reactions: A French multicenter retrospective study.
Topics: Erythema Nodosum; Female; Glucocorticoids; Humans; Leprosy; Leprosy, Lepromatous; Male; Methotrexate; Recurrence; Retrospective Studies | 2023 |
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice change.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; COVID-19; Cyclophosphamide; Humans; Methotrexate; Pandemics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Vincristine | 2023 |
What predicts the recurrence in ıdiopathic granulomatous mastitis?
Topics: Abscess; Adult; Aged; Azathioprine; Cross-Sectional Studies; Female; Granulomatous Mastitis; Humans; Immunoglobulin M; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Steroids; Treatment Outcome | 2023 |
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning.
Topics: Busulfan; Graft vs Host Disease; Humans; Methotrexate; Primary Myelofibrosis; Recurrence; Tacrolimus | 2023 |
Recurrence of Metastatic Crohn's Disease after Surgical Resection.
Topics: Abscess; Adult; Crohn Disease; Female; Humans; Infliximab; Mercaptopurine; Methotrexate; Neoplasms; Recurrence | 2023 |
Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort.
Topics: Adolescent; Adrenal Cortex Hormones; Antibodies, Antinuclear; Arthritis, Juvenile; Biological Factors; Cataract; Child; Child, Preschool; Chronic Disease; Female; France; Glaucoma; Humans; Immunosuppressive Agents; Infant; Macular Edema; Male; Methotrexate; Noncommunicable Diseases; Papilledema; Prognosis; Recurrence; Remission, Spontaneous; Retrospective Studies; Sarcoidosis; Uveitis; Vision Disorders | 2019 |
Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.
Topics: Adalimumab; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Cardiomyopathies; Deprescriptions; Drug Therapy, Combination; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sarcoidosis; Treatment Outcome | 2019 |
Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation.
Topics: Acetyl-CoA C-Acetyltransferase; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Japan; Male; Methotrexate; Middle Aged; Polymorphism, Single Nucleotide; Recurrence; Siblings; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Young Adult | 2020 |
Stopping anti-tumour necrosis factor therapy in patients with perianal Crohn's disease.
Topics: Adalimumab; Adolescent; Adult; Asia; Crohn Disease; Databases, Factual; Female; Humans; Infliximab; Male; Methotrexate; Recurrence; Tumor Necrosis Factor-alpha; Withholding Treatment; Young Adult | 2019 |
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cyclosporine; Deprescriptions; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Risk Factors; Symptom Flare Up; Time Factors | 2020 |
GVHD prophylaxis by tacrolimus and mini-MTX in single-unit CBT: a single institute experience.
Topics: Drug Therapy, Combination; Graft vs Host Disease; Humans; Methotrexate; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus; Treatment Outcome | 2020 |
Lung metastases in low-risk gestational trophoblastic neoplasia: a retrospective cohort study.
Topics: Adult; Antimetabolites, Antineoplastic; Choriocarcinoma; Cohort Studies; Drug Resistance, Neoplasm; Female; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Netherlands; Outcome Assessment, Health Care; Pregnancy; Recurrence; Risk Assessment; United Kingdom | 2020 |
Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease.
Topics: Adult; Aged; Chromones; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Lacrimal Apparatus; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence; Retrospective Studies; Salivary Glands; Sulfonamides; Treatment Outcome; Young Adult | 2020 |
Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma.
Topics: Abnormal Karyotype; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Biopsy; Cyclophosphamide; Disease Progression; DNA Nucleotidylexotransferase; Doxorubicin; Fatal Outcome; Female; Humans; Lymphoma, Follicular; Mercaptopurine; Methotrexate; Middle Aged; Pancytopenia; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Rituximab; Salvage Therapy; Splenic Rupture; Splenomegaly; Stomach; Vincristine | 2020 |
A Long-Term Follow-up of Retinal Vasculitis - Do They Develop Systemic Disease?
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retinal Vasculitis; Retrospective Studies; Tuberculin Test; Tuberculosis, Ocular; Visual Acuity; Vitreous Hemorrhage | 2020 |
Intravenous methotrexate at a dose of 1 g/m
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cerebrospinal Fluid; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Kidney Diseases; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mucositis; Neoplasm Invasiveness; Prednisone; Proportional Hazards Models; Prospective Studies; Recurrence; Rituximab; Vincristine | 2020 |
Distinct decrease in peripheral lymphocytes in EBER-positive cases of MTX-LPD.
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Japan; Lymphocyte Count; Lymphocytes; Lymphoproliferative Disorders; Male; Methotrexate; Outcome Assessment, Health Care; Recurrence; Withholding Treatment | 2021 |
Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.
Topics: Adult; Age Factors; Azathioprine; Biomarkers; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome | 2020 |
Pleural effusion: An uncommon manifestation of SAPHO syndrome?
Topics: Acquired Hyperostosis Syndrome; Aged; Humans; Immunosuppressive Agents; Male; Methotrexate; Pleural Effusion; Recurrence | 2020 |
Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Incidence; Japan; Lymphocyte Count; Lymphocytes; Lymphoproliferative Disorders; Male; Methotrexate; Recurrence; Risk Assessment; Withholding Treatment | 2021 |
Use of methotrexate in the management of recurrent Tolosa-Hunt syndrome: Two case reports.
Topics: Adult; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Recurrence; Steroids; Tolosa-Hunt Syndrome; Treatment Outcome | 2020 |
Treatment of idiopathic granulomatous mastitis and factors related with disease recurrence
Topics: Adult; Breast; Female; Granulomatous Mastitis; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Recurrence; Retrospective Studies | 2020 |
Methotrexate in Linear Scleroderma: Long-Term Efficacy in Fifty Children From a Single Pediatric Rheumatology Center.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cross-Sectional Studies; Disease-Free Survival; Female; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Methotrexate; Recurrence; Remission Induction; Retrospective Studies; Scleroderma, Localized; Time Factors; Treatment Outcome | 2021 |
Usefulness of Methotrexate in the Reduction of Relapses and Recurrences in Polymyalgia Rheumatica: An Observational Study.
Topics: Antirheumatic Agents; Female; Humans; Longitudinal Studies; Male; Methotrexate; Polymyalgia Rheumatica; Recurrence | 2020 |
Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: A single center real-world study.
Topics: Adult; Aged; Disease Progression; Female; Humans; Immunosuppressive Agents; Lung; Male; Methotrexate; Middle Aged; Progression-Free Survival; Recurrence; Retrospective Studies; Sarcoidosis, Pulmonary; Time Factors; Tomography, X-Ray Computed | 2019 |
Biological agent in prevention of ocular recurrence in Behçets disease: a case report.
Topics: Adalimumab; Administration, Oral; Adult; Anti-Inflammatory Agents; Behcet Syndrome; Drug Combinations; Genital Diseases, Male; Humans; Immunosuppressive Agents; Male; Methotrexate; Oral Ulcer; Recurrence; Ulcer; Uveitis, Anterior | 2019 |
Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Blood Sedimentation; Deprescriptions; Female; Glucocorticoids; Humans; Infliximab; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Tumor Necrosis Factor Inhibitors | 2020 |
Incidence, Clinical Features, and Outcomes of Late-Onset Neutropenia From Rituximab for Autoimmune Disease.
Topics: Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Asymptomatic Diseases; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Fever; Filgrastim; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Hematologic Agents; Humans; Immunologic Factors; Incidence; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nephrosis, Lipoid; Neutropenia; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Rituximab; Sepsis | 2021 |
Gastrointestinal lesion in adult-onset Langerhans cell histiocytosis.
Topics: Adolescent; Adult; Age of Onset; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Colonoscopy; Endoscopy, Gastrointestinal; Female; Gastrointestinal Diseases; Histiocytosis, Langerhans-Cell; Humans; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Treatment Outcome; Vinblastine; Young Adult | 2020 |
Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8
Topics: Animals; Artemisinins; CD8-Positive T-Lymphocytes; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Imiquimod; Immunologic Memory; Interleukin-15; Interleukin-17; Male; Methotrexate; Mice; Psoriasis; Recurrence; Secondary Prevention; Skin; Skin Transplantation; Transplantation Chimera | 2020 |
Repeat-positive SARS-CoV-2 in a child with cancer.
Topics: Antimetabolites, Antineoplastic; Asymptomatic Diseases; Child, Preschool; COVID-19; Humans; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; SARS-CoV-2 | 2021 |
How I treat adult T-cell leukemia/lymphoma.
Topics: Aged; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prednisone; Raltegravir Potassium; Recurrence; Remission Induction; Therapies, Investigational; Vincristine; Virus Activation; Zidovudine | 2021 |
Central nervous system relapse of primary cutaneous CD8
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autografts; CD8-Positive T-Lymphocytes; Central Nervous System; Cranial Nerve Diseases; Cytarabine; Humans; Lymphoma, T-Cell, Cutaneous; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Recurrence; Referral and Consultation; Remission Induction; Skin Neoplasms; Spinal Puncture; Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Treatment Outcome | 2021 |
TNFi-induced sustained clinical remission in peripheral spondyloarthritis patients cannot be maintained with a step-down strategy based on methotrexate.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Prospective Studies; Recurrence; Remission Induction; Spondylarthritis; Time Factors; Tumor Necrosis Factor Inhibitors | 2021 |
Rheumatoid arthritis relapse in patients with other iatrogenic immunodeficiency-associated lymphoproliferative disorders and its treatment.
Topics: Arthritis, Rheumatoid; Humans; Iatrogenic Disease; Lymphoproliferative Disorders; Methotrexate; Recurrence; Retrospective Studies | 2021 |
Relapsed granulomatosis with polyangiitis with panhypopituitarism.
Topics: Adrenal Insufficiency; Androgens; Diabetes Insipidus; Fatigue; Glucocorticoids; Granulomatosis with Polyangiitis; Hormone Replacement Therapy; Humans; Hypogonadism; Hypopituitarism; Hypothyroidism; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Pituitary Diseases; Pituitary Gland; Recurrence; Rhinitis; Sella Turcica; Sinusitis; Testosterone; Thyroxine; Weight Loss | 2021 |
MTX-HOPE is a low-dose salvage chemotherapy for aged patients with relapsed or refractory non-Hodgkin lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Grading; Neoplasm Staging; Piperazines; Prognosis; Proportional Hazards Models; Recurrence; Salvage Therapy; Treatment Outcome; Vincristine | 2021 |
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Transplantation Conditioning; Unrelated Donors | 2022 |
The effect of methotrexate monotherapy on treatment-resistant idiopathic granulomatous mastitis patients.
Topics: Breast; Female; Granulomatous Mastitis; Humans; Immunoglobulin M; Methotrexate; Recurrence | 2022 |
No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; DNA; Female; Genotype; Humans; Infant; Male; Mercaptopurine; Methotrexate; Methyltransferases; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 2021 |
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience.
Topics: Adult; Allografts; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Immunologic; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Recurrence; Retrospective Studies; T-Lymphocytes; Unrelated Donors | 2021 |
Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX-based regimens in clinical routine.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Germany; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prognosis; Recurrence; Retreatment; Survival Analysis; Treatment Outcome; Young Adult | 2021 |
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Risk Factors; Rituximab; Vincristine | 2021 |
Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report.
Topics: Aged; Autoimmunity; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Male; Methotrexate; Microscopic Polyangiitis; Recurrence; SARS-CoV-2 | 2021 |
Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: a prospective observational study.
Topics: Adolescent; Adult; Antirheumatic Agents; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Janus Kinase Inhibitors; Male; Methotrexate; Middle Aged; Piperidines; Prospective Studies; Pyrimidines; Recurrence; Takayasu Arteritis; Time Factors; Treatment Outcome; Young Adult | 2022 |
Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child, Preschool; Clinical Protocols; Drug Monitoring; Female; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Male; Medication Therapy Management; Methotrexate; Monitoring, Immunologic; Quality of Life; Recurrence; Remission Induction; Sex Factors | 2021 |
Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Female; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Recurrence; Sulfonamides | 2021 |
The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Arthritis, Rheumatoid; Female; Hodgkin Disease; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Remission Induction | 2017 |
Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Child; Cohort Studies; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Diseases; Lung Diseases; Male; Methotrexate; Mycophenolic Acid; Prospective Studies; Recurrence; Registries; Remission Induction; Retrospective Studies; Rituximab | 2017 |
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Recurrence; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vincristine | 2017 |
Granulomatosis with polyangiitis in Tunisia.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Biomarkers; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Granulomatosis with Polyangiitis; Hospitals, University; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prevalence; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Tunisia | 2017 |
[A Case of Intrathecal Infusion of Methotrexate and Ara-C for a Patient with Meningitis Due to Recurrent Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Biopsy; Chemotherapy, Adjuvant; Female; Gastrectomy; Humans; Meningitis; Methotrexate; Recurrence; Stomach Neoplasms | 2017 |
Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Cytokines; Drug Therapy, Combination; Etanercept; Female; Humans; Male; Methotrexate; Proportional Hazards Models; Recurrence; Remission Induction; Retrospective Studies; ROC Curve; Taiwan; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Factorial Analysis of Hepatitis B Virus Reactivation-Induced Hepatitis B Using JADER.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Antineoplastic Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Child; Cyclophosphamide; Databases, Factual; Doxorubicin; Factor Analysis, Statistical; Female; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Japan; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Rituximab; Vincristine; Young Adult | 2017 |
Intraocular Lymphoma Masquerading as Recurrent Iridocyclitis: Findings Based on in vivo Confocal Microscopy.
Topics: Anterior Eye Segment; Antimetabolites, Antineoplastic; Aqueous Humor; Diagnosis, Differential; Female; Humans; Intraocular Lymphoma; Intravitreal Injections; Iridocyclitis; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Microscopy, Confocal; Middle Aged; Recurrence; Retrospective Studies | 2018 |
Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Topics: Acute Disease; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Off-Label Use; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity | 2018 |
A prospective observational study to compare efficacy of topical triamcinolone acetonide 0.1% oral paste, oral methotrexate, and a combination of topical triamcinolone acetonide 0.1% and oral methotrexate in moderate to severe oral lichen planus.
Topics: Administration, Oral; Administration, Topical; Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lichen Planus, Oral; Male; Methotrexate; Middle Aged; Ointments; Prospective Studies; Quality of Life; Recurrence; Remission Induction; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome; Triamcinolone Acetonide | 2018 |
Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Disability Evaluation; Disease Progression; Drug Therapy, Combination; Ethics, Research; Female; Humans; Male; Methotrexate; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Remission Induction; Research Design; Research Subjects; Time Factors; Treatment Outcome; Vulnerable Populations | 2018 |
T-cell-replete haploidentical stem cell transplantation using low-dose antithymocyte globulin in children with relapsed or refractory acute leukemia.
Topics: Adolescent; Antilymphocyte Serum; Child; Child, Preschool; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation Conditioning; Treatment Outcome; Young Adult | 2018 |
UVA-1 phototherapy for the management of atopic dermatitis: a large retrospective study conducted in a low-middle income country.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Colombia; Dermatitis, Atopic; Developing Countries; Emollients; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Radiotherapy Dosage; Recurrence; Retrospective Studies; Severity of Illness Index; Ultraviolet Therapy; Young Adult | 2018 |
Low-dose weekly methotrexate used to treat cutaneous Rosai-Dorfman disease.
Topics: Administration, Oral; Adrenal Cortex Hormones; Antimetabolites, Antineoplastic; Female; Histiocytosis, Sinus; Humans; Injections, Intramuscular; Methotrexate; Middle Aged; Radiotherapy; Rare Diseases; Recurrence; Skin; Skin Diseases; Thigh; Treatment Failure; Treatment Outcome | 2018 |
The effect of methotrexate and sulfasalazine on the course of HLA-B27-positive anterior uveitis: results from a retrospective cohort study.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Sulfasalazine; Treatment Outcome; Uveitis, Anterior; Visual Acuity | 2018 |
Relapsed lymphoma mimicking venous ulcer: A case report.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Humans; Leg Ulcer; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Prednisone; Recurrence; Rituximab; Vincristine | 2018 |
The treatment outcomes in IgG4-related disease.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Autoimmune Diseases; Cohort Studies; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Male; Methotrexate; Middle Aged; Netherlands; Recurrence; Retrospective Studies; Risk Assessment; Rituximab; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2018 |
Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in Rwanda.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cancer Care Facilities; Child; Cyclophosphamide; Developing Countries; Dexamethasone; Female; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Rwanda; Treatment Outcome; Vincristine | 2018 |
Cesarean Scar Pregnancy, Incidence, and Recurrence: Five-Year Experience at a Single Tertiary Care Referral Center.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Cesarean Section; Cicatrix; Combined Modality Therapy; Curettage; Female; Humans; Hysteroscopy; Methotrexate; Potassium Chloride; Pregnancy; Pregnancy Rate; Pregnancy, Ectopic; Recurrence; Tertiary Care Centers; Uterine Artery Embolization; Uterine Balloon Tamponade; Watchful Waiting; Young Adult | 2018 |
Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma.
Topics: Adolescent; Age of Onset; Antibodies, Antinuclear; Child; Child, Preschool; Cohort Studies; Disease Progression; Female; Glucocorticoids; Humans; Male; Medication Adherence; Methotrexate; Prognosis; Prospective Studies; Recurrence; Registries; Remission Induction; Retrospective Studies; Scleroderma, Localized | 2019 |
Recurrent Henoch Schönlein purpura without renal involvement successfully treated with methotrexate.
Topics: Child; Humans; IgA Vasculitis; Immunosuppressive Agents; Male; Methotrexate; Recurrence; Retreatment | 2019 |
Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Combined Modality Therapy; Female; Gamma Rays; Humans; Injections, Intravenous; Intravitreal Injections; Lymphoma; Male; Methotrexate; Middle Aged; Recurrence; Retina; Retinal Neoplasms; Retrospective Studies; Rituximab; Survival Analysis; Treatment Outcome; Vitreous Body | 2019 |
Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease.
Topics: Adult; Antibodies, Bispecific; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Cytarabine; Humans; Hydrocortisone; Male; Methotrexate; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 2019 |
TNF-α inhibitor-induced psoriasis: A decade of experience at the Cleveland Clinic.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retrospective Studies; Risk Factors; Sex Factors; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2020 |
Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.
Topics: Academic Medical Centers; Aged; Biopsy, Needle; Case-Control Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; North America; Positron-Emission Tomography; Prednisone; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |
Limited GPA and Alpha-1 Antitrypsin Deficiency in a Pediatric Patient.
Topics: Administration, Oral; alpha 1-Antitrypsin Deficiency; Child, Preschool; Dexamethasone; Diagnosis, Differential; Emergency Service, Hospital; Female; Granulomatosis with Polyangiitis; Humans; Laryngostenosis; Methotrexate; Rare Diseases; Recurrence; Risk Assessment; Treatment Outcome | 2019 |
A 74-year-old female with recurrent infections receiving methotrexate for rheumatoid arthritis.
Topics: Aged; Antibiotic Prophylaxis; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Immunocompromised Host; Immunologic Deficiency Syndromes; Methotrexate; Opportunistic Infections; Recurrence | 2019 |
Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Doxorubicin; Duodenal Diseases; Endoscopy, Digestive System; Female; Humans; Lymphoproliferative Disorders; Methotrexate; Prednisone; Recurrence; Rituximab; Stomach Diseases; Vincristine; Withholding Treatment | 2019 |
Methotrexate-associated primary hepatic lymphoma and cranial neuropathy in a patient with rheumatoid arthritis: A case report with clinical follow-up over a 7-year period.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cranial Nerve Diseases; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lymphoma; Methotrexate; Recurrence | 2019 |
Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analysis.
Topics: Adult; Aged; Central Nervous System Neoplasms; Cohort Studies; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Premedication; Prospective Studies; Recurrence; Risk Assessment; Survival Analysis; Treatment Outcome | 2019 |
Inotuzumab ozogamicin, a nonchemotherapy option for relapsed acute lymphoblastic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Bispecific; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Dexamethasone; Humans; Inotuzumab Ozogamicin; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy; Vascular Diseases | 2019 |
Leflunomide treatment in juvenile idiopathic arthritis.
Topics: Adolescent; Arthritis, Juvenile; Biological Products; Child; Child, Preschool; Drug Substitution; Female; Humans; Immunosuppressive Agents; Infant; Leflunomide; Male; Methotrexate; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome | 2019 |
Success rate of methotrexate treatment for recurrent
Topics: Abortifacient Agents, Nonsteroidal; Adult; Case-Control Studies; Chorionic Gonadotropin; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Israel; Methotrexate; Pregnancy; Pregnancy, Tubal; Recurrence; Risk Factors; Treatment Outcome | 2020 |
Mechanic's hand: is it a marker of disease relapse?
Topics: Adult; Arthritis; Drug Therapy, Combination; Female; Hand Dermatoses; Humans; Methotrexate; Myositis; Prednisolone; Recurrence; Severity of Illness Index | 2020 |
ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Europe; Hematopoietic Stem Cell Transplantation; Humans; Mercaptopurine; Methotrexate; Multicenter Studies as Topic; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Retreatment; Survival Rate; Vincristine | 2013 |
Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Arabinonucleosides; Cerebellum; Child; Cyclophosphamide; Cytarabine; Etoposide; Fatal Outcome; Guillain-Barre Syndrome; Humans; Magnetic Resonance Imaging; Male; Medulla Oblongata; Methotrexate; Necrosis; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Seizures; Spinal Cord | 2013 |
Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; China; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Dexamethasone; Drug Evaluation; Female; Harringtonines; Homoharringtonine; Humans; Idarubicin; Infusions, Intravenous; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Oncogene Proteins, Fusion; Oxides; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Tretinoin; Young Adult | 2014 |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Paclitaxel; Prognosis; Recurrence; Survival Analysis; Taxoids | 2013 |
[MTX associated lymphoproliferative disorder].
Topics: Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Methotrexate; Recurrence | 2013 |
Nephrolithiasis in pediatric hematopoietic cell transplantation with up to 40 years of follow-up.
Topics: Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Methotrexate; Nephrolithiasis; Prednisone; Prevalence; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Survivors | 2014 |
High cut-off dialysis as a salvage therapy option in high-dose methotrexate chemotherapy?
Topics: Acute Kidney Injury; Aged; Brain; Combined Modality Therapy; Cranial Irradiation; Humans; Kidney Tubular Necrosis, Acute; Leucovorin; Lymphoma, B-Cell; Male; Metabolic Clearance Rate; Methotrexate; Recurrence; Renal Dialysis; Salvage Therapy | 2014 |
The risk of CNS involvement in aggressive lymphomas in the rituximab era.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Recurrence; Risk Factors; Rituximab; Stem Cell Transplantation; Transplantation, Autologous | 2013 |
Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Azathioprine; Female; Follow-Up Studies; Histidine-tRNA Ligase; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myositis; Outcome Assessment, Health Care; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Severity of Illness Index; Steroids; Surveys and Questionnaires; Young Adult | 2013 |
Steroid-resistant relapsing IgG4-related pachymeningitis treated with methotrexate.
Topics: Administration, Oral; Aged; Drug Resistance; Humans; Immunoglobulin G; Male; Meningitis; Methotrexate; Recurrence; Steroids; Treatment Outcome | 2014 |
An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).
Topics: Abatacept; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cohort Studies; Drug Therapy, Combination; Female; Granulomatosis with Polyangiitis; Humans; Immunoconjugates; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Recurrence; Remission Induction; Severity of Illness Index; Treatment Outcome; Young Adult | 2014 |
High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Psoriatic; Female; Humans; Joints; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alpha; Ultrasonography; Young Adult | 2015 |
Febrile ulceronecrotic Mucha-Habermann disease.
Topics: Abdominal Pain; Adolescent; Anti-Inflammatory Agents; Female; Fever; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Necrosis; Pityriasis Lichenoides; Recurrence; Skin; Skin Ulcer | 2013 |
Patients with primary diffuse large B-cell lymphoma of female genital tract have high risk of central nervous system relapse.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Genitalia, Female; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednisone; Prognosis; Recurrence; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2014 |
High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Survival Analysis; Sweden; Transplantation, Homologous; Vincristine | 2014 |
Recurrent Bell's palsy in a patient with Crohn's disease on methotrexate.
Topics: Adult; Bell Palsy; Crohn Disease; Herpes Simplex; Humans; Immunosuppressive Agents; Male; Methotrexate; Recurrence | 2014 |
Granulomatosis with polyangiitis (Wegener's): impact of maintenance therapy duration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Drug Administration Schedule; Female; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Young Adult | 2014 |
[A retrospective study of tegafur/uracil compared with cyclophosphamide, methotrexate, and fluorouracil as adjuvant chemotherapy in patients with node-negative, triple-negative breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Tegafur; Triple Negative Breast Neoplasms; Uracil | 2014 |
Disease flare after 7 year-remission of systemic type juvenile idiopathic arthritis: is growth hormone therapy a culprit or innocent bystander?
Topics: Administration, Oral; Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Drug Therapy, Combination; Glucocorticoids; Growth Disorders; Human Growth Hormone; Humans; Male; Methotrexate; Recurrence; Remission Induction; Risk Factors; Time Factors; Treatment Outcome | 2015 |
Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antimetabolites; Azathioprine; Crohn Disease; Female; Follow-Up Studies; Humans; Infliximab; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Recurrence; Remission Induction; Retreatment; Retrospective Studies; Risk Factors; Treatment Failure; Withholding Treatment; Young Adult | 2014 |
Cure rates of childhood acute lymphoblastic leukemia in Lithuania and the benefit of joining international treatment protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Incidence; Lithuania; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Treatment Outcome; Young Adult | 2014 |
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma.
Topics: Acute Kidney Injury; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Risk Assessment; Rituximab; Survival Rate; Vincristine; Young Adult | 2014 |
Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age.
Topics: Adalimumab; Age Factors; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Child, Preschool; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Infant; Male; Methotrexate; Receptors, Tumor Necrosis Factor; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Tumor Necrosis Factor-alpha; Withholding Treatment | 2015 |
Primary thyroid marginal zone B-cell lymphoma in a patient with psoriatic arthritis treated with etanercept.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Etanercept; Female; Follow-Up Studies; Humans; Immunoglobulin G; Lymphoma, B-Cell, Marginal Zone; Methotrexate; Middle Aged; Psoriasis; Radiotherapy, Adjuvant; Rare Diseases; Receptors, Tumor Necrosis Factor; Recurrence; Retreatment; Risk Assessment; Severity of Illness Index; Thyroid Neoplasms; Thyroidectomy; Treatment Refusal | 2014 |
Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Kaplan-Meier Estimate; Los Angeles; Male; Methotrexate; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody-associated small vessel vasculitis.
Topics: Abortion, Spontaneous; Adolescent; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Azathioprine; Cesarean Section; Cyclophosphamide; Female; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Live Birth; Methotrexate; Microscopic Polyangiitis; Plasma Exchange; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy, High-Risk; Pregnancy, Unplanned; Recurrence; Retrospective Studies; Term Birth; United Kingdom; Young Adult | 2015 |
Effectiveness of medical treatment with methotrexate for interstitial pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Injections, Intra-Arterial; Injections, Intramuscular; Leucovorin; Methotrexate; Pregnancy; Pregnancy, Interstitial; Recurrence; Retreatment; Retrospective Studies; Treatment Failure; Ultrasonography; Uterine Artery; Uterine Artery Embolization; Vitamin B Complex | 2014 |
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Neutrophils; Recurrence; Retrospective Studies; Siblings; Survival Analysis; Tissue Donors; Transplantation, Homologous | 2015 |
High-dose methotrexate (HD-MTX) used as an adjunct with other chemotherapeutics for the treatment of osteosarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Child; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Osteosarcoma; Prognosis; Recurrence; Retrospective Studies; Young Adult | 2015 |
Eosinophilic fasciitis: clinical characteristics and response to methotrexate.
Topics: Adult; Aged; Biopsy; Eosinophilia; Fasciitis; Female; Florida; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome | 2015 |
Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Denmark; Genotype; Haplotypes; Humans; Infant; Male; Methotrexate; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Recurrence; Risk Assessment; Treatment Outcome | 2015 |
Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous | 2015 |
Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma.
Topics: Administration, Intravenous; Adult; Aged; Antineoplastic Agents; Busulfan; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2015 |
Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cytarabine; Disease-Free Survival; Female; Finland; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Rituximab; Survival Rate; Treatment Outcome | 2015 |
Polymyalgia rheumatica in a patient with splenic marginal zone lymphoma - a case report.
Topics: Drug Therapy, Combination; Female; Humans; Lymphoma; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone; Recurrence; Splenectomy; Splenic Neoplasms | 2015 |
Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Prednisone; Recurrence; Regression Analysis; Risk; Rituximab; Treatment Failure; Tumor Burden; Vincristine; Young Adult | 2015 |
Chédiak-Higashi syndrome: brain MRI and MR spectroscopy manifestations.
Topics: Brain; Chediak-Higashi Syndrome; Child; Contrast Media; Cyclosporine; Dexamethasone; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Immunosuppressive Agents; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methotrexate; Recurrence; Treatment Outcome | 2015 |
[Subacute encephalopathy after high-dose methotrexate as prophylaxis for central nervous system relapse in a patient with intravascular large B-cell lymphoma].
Topics: Central Nervous System; Female; Humans; Injections, Spinal; Lymphoma, B-Cell; Methotrexate; Middle Aged; Recurrence; Treatment Outcome | 2015 |
Combination therapy of methotrexate plus NBUVB phototherapy is more effective than methotrexate monotherapy in the treatment of chronic plaque psoriasis.
Topics: Adolescent; Adult; Combined Modality Therapy; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Ultraviolet Therapy; Young Adult | 2015 |
[Efficacy Analysis of MAC Regimen as Salvage Treatment Protocol for Acute Myeloid Leukemia Patients Older Than 55 Years].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cytarabine; Dactinomycin; Humans; Leukemia, Myeloid, Acute; Methotrexate; Middle Aged; Recurrence; Remission Induction; Salvage Therapy | 2015 |
Chronological assessment of airway lesions in relapsing polychondritis by positron emission tomography.
Topics: Adult; Bronchoscopy; Chest Pain; Costal Cartilage; Cyclosporine; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Methotrexate; Multimodal Imaging; Polychondritis, Relapsing; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Trachea | 2015 |
A case of relapsing neurosarcoidosis with brain nodules and hydrocephalus successfully treated by corticosteroid and methotrexate.
Topics: Adrenal Cortex Hormones; Central Nervous System Diseases; Cognition Disorders; Comorbidity; Drug Therapy, Combination; Female; Humans; Hydrocephalus; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Recurrence; Rheumatic Nodule; Sarcoidosis; Treatment Outcome | 2015 |
Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Chronic Disease; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Infant; Isoxazoles; Leflunomide; Male; Methotrexate; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis | 2015 |
Langerhans Cell Histiocytosis (LCH) in Egyptian Children: Does Reactivation Affect the Outcome?
Topics: Child; Child, Preschool; Egypt; Female; Follow-Up Studies; Glucocorticoids; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Prednisone; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome; Tubulin Modulators; Vinblastine | 2016 |
Methotrexate ultraviolet reactivation reaction in the setting of voriconazole-induced phototoxicity.
Topics: Adolescent; Antifungal Agents; Bone Marrow Transplantation; Dermatitis, Phototoxic; Drug Eruptions; Humans; Immunosuppressive Agents; Male; Methotrexate; Recurrence; Sunburn; Ultraviolet Therapy; Voriconazole | 2015 |
Clinical outcome in a Norwegian cohort of patients with chronic recurrent multifocal osteomyelitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Child; Cohort Studies; Female; Humans; Male; Methotrexate; Norway; Osteomyelitis; Recurrence; Retrospective Studies; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Disability Evaluation; Disease Progression; Follow-Up Studies; Humans; Joints; Methotrexate; Netherlands; Pain; Pain Measurement; Recurrence; Registries; Severity of Illness Index; Surveys and Questionnaires; Time Factors | 2015 |
Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Chemoradiotherapy; Cisplatin; Consolidation Chemotherapy; Dexamethasone; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Recurrence; Treatment Outcome | 2015 |
Thromboembolism as an important complication of inflammatory bowel disease.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Pulmonary Embolism; Recurrence; Retrospective Studies; Severity of Illness Index; Venous Thromboembolism; Venous Thrombosis | 2016 |
[Clinical features of patients with juvenile and adult dermatomyositis].
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatomyositis; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Muscle Weakness; Recurrence; Retrospective Studies; Young Adult | 2015 |
[Case Report; Successful treatment with methotrexate and low-dose corticosteroids for recurrent cardiac sarcoidosis].
Topics: Adrenal Cortex Hormones; Aged; Cardiomyopathies; Drug Combinations; Female; Humans; Methotrexate; Recurrence; Sarcoidosis | 2015 |
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha | 2015 |
Non-Hodgkin lymphoma and idiopathic inflammatory cardiomyopathy.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Coronary Angiography; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Angiography; Methotrexate; Middle Aged; Multimodal Imaging; Myocarditis; Positron Emission Tomography Computed Tomography; Recurrence; Ventricular Dysfunction, Left | 2016 |
Idiopathic Dacryoadenitis: Clinical Features, Histopathology, and Treatment Outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Biopsy; Child; Dacryocystitis; Drug Resistance; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Retrospective Studies; Risk Factors; Tertiary Care Centers; Treatment Outcome; Triamcinolone Acetonide | 2016 |
Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Chi-Square Distribution; Disability Evaluation; Female; Humans; Joints; Logistic Models; Male; Methotrexate; Middle Aged; Multivariate Analysis; Odds Ratio; Predictive Value of Tests; Prospective Studies; Recurrence; Remission Induction; Synovitis; Tendons; Tenosynovitis; Time Factors; Treatment Outcome; Ultrasonography, Doppler | 2016 |
[Clinical practice guideline for ANCA-associated vasculitis with renal involvement].
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Antirheumatic Agents; Azathioprine; Child; Clinical Trials as Topic; Cyclophosphamide; Evidence-Based Medicine; Glucocorticoids; Humans; Induction Chemotherapy; Kidney Diseases; Maintenance Chemotherapy; Methotrexate; Organ Dysfunction Scores; Plasmapheresis; Recurrence; Severity of Illness Index | 2015 |
Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone.
Topics: Adult; Antimetabolites, Antineoplastic; Chorionic Gonadotropin; Female; Gestational Trophoblastic Disease; Humans; Kaplan-Meier Estimate; Methotrexate; Pregnancy; Recurrence; Retrospective Studies; Risk Factors | 2016 |
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Lineage; Central Nervous System; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Proportional Hazards Models; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Recurrence; Risk; Rituximab; Tissue Array Analysis; Translocation, Genetic; Treatment Outcome; Vincristine; Young Adult | 2016 |
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Etanercept; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Tumor Necrosis Factor-alpha; Ultrasonography | 2016 |
Complicated abdominal pregnancy with placenta feeding off sacral plexus and subsequent multiple ectopic pregnancies during a 4-year follow-up: a case report.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Female; Follow-Up Studies; Humans; Lumbosacral Plexus; Methotrexate; Placenta; Pregnancy; Pregnancy, Abdominal; Recurrence | 2016 |
Inflammatory bowel disease in the clinic: Escalation and de-escalation of therapy: A longitudinal case-based discussion.
Topics: Adolescent; Azathioprine; Crohn Disease; Drug Substitution; Drug Therapy, Combination; Enteral Nutrition; Guanine Nucleotides; Humans; Immunosuppressive Agents; Infliximab; Lymphoma, T-Cell; Male; Methotrexate; Recurrence; Remission Induction; Thionucleotides | 2016 |
Central nervous system involvement in T-cell lymphoma: A single center experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Female; Glioblastoma; Humans; Incidence; Injections, Spinal; Lactate Dehydrogenases; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Neoplasm Staging; Practice Guidelines as Topic; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Young Adult | 2016 |
High Efficacy of Methotrexate in Patients with Recurrent Idiopathic Acute Anterior Uveitis: a Prospective Study.
Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Female; Follow-Up Studies; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Immunotherapy; Inflammation; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Recurrence; Time Factors; Uveitis, Anterior | 2017 |
Predominant Neurologic Manifestations Seen in a Patient With a Biallelic Perforin1 Mutation (PRF1; p.R225W).
Topics: Adult; Brain Stem; Child, Preschool; Codon; Cyclosporine; Demyelinating Diseases; Dexamethasone; Exons; Female; Ferritins; Frontal Lobe; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Muscle Weakness; Mutation, Missense; Perforin; Recurrence; Respiratory Tract Infections | 2017 |
[Panniculitis in patient undergoing treatment for dermatomyositis with methotrexate].
Topics: Dermatologic Agents; Dermatomyositis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Methotrexate; Middle Aged; Panniculitis; Prednisone; Recurrence | 2016 |
ANCA-associated vasculitis: a comparison of cases presenting to nephrology and rheumatology services.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; C-Reactive Protein; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Ireland; Male; Methotrexate; Middle Aged; Nephrology; Recurrence; Remission Induction; Retrospective Studies; Rheumatology; Treatment Outcome | 2016 |
[Surgical treatment of a female patient with type III nonspecific aortoarteritis].
Topics: Antirheumatic Agents; Aorta, Abdominal; Aorta, Thoracic; Aortitis; Arteritis; Blood Vessel Prosthesis Implantation; Combined Modality Therapy; Female; Humans; Mesenteric Arteries; Methotrexate; Methylprednisolone Hemisuccinate; Recurrence; Renal Artery; Reoperation; Subclavian Artery; Tomography, Spiral Computed; Treatment Outcome; Young Adult | 2016 |
Canakinumab for Childhood Sight-threatening Refractory Uveitis: A Case Series.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infliximab; Male; Methotrexate; Recurrence; Risk Assessment; Severity of Illness Index; Tomography, Optical Coherence; Treatment Outcome; Uveitis; Vision Disorders | 2016 |
The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis.
Topics: Adult; Female; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Proportional Hazards Models; Recurrence; Survival Rate; Transplantation, Homologous | 2016 |
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Leucovorin; Liver; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Rituximab; Statistics, Nonparametric; Vincristine; Young Adult | 2017 |
Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Central Nervous System Diseases; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Recurrence; Retrospective Studies; Sarcoidosis; Treatment Outcome; Young Adult | 2016 |
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
Topics: Adalimumab; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Colitis, Ulcerative; Colon; Constriction, Pathologic; Crohn Disease; Deprescriptions; Disease Progression; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Ileum; Immunologic Factors; Incidence; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Retreatment; Retrospective Studies; Risk Factors; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
CD25 targeted therapy of chemotherapy resistant leukemic stem cells using DR5 specific TRAIL peptide.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Immunotoxins; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Leukemia; Leukocytes, Mononuclear; Methotrexate; Microscopy, Fluorescence; Neoplastic Stem Cells; Peptides; Receptors, TNF-Related Apoptosis-Inducing Ligand; Recurrence; TNF-Related Apoptosis-Inducing Ligand | 2017 |
Takayasu's Arteritis with Isolated Pulmonary Artery Involvement in a Middle-Aged Asian Woman with Hepatitis B and Latent Tuberculosis Infection.
Topics: Angiography, Digital Subtraction; Antitubercular Agents; Antiviral Agents; Azathioprine; Female; Fluorodeoxyglucose F18; Glucocorticoids; Guanine; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Isoniazid; Latent Tuberculosis; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Recurrence; Stenosis, Pulmonary Artery; Takayasu Arteritis | 2017 |
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leukemia, B-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Methotrexate; Polyethylene Glycols; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome; Vincristine | 2017 |
[Generalized circumscribed scleroderma with blisters].
Topics: Administration, Oral; Administration, Topical; Biopsy; Blister; Combined Modality Therapy; Disease Progression; Female; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Penicillins; Prednisolone; Recurrence; Scleroderma, Localized; Skin; Ultraviolet Therapy | 2017 |
Recurrent impetigo herpetiformis successfully treated with methotrexate.
Topics: Adult; Female; Humans; Impetigo; Methotrexate; Pregnancy; Pregnancy Complications; Recurrence | 2009 |
Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al.
Topics: Antirheumatic Agents; Chondrocalcinosis; Humans; Methotrexate; Recurrence; Treatment Outcome | 2008 |
Re: High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphatic leukemia.
Topics: Child; Dose-Response Relationship, Drug; Humans; Leucovorin; Leukemia, Lymphoid; Methotrexate; Recurrence | 2008 |
[Fusion protein abatacept. Remission in every 5th TNF-alpha refractory patient].
Topics: Abatacept; Antigen-Presenting Cells; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Immunoconjugates; Methotrexate; Recurrence; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2008 |
Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Cytarabine; Female; Humans; Injections, Spinal; Leukemia, Promyelocytic, Acute; Male; Methotrexate; Middle Aged; Oxides; Recurrence | 2008 |
The impact of histopathologic diagnosis on the proper management of testis neoplasms.
Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Cisplatin; Cytarabine; Diagnosis, Differential; Etoposide; Fatal Outcome; Humans; Immunohistochemistry; Interferon Regulatory Factors; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Orchiectomy; Radiography; Recurrence; Remission Induction; Seminoma; Testicular Neoplasms | 2008 |
Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relationship, Drug; Down Syndrome; Humans; Matched-Pair Analysis; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome | 2009 |
Recurrent intrathecal methotrexate induced neurotoxicity in an adolescent with acute lymphoblastic leukemia: Serial clinical and radiologic findings.
Topics: Adolescent; Diffusion; Humans; Injections, Spinal; Magnetic Resonance Imaging; Male; Methotrexate; Neurotoxicity Syndromes; Paresis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Speech Disorders | 2009 |
Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.
Topics: Adaptor Proteins, Vesicular Transport; Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemokine CXCL9; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; GTP-Binding Protein alpha Subunit, Gi2; Histones; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mastectomy; Methotrexate; Middle Aged; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Recurrence; RNA, Messenger; RNA, Neoplasm | 2009 |
Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Methotrexate; Prednisone; Recurrence; Retinal Vasculitis; Retrospective Studies; Treatment Outcome; Visual Acuity; Young Adult | 2008 |
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Female; Flow Cytometry; Follow-Up Studies; Genotype; Germ-Line Mutation; Humans; Infant; Linear Models; Linkage Disequilibrium; Male; Methotrexate; Neoplasm, Residual; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Retrospective Studies; Risk Assessment; Risk Factors | 2009 |
Little dose, huge toxicity: profound hematological toxicity of intrathecal methotrexate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hematologic Tests; Humans; Injections, Spinal; Lymphoma, Follicular; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Recurrence; Vincristine | 2009 |
Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Cohort Studies; Female; Humans; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Scleroderma, Localized; Time Factors; Young Adult | 2009 |
Surgical treatment of ectopic pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Laparoscopy; Methotrexate; Pregnancy; Pregnancy, Ectopic; Recurrence; Salpingostomy; Treatment Outcome | 2009 |
Methotrexate and aminopterin exhibit similar in vitro and in vivo preclinical activity against acute lymphoblastic leukaemia and lymphoma.
Topics: Aminopterin; Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Folic Acid Antagonists; Humans; Inhibitory Concentration 50; Lymphoma; Methotrexate; Mice; Mice, SCID; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Regression Analysis; Xenograft Model Antitumor Assays | 2009 |
False-photosensitivity and transient hemiparesis following high-dose intravenous and intrathecal methotrexate for treatment of acute lymphoblastic leukemia.
Topics: Adolescent; Dysarthria; False Positive Reactions; Humans; Injections, Intravenous; Injections, Spinal; Male; Methotrexate; Nucleic Acid Synthesis Inhibitors; Paresis; Photosensitivity Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 2009 |
[Present status and future perspective of RPGN in Japan].
Topics: Adrenal Cortex Hormones; Azathioprine; Blood Component Removal; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Glomerulonephritis; Humans; Immunosuppressive Agents; Japan; Methotrexate; Multicenter Studies as Topic; Prognosis; Recurrence; Severity of Illness Index; Surveys and Questionnaires | 2009 |
[Therapeutic strategies in idiopatic inflammatory myopathies].
Topics: Adolescent; Age Factors; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Biopsy; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Muscles; Myositis; Polymyositis; Prednisone; Prognosis; Recurrence; Treatment Outcome | 2009 |
A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period.
Topics: Arthritis, Juvenile; Child; Female; Heart Failure; Humans; Ibuprofen; Methotrexate; Recurrence; Rubella Vaccine; Vaccination; Vaccines, Attenuated | 2009 |
[Prophylaxis and treatment of modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents accompanied with infection].
Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Cross Infection; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Female; Humans; Itraconazole; Male; Mercaptopurine; Methotrexate; Mouth Diseases; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Respiratory Tract Infections; Vincristine | 2009 |
Conidiobolomycosis in relapsed acute lymphoblastic leukemia.
Topics: Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined Modality Therapy; Conidiobolus; Debridement; Dexamethasone; Fatal Outcome; Female; Humans; Immunocompromised Host; Maxillary Sinusitis; Methotrexate; Orbital Cellulitis; Pancytopenia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Vincristine; Zygomycosis | 2009 |
Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins.
Topics: Acitretin; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorouracil; Forearm; Humans; Injections, Intralesional; Keratoacanthoma; Keratolytic Agents; Male; Methotrexate; Recurrence; Skin Neoplasms | 2009 |
Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell trans
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Central Nervous System; Cytarabine; Disease-Free Survival; Female; Germinal Center; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Severity of Illness Index; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2009 |
Pulsed high-dose corticosteroids combined with low-dose methotrexate treatment in patients with refractory generalized extragenital lichen sclerosus.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lichen Sclerosus et Atrophicus; Male; Methotrexate; Middle Aged; Probability; Pulse Therapy, Drug; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2009 |
Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Egypt; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Mercaptopurine; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Neoplasm Proteins; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Stomatitis; Vincristine | 2010 |
Febrile ulceronecrotic Mucha-Habermann disease: a rare dermatological emergency.
Topics: Adolescent; Dermatologic Agents; Fever; Humans; Male; Methotrexate; Necrosis; Pityriasis Lichenoides; Recurrence; Skin Ulcer | 2009 |
Polymorphisms of the gamma-glutamyl hydrolase gene and risk of relapse to acute lymphoblastic leukemia in Mexico.
Topics: Adolescent; Antimetabolites, Antineoplastic; Case-Control Studies; Child; Child, Preschool; Female; gamma-Glutamyl Hydrolase; Gene Frequency; Genotype; Humans; Infant; Male; Methotrexate; Mexico; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk; Treatment Outcome | 2010 |
New agents for the treatment of patients with acute lymphoblastic leukemia.
Topics: Age Factors; Antibodies, Monoclonal; Asparaginase; Disease-Free Survival; Enzyme Inhibitors; HSP90 Heat-Shock Proteins; Humans; Liposomes; Methotrexate; Nucleosides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Notch; Recurrence | 2008 |
[Reactivation of tuberculosis with Mycobacterium bovis infection of the oral mucosa during immunosuppression].
Topics: Adalimumab; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Methotrexate; Mouth Mucosa; Mycobacterium bovis; Opportunistic Infections; Recurrence; Tuberculosis, Oral | 2010 |
CNS relapse in acute promyeloctyic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow Neoplasms; Brain Neoplasms; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cranial Irradiation; Cytarabine; Drug Administration Schedule; Female; fms-Like Tyrosine Kinase 3; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Mercaptopurine; Methotrexate; Mutation; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Receptors, Retinoic Acid; Recurrence; Remission Induction; Retinoic Acid Receptor alpha; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Translocation, Genetic; Transplantation, Autologous; Treatment Outcome; Tretinoin; Tumor Suppressor Proteins | 2010 |
Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Risk; Rituximab; Vincristine | 2010 |
Secondary adrenal insufficiency in an infant after intrathecal triple chemotherapy.
Topics: Adrenal Insufficiency; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Hydrocortisone; Immunosuppressive Agents; Injections, Spinal; Leukemia, Myeloid, Acute; Methotrexate; Recurrence | 2010 |
Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Recurrence; Salvage Therapy | 2011 |
Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.
Topics: Adrenal Cortex Hormones; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Asparaginase; Bone Marrow Diseases; Diagnosis, Differential; Doxorubicin; Humans; Ischemia; Leukemic Infiltration; Male; Mercaptopurine; Methotrexate; Myelitis, Transverse; Paraplegia; Paresthesia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy; Spinal Cord; Vincristine | 2010 |
An evaluation of long-term outcomes in adults with pediatric-onset morphea.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Distribution; Age of Onset; Aged; Child; Child, Preschool; Cohort Studies; Female; Follow-Up Studies; Humans; Incidence; Male; Methotrexate; Middle Aged; Recurrence; Risk Assessment; Scleroderma, Localized; Severity of Illness Index; Sex Distribution; Time Factors; Treatment Outcome; Young Adult | 2010 |
Salvage radiotherapy in patients with recurrent or refractory primary or secondary central nervous system lymphoma after methotrexate-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Neoplasms; Disease-Free Survival; Female; Humans; Lymphoma; Male; Methotrexate; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2011 |
Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Disease Progression; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prognosis; Recurrence; Republic of Korea; Retrospective Studies; Survival Analysis; Young Adult | 2011 |
Proximal ectopic pregnancy: a descriptive general population-based study and results of different management options in 86 cases.
Topics: Abortifacient Agents, Nonsteroidal; Adolescent; Adult; Combined Modality Therapy; Female; Humans; Incidence; Laparoscopy; Methotrexate; Pregnancy; Pregnancy, Ectopic; Recurrence; Registries; Risk Factors; Salpingostomy; Treatment Outcome; Young Adult | 2011 |
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Child; Constriction, Pathologic; Crohn Disease; Diet Therapy; Humans; Immunosuppressive Agents; Infliximab; Intestines; Methotrexate; Purines; Recurrence; Remission Induction; Tumor Necrosis Factor-alpha | 2010 |
Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis.
Topics: Anterior Chamber; Arthritis, Juvenile; Child; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Recurrence; Retrospective Studies; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Uveitis, Anterior | 2011 |
Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques.
Topics: Adult; Aorta, Abdominal; Constriction, Pathologic; Drug Substitution; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Methotrexate; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Subclavian Artery; Takayasu Arteritis; Treatment Outcome; Vascular Patency | 2012 |
Methotrexate pharmacokinetics in childhood acute lymphoblastic leukaemia: a prognostic value?
Topics: Adolescent; Age Factors; Antimetabolites, Antineoplastic; Area Under Curve; Bayes Theorem; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infant; Male; Methotrexate; Models, Biological; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Time Factors | 2011 |
Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series.
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Treatment Outcome | 2011 |
Management of bullous pemphigoid with topical steroids in the clinical practice of a single center: outcome at 6 and 12 months.
Topics: Aged; Aged, 80 and over; Clobetasol; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lost to Follow-Up; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Patient Compliance; Pemphigoid, Bullous; Recurrence; Retrospective Studies; Treatment Outcome | 2011 |
Factors influencing the response to high dose methotrexate-based vincristine and procarbazine combination chemotherapy for primary central nervous system lymphoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Contrast Media; Disease-Free Survival; DNA-Binding Proteins; Drug Administration Schedule; Female; Follow-Up Studies; Gadolinium; Humans; Interferon Regulatory Factors; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Odds Ratio; Procarbazine; Prospective Studies; Recurrence; Regulatory Factor X Transcription Factors; Severity of Illness Index; Transcription Factors; Tumor Suppressor Protein p53; Vincristine; X-Box Binding Protein 1 | 2011 |
Inflammatory myofibroblastic tumours of the respiratory tract: paediatric case series with varying clinical presentations.
Topics: Adolescent; Anaplastic Lymphoma Kinase; Antirheumatic Agents; Arthralgia; Arthritis, Juvenile; Bronchoscopy; Child; Dyspnea; Female; Granuloma, Plasma Cell; Histiocytoma, Benign Fibrous; Humans; Lung Neoplasms; Methotrexate; Neoplasms, Muscle Tissue; Osteoarthropathy, Secondary Hypertrophic; Receptor Protein-Tyrosine Kinases; Recurrence; Respiratory Sounds; Respiratory Tract Diseases; Skin Neoplasms; Staining and Labeling; Thigh; Tomography, X-Ray Computed | 2011 |
T-cell depletion in GVHD: less is more?
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Juvenile; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Interleukin 1 Receptor Antagonist Protein; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Steroids; Still's Disease, Adult-Onset; Treatment Outcome; Young Adult | 2011 |
Relapse after systemic treatment in paediatric morphoea.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Age of Onset; Analysis of Variance; Child; Child, Preschool; Dermatologic Agents; Female; Humans; Infant; Male; Methotrexate; Recurrence; Scleroderma, Localized | 2012 |
Relapse of primary central nervous system lymphoma 13 years after high-dose methotrexate-based polychemotherapy.
Topics: Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Recurrence; Remission Induction | 2011 |
Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplant.
Topics: Adult; Aged; Cause of Death; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Recurrence; Siblings; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2011 |
Mercaptopurine-induced hypersensitivity febrile reaction in patient with acute promyelocytic leukemia.
Topics: Anthracyclines; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Fever; Humans; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Middle Aged; Recurrence; Tretinoin | 2012 |
Clinical features and treatment outcomes of isolated secondary central nervous system lymphomas in Miyazaki Prefecture.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prognosis; Recurrence; Rituximab; Treatment Outcome | 2012 |
Effect of maintenance chemotherapy with gemcitabine and paclitaxel on recurrent squamous cell carcinoma of the bladder: a case report.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Cystectomy; Deoxycytidine; Epirubicin; Gemcitabine; Humans; Japan; Male; Methotrexate; Middle Aged; Paclitaxel; Prognosis; Recurrence; Remission Induction; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2011 |
Chemotherapy-related magnetic resonance imaging abnormalities mimicking disease progression following intraventricular liposomal cytarabine and high dose methotrexate for neurolymphomatosis.
Topics: Aged; Antineoplastic Agents; Autopsy; Brain; Brain Injuries; Chlorambucil; Cytarabine; Disease Progression; Fatal Outcome; Humans; Injections, Spinal; Leukemia, Lymphocytic, Chronic, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Nervous System Diseases; Positron-Emission Tomography; Recurrence; Waldenstrom Macroglobulinemia | 2012 |
Good response to infliximab in a patient with deep vein thrombosis associated with Behçet disease.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Recurrence; Treatment Outcome; Venous Thrombosis | 2012 |
The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; ATP-Binding Cassette Transporters; Biomarkers; Calgranulin B; Child; Child, Preschool; Drug Monitoring; Female; Follow-Up Studies; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Methotrexate; Methylprednisolone; Predictive Value of Tests; Recurrence; Risk Factors; Toll-Like Receptor 4; Young Adult | 2012 |
Resolution of recalcitrant uveitic optic disc edema following administration of methotrexate: two case reports.
Topics: Administration, Oral; Adolescent; Chronic Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Papilledema; Prednisolone; Recurrence; Uveitis | 2012 |
[Misleading improvement of abdominal tuberculosis with amikacin, within 72 hours].
Topics: Adrenal Cortex Hormones; Adult; Amikacin; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Drug Resistance, Microbial; Drug Therapy, Combination; Etanercept; Female; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Penicillanic Acid; Peritonitis, Tuberculous; Piperacillin; Piperacillin, Tazobactam Drug Combination; Receptors, Tumor Necrosis Factor; Recurrence; Streptomycin; Time Factors; Tuberculosis, Splenic | 2012 |
Clinical features and outcomes of ANCA-associated renal vasculitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Churg-Strauss Syndrome; Creatinine; Cyclophosphamide; Female; Glomerulonephritis; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Male; Methotrexate; Microscopic Polyangiitis; Middle Aged; Plasmapheresis; Recurrence; Remission Induction; Renal Dialysis; Retrospective Studies | 2012 |
[Guidelines for the management of Crohn's disease].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Budesonide; Crohn Disease; Databases, Factual; Female; Fistula; Humans; Infliximab; Intestinal Perforation; Male; Mercaptopurine; Mesalamine; Methotrexate; Prednisolone; Pregnancy; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine | 2012 |
Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Chorionic Gonadotropin; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Middle Aged; Pregnancy; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult | 2012 |
Recurrent ventricular tachycardia in a child with juvenile dermatomyositis - an unusual association.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Dermatomyositis; Fatal Outcome; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisolone; Recurrence; Tachycardia, Ventricular | 2012 |
Retinitis from cytomegalovirus during maintenance treatment for acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Child; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Humans; Immunocompromised Host; Immunosuppressive Agents; L-Lactate Dehydrogenase; Lymphohistiocytosis, Hemophagocytic; Male; Methotrexate; Methylprednisolone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Retinal Detachment; Vincristine | 2012 |
Recurrent parotitis as a first manifestation in a child with primary Sjogren's syndrome.
Topics: Antirheumatic Agents; Child; Diagnosis, Differential; Glucocorticoids; Humans; Male; Methotrexate; Parotitis; Prednisolone; Recurrence; Sjogren's Syndrome | 2011 |
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Recurrence; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine | 2012 |
Isolated central nervous system relapse in a patient with diffuse large B cell lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Diagnostic Imaging; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Procarbazine; Recurrence; Rituximab; Vincristine | 2012 |
[Bilateral tuberculous mastitis nulliparous patient, initially treated as idiopathic granulomatous mastitis].
Topics: Adult; Antitubercular Agents; Diagnostic Errors; Drug Therapy, Combination; Ethambutol; Female; Granulomatous Mastitis; Humans; Isoniazid; Mastitis; Methotrexate; Mycobacterium tuberculosis; Polymerase Chain Reaction; Prednisone; Pyrazinamide; Recurrence; Rifampin; Tuberculosis | 2012 |
Fertility after tubal ectopic pregnancy: results of a population-based study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Abortion, Therapeutic; Female; Fertility; France; Humans; Kaplan-Meier Estimate; Laparoscopy; Live Birth; Methotrexate; Multivariate Analysis; Pregnancy; Pregnancy, Ectopic; Proportional Hazards Models; Recurrence; Registries; Risk Assessment; Risk Factors; Salpingectomy; Salpingostomy; Time Factors; Time-to-Pregnancy; Treatment Outcome | 2012 |
Methotrexate is an option for patients with refractory calcium pyrophosphate crystal arthritis.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Chondrocalcinosis; Chronic Disease; Female; Humans; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 2012 |
Sternocostal involvement in chronic recurrent multifocal osteomyelitis associated with ulcerative colitis.
Topics: Adult; Bone Density Conservation Agents; Colitis, Ulcerative; Diphosphonates; Drug Therapy, Combination; Humans; Male; Methotrexate; Osteomyelitis; Pamidronate; Recurrence; Treatment Outcome | 2013 |
Recurrent Langerhans cell histiocytosis of the mandible.
Topics: Antimetabolites; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biopsy; Child; Cladribine; Curettage; Eosinophilic Granuloma; Female; Glucocorticoids; Histiocytosis, Langerhans-Cell; Humans; Mandibular Diseases; Mercaptopurine; Methotrexate; Prednisolone; Recurrence; Tomography, X-Ray Computed; Vinblastine | 2013 |
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cranial Nerve Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Eye Neoplasms; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2013 |
Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2012 |
Successful allogeneic stem cell transplantation for Lennert lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Melphalan; Methotrexate; Middle Aged; Nitrosourea Compounds; Pharyngitis; Prednisolone; Recurrence; Rituximab; Salvage Therapy; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 2013 |
Successful treatment of immunodeficiency-associated EBV-negative lymphoproliferative disorders in rheumatoid arthritis by methotrexate withdrawal and prevention of its relapse by rituximab administration.
Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antirheumatic Agents; Arthritis, Rheumatoid; Disease-Free Survival; Drug Administration Schedule; Herpesvirus 4, Human; Humans; Immunologic Deficiency Syndromes; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Recurrence; Rituximab | 2012 |
Correlating pathology with the clinical symptoms of methotrexate-induced leukoencephalopathy in a child with relapsed T-cell acute lymphoblastic leukemia.
Topics: Adolescent; Antimetabolites, Antineoplastic; Fatal Outcome; Female; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Methotrexate; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 2014 |
Hypopyon as the first sign of relapse in acute lymphoblastic leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cyclophosphamide; Cytarabine; Doxorubicin; Eye Neoplasms; Fatal Outcome; Female; Humans; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Vincristine | 2013 |
Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate.
Topics: Administration, Oral; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Infusions, Parenteral; Male; Methotrexate; Middle Aged; Recurrence | 2002 |
Multiple bilateral eyelid molluscum contagiosum lesions associated with TNFalpha-antibody and methotrexate therapy.
Topics: Aged; Antibodies, Monoclonal; Arthritis, Rheumatoid; CD4 Lymphocyte Count; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Eye Infections, Viral; Eyelid Diseases; Female; Humans; Infliximab; Methotrexate; Molluscum Contagiosum; Opportunistic Infections; Recurrence; Tumor Necrosis Factor-alpha; Warts | 2002 |
Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease.
Topics: Acute Disease; Adult; Antimetabolites, Antineoplastic; Bone Marrow Transplantation; Child; Drug Administration Schedule; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Methotrexate; Recurrence; Retrospective Studies; Risk; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2002 |
A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azathioprine; Bone Marrow Transplantation; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Living Donors; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2002 |
Large B-cell lymphoma manifesting as an invasive cardiac mass: sustained local remission after combination of methotrexate and rituximab.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Female; Heart Neoplasms; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Invasiveness; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Transplantation, Autologous | 2002 |
Methotrexate polyglutamation may lack prognostic significance in children with B-cell precursor acute lymphoblastic leukemia treated with intensive oral methotrexate.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Female; Humans; Hydrocortisone; Injections, Spinal; Karyotyping; Leucovorin; Life Tables; Lymphocytes; Male; Mercaptopurine; Methotrexate; Neoplastic Stem Cells; Polyglutamic Acid; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pteroylpolyglutamic Acids; Recurrence; Remission Induction; Survival Analysis; Tumor Cells, Cultured; Vincristine | 2002 |
G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow; Cell Lineage; Child; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Haplotypes; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Lenograstim; Leukemia; Life Tables; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Recurrence; Risk Factors; Survival Analysis; T-Lymphocytes; Treatment Outcome | 2002 |
[Maintaining a remission].
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Child; Crohn Disease; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Meta-Analysis as Topic; Methotrexate; Placebos; Postoperative Care; Prednisolone; Pregnancy; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Risk Factors; Time Factors | 2003 |
[Chronically active Crohn's disease].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Child; Chronic Disease; Contraindications; Crohn Disease; Endoscopy; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nutritional Physiological Phenomena; Placebos; Prednisone; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Ultrasonography | 2003 |
[Follow up of Crohn's disease under therapy with hydro-MRI].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azathioprine; Crohn Disease; Cyclosporins; Enema; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Sulfonamides; Time Factors | 2003 |
[Anti-TNF-alpha treatment--an effective complement in spondyloarthropathy].
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Recurrence; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2002 |
Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence; Remission Induction; Tissue Donors; Transplantation Chimera; Transplantation Conditioning | 2003 |
Treatment of acute lymphoblastic leukemia in Hong Kong children: HKALL 93 study.
Topics: Adolescent; Age Factors; Central Nervous System Neoplasms; Child; Child, Preschool; Disease-Free Survival; Female; Hong Kong; Humans; Immunophenotyping; Infant; Logistic Models; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Regression Analysis; Salvage Therapy; Time Factors | 2003 |
Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Burkitt Lymphoma; Child; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Humans; Immunotherapy; Leukemic Infiltration; Male; Meninges; Methotrexate; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Testis; Topotecan; Transplantation, Autologous; Vindesine | 2003 |
Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al.
Topics: Antirheumatic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Methotrexate; Multicenter Studies as Topic; Placebos; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Reproducibility of Results; Treatment Outcome | 2003 |
Localized non-Hodgkin's lymphoma with B-cell histology: cure without cyclophosphamide? A report of the United Kingdom Children's Cancer Study Group on studies NHL 8501 and NHL 9001 (1985-1996).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Lymphoma, B-Cell; Male; Methotrexate; Recurrence; Survival Analysis; Treatment Failure | 2003 |
Current status and future of relapsed primary central nervous system lymphoma (PCNSL).
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Organophosphorus Compounds; Radioimmunotherapy; Recurrence; Rituximab; Time Factors | 2003 |
Gestational trophoblastic disease following complete hydatidiform mole in Mulago Hospital, Kampala, Uganda.
Topics: Administration, Oral; Adolescent; Adult; Age Distribution; Antimetabolites, Antineoplastic; Female; Humans; Hydatidiform Mole; Incidence; Methotrexate; Middle Aged; Pregnancy; Pregnancy Outcome; Prospective Studies; Recurrence; Survival Analysis; Treatment Outcome; Uganda; Uterine Neoplasms | 2002 |
Erythema annulare centrifugum-type psoriasis: a particular variant of acute-eruptive psoriasis.
Topics: Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Female; Follow-Up Studies; Humans; Immunohistochemistry; Methotrexate; Middle Aged; Psoriasis; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2003 |
Response of cutaneous Crohn's disease to infliximab and methotrexate.
Topics: Adult; Antibodies, Monoclonal; Crohn Disease; Cutaneous Fistula; Dermatologic Agents; Disease Progression; Drug Therapy, Combination; Female; Humans; Infliximab; Methotrexate; Recurrence; Skin Diseases | 2003 |
A case of seven recurrent ectopic pregnancies.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Female; Humans; Methotrexate; Pregnancy; Pregnancy, Tubal; Recurrence; Ultrasonography, Prenatal | 2003 |
Acute secondary gastrointestinal amyloidosis in a patient with rheumatoid arthritis.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Amyloidosis; Arthritis, Rheumatoid; Congo Red; Female; Gastrointestinal Diseases; Humans; Immunosuppressive Agents; Methotrexate; Recurrence; Time Factors | 2003 |
Rituximab in heavily pretreated cutaneous B-cell lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Orchiectomy; Prednisone; Recurrence; Remission Induction; Rituximab; Skin Neoplasms; Testis; Vincristine | 2003 |
[Innovative technologies in the complex treatment of patients with rheumatoid arthritis].
Topics: Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisolone; Recurrence; Stem Cell Transplantation; Time Factors; Treatment Outcome; Vincristine | 2003 |
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunophenotyping; Lymphocyte Depletion; Lymphocyte Transfusion; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Prednisolone; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Vincristine | 2003 |
Effect of a drug combination treatment on ocular perfusion in recurrent idiopathic intermediate uveitis.
Topics: Adult; Blood Flow Velocity; Ciliary Arteries; Cortisone; Cyclosporine; Drug Therapy, Combination; Eye; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Ophthalmic Artery; Perfusion; Prospective Studies; Recurrence; Regional Blood Flow; Retinal Artery; Ultrasonography, Doppler, Color; Uveitis, Intermediate; Visual Acuity | 2003 |
Progressive form of pulmonary Langenharns' cell histiocytosis in a female adult non-smoker.
Topics: Adrenal Cortex Hormones; Adult; Bronchoalveolar Lavage Fluid; Combined Modality Therapy; Female; Histiocytosis, Langerhans-Cell; Humans; Immunophenotyping; Immunosuppressive Agents; Methotrexate; Radiotherapy; Recurrence | 2003 |
Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop?
Topics: Adult; Antirheumatic Agents; Arthritis, Juvenile; Biomarkers; Calgranulin A; Calgranulin B; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Prospective Studies; Recurrence; Remission Induction; Statistics, Nonparametric | 2004 |
Urinary tract infections and lupus erythematosus.
Topics: Adult; Age Factors; Antibodies, Antinuclear; Antirheumatic Agents; Escherichia coli; Female; Hospitalization; Humans; Leukopenia; Lupus Erythematosus, Systemic; Male; Methotrexate; Prevalence; Prospective Studies; Recurrence; Risk Factors; Thrombocytopenia; Urinary Tract Infections | 2004 |
Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.
Topics: Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Recurrence | 2004 |
Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Arthritis, Juvenile; Biomarkers; Child; Child, Preschool; Etanercept; Female; Humans; Immunoglobulin G; Infant; Injections, Intra-Articular; Male; Methotrexate; Neutrophil Activation; Predictive Value of Tests; Receptors, Tumor Necrosis Factor; Recurrence; Risk Factors; S100 Proteins; S100A12 Protein; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2004 |
Previous ectopic pregnancy as a predictor of methotrexate failure.
Topics: Abortifacient Agents, Nonsteroidal; Female; Follow-Up Studies; Humans; Logistic Models; Methotrexate; Predictive Value of Tests; Pregnancy; Pregnancy, Ectopic; Recurrence; Retrospective Studies; Treatment Failure | 2004 |
Isolated central nervous system relapse in lymphoid blast crisis chronic myeloid leukemia and acute lymphoblastic leukemia in patients on imatinib therapy.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Benzamides; Blast Crisis; Bone Marrow; Central Nervous System Neoplasms; Cytarabine; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Middle Aged; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction | 2004 |
Primary central nervous system lymphoma with testicular relapse.
Topics: Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Testicular Neoplasms | 2004 |
Joint lavage for treating recurrent knee involvement in patients with juvenile idiopathic arthritis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Azathioprine; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Knee Joint; Male; Methotrexate; Recurrence; Retrospective Studies; Therapeutic Irrigation; Treatment Outcome | 2004 |
Methotrexate and reactivation tuberculosis.
Topics: Aged; Eczema; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Recurrence; Tuberculosis | 2004 |
[Ulcerative colitis. Chronic active course].
Topics: Administration, Oral; Adult; Age Factors; Anti-Infective Agents; Azathioprine; Child; Chronic Disease; Ciprofloxacin; Colectomy; Colitis, Ulcerative; Controlled Clinical Trials as Topic; Diabetes Mellitus; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Nutritional Physiological Phenomena; Pregnancy; Recurrence; Remission Induction; Risk Factors; Time Factors | 2004 |
Cure of metastatic melanoma with surgery, low-dose methotrexate and heparin: a case report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Heparin; Humans; Melanoma; Methotrexate; Recurrence; Skin Neoplasms; Time Factors; Treatment Outcome | 2004 |
Could immunosuppressive drugs reduce recurrence rate after second resection for Crohn disease?
Topics: Adult; Azathioprine; Colon; Crohn Disease; Female; Gastrointestinal Agents; Humans; Ileum; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Postoperative Care; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome | 2004 |
Unexpected response of hormone-refractory prostate cancer to treatment with an antileukemic chemotherapy regimen.
Topics: Adenocarcinoma; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Fatal Outcome; Goserelin; Humans; Immunocompromised Host; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasms, Second Primary; Neutropenia; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostate-Specific Antigen; Prostatic Neoplasms; Recurrence; Sepsis; Tosyl Compounds; Vincristine | 2004 |
Images in haematology. Combined central retinal artery and vein occlusions as the presenting signs of ocular relapse in acute lymphoblastic leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Leukemic Infiltration; Methotrexate; Middle Aged; Ophthalmoscopy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retinal Artery Occlusion; Retinal Vein Occlusion | 2005 |
Crohn's disease over 20 years after diagnosis in a referral population.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Crohn Disease; Female; Follow-Up Studies; France; Health Status; Humans; Immunosuppressive Agents; Intestinal Neoplasms; Male; Mesalamine; Methotrexate; Middle Aged; Multivariate Analysis; Parenteral Nutrition, Home; Quality of Life; Recurrence; Reoperation; Retrospective Studies; Surveys and Questionnaires | 2004 |
Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Doxorubicin; Female; Humans; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Vincristine | 2005 |
[Examination of the escape phenomenon in disease modifying antirheumatic drugs].
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Cysteine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Phenylacetates; Recurrence; Secondary Prevention; Sulfasalazine | 2005 |
[Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Male; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Analysis; Vincristine | 2005 |
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Busulfan; Cohort Studies; Comorbidity; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Patient Selection; Postoperative Complications; Recurrence; Renal Dialysis; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2005 |
[Severe psoriasis: 160 cases].
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Child; Dermatologic Agents; Female; Humans; Male; Methotrexate; Middle Aged; Prognosis; Psoriasis; Recurrence; Retrospective Studies; Severity of Illness Index; Vitamin D | 2005 |
Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; CD3 Complex; Child; Chimerism; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukocytes; Lymphocytes; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Recurrence; Risk; Stem Cell Transplantation; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings.
Topics: Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Recurrence; Retrospective Studies; Siblings; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria.
Topics: Basophils; Calcineurin Inhibitors; Cells, Cultured; Chronic Disease; Complement C5a; Cyclosporine; Diphenhydramine; Dose-Response Relationship, Immunologic; Histamine H1 Antagonists; Histamine Release; Humans; Hydroxyzine; Immunoglobulin G; Immunosuppressive Agents; Leukocytes; Methotrexate; Recurrence; Tacrolimus; Urticaria | 2005 |
Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
Topics: Adolescent; Antimetabolites, Antineoplastic; Brain; Brain Diseases; Child; Diffusion Magnetic Resonance Imaging; Humans; Injections, Spinal; Male; Methotrexate; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Treatment Outcome | 2005 |
Recurrent cornual pregnancy after heterotopic cornual pregnancy successfully treated with systemic methotrexate.
Topics: Abortifacient Agents, Nonsteroidal; Administration, Oral; Adult; Chorionic Gonadotropin, beta Subunit, Human; Diagnosis, Differential; Female; Humans; Methotrexate; Pregnancy; Pregnancy, Ectopic; Recurrence; Ultrasonography, Prenatal | 2005 |
Methotrexate for Crohn's disease: experience in a district general hospital.
Topics: Adult; Aged; Crohn Disease; Diffusion of Innovation; Drug Administration Schedule; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Hospitals, District; Hospitals, General; Humans; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 2005 |
Successful treatment with adalimumab in infliximab-resistant Crohn's disease.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Digestive System Surgical Procedures; Female; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Middle Aged; Prednisolone; Recurrence; Reoperation; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
[Symmetric polyarthritis in a patient with Churg-Strauss syndrome].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Recurrence; Sulfasalazine | 2005 |
[Recurrent aseptic osteonecrosis in Crohn's disease - extraintestinal manifestation or steroid related complication?].
Topics: Anti-Inflammatory Agents; Arthroplasty, Replacement, Hip; Biopsy; Bone and Bones; Bone Density; Crohn Disease; Dose-Response Relationship, Drug; Female; Femur Head Necrosis; Follow-Up Studies; Hip; Humans; Long-Term Care; Methotrexate; Middle Aged; Muscle Weakness; Osteonecrosis; Prednisone; Recurrence | 2005 |
Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Female; Humans; Infant; Leukemia, Promyelocytic, Acute; Mercaptopurine; Methotrexate; Recurrence; Remission Induction; Tretinoin | 2007 |
T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Antigens, CD7; Antigens, Differentiation, T-Lymphocyte; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cell Differentiation; Cell Lineage; Core Binding Factor Alpha 2 Subunit; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Female; Gene Dosage; Histone-Lysine N-Methyltransferase; Humans; Immunophenotyping; Karyotyping; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Mercaptopurine; Methotrexate; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Neoplastic Stem Cells; Proto-Oncogenes; Recurrence; T-Lymphocyte Subsets; Vincristine | 2007 |
IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Recurrence; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Intracranial plasma cell granuloma: case report and treatment of recurrence with methotrexate and 6-mercaptopurine.
Topics: Adolescent; Brain Diseases; Drug Therapy, Combination; Female; Granuloma, Plasma Cell; Humans; Magnetic Resonance Imaging; Mercaptopurine; Methotrexate; Recurrence | 2005 |
Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia.
Topics: AC133 Antigen; Amphotericin B; Antifungal Agents; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Caspofungin; Child; Combined Modality Therapy; Contraindications; Dexamethasone; Drug Therapy, Combination; Echinocandins; Glycoproteins; Humans; Immunomagnetic Separation; Lipopeptides; Male; Mercaptopurine; Methotrexate; Peptides; Peptides, Cyclic; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Vincristine; Voriconazole; Zygomycosis | 2007 |
p16 inactivation associated with aggressive clinical course and fatal outcome in TEL/AML1-positive acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Chromosomes, Human, Pair 9; Combined Modality Therapy; Core Binding Factor Alpha 2 Subunit; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Cytarabine; Daunorubicin; Fatal Outcome; Gene Deletion; Genes, p16; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm Proteins; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Vincristine | 2005 |
Recurrent hyponatremia after intrathecal methotrexate not related to antidiuretic hormone: is a natriuretic peptide activated?
Topics: Aged; Antimetabolites, Antineoplastic; Female; Humans; Hyponatremia; Injections, Spinal; Methotrexate; Natriuretic Peptides; Recurrence; Vasopressins | 2006 |
The old grey mare, she ain't what she used to be. Is she?: (commentary on Kaspers et al., page 539).
Topics: Child; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Recurrence; Treatment Failure; Treatment Outcome | 2006 |
Ophthalmic zoster sine herpete presenting as oculomotor palsy after marrow transplantation for acute myeloid leukemia.
Topics: Acyclovir; Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Combined Modality Therapy; Cranial Irradiation; False Negative Reactions; Hematopoietic Stem Cell Transplantation; Herpes Zoster Ophthalmicus; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Leukemia, Myeloid; Leukemic Infiltration; Male; Mesencephalon; Methotrexate; Oculomotor Nerve Diseases; Recurrence; Transplantation, Homologous; Virus Activation | 2005 |
Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Cohort Studies; Dietary Supplements; Female; Folic Acid; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2006 |
Long-term treatment of Hashimoto's encephalopathy.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anticonvulsants; Antithyroid Agents; Autoantibodies; Brain Damage, Chronic; Child; Cyclophosphamide; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hashimoto Disease; Humans; Hypothyroidism; Infusions, Intravenous; Iodide Peroxidase; Long-Term Care; Male; Methotrexate; Methylprednisolone; Middle Aged; Neurologic Examination; Prednisone; Recurrence; Thyroiditis, Autoimmune | 2006 |
[IEMAD (modified MIME) therapy for refractory or relapsed non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Recurrence | 2006 |
[A young woman with granulomatous mastitis: a corynebacteria may be involved in the pathogenesis of these disease].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Corynebacterium; Corynebacterium Infections; Diagnosis, Differential; Female; Glucocorticoids; Granuloma, Plasma Cell; Humans; Immunosuppressive Agents; Mastitis; Methotrexate; Prednisone; Punctures; Recurrence | 2006 |
[Twenty years of treating childhood acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Recurrence; Risk Factors; Survival Rate; Time Factors; Vincristine | 2006 |
Infliximab- and methotrexate-resistant rebound of psoriasis after discontinuation of efalizumab (Raptiva).
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Drug Resistance; Humans; Infliximab; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence | 2006 |
Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children.
Topics: Adolescent; Child; Child, Preschool; Dermatologic Agents; Disease Progression; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Methotrexate; Prednisolone; Recurrence; Retrospective Studies; Scleroderma, Localized; Thermography; Treatment Outcome | 2006 |
Is mega dose of methotrexate beneficial to patients with acute lymphoblastic leukemia?
Topics: Central Nervous System; Central Nervous System Neoplasms; Child; Clinical Trials as Topic; Humans; Leucovorin; Methotrexate; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Recurrence; Risk | 2006 |
Reactivation of hepatitis in a bladder cancer patient receiving chemotherapy.
Topics: Antineoplastic Agents; Cisplatin; Epirubicin; Female; Hepatitis B; Humans; Methotrexate; Middle Aged; Recurrence; Urinary Bladder Neoplasms | 2007 |
Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Etoposide; Humans; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Skin; Sunburn; Ultraviolet Rays; Whole-Body Irradiation | 2007 |
[Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Radiotherapy Dosage; Recurrence; Remission Induction; Vincristine | 2007 |
EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Doxorubicin; Drug Therapy, Combination; Epstein-Barr Virus Infections; Fatal Outcome; Female; Herpesvirus 4, Human; Histiocytosis, Langerhans-Cell; Humans; Immunocompromised Host; Infant; Lymphoma, Large B-Cell, Diffuse; Mercaptopurine; Methotrexate; Mycoses; Prednisone; Recurrence; Rituximab; Vinblastine; Vincristine; Virus Activation | 2008 |
Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Topics: Adolescent; Antimetabolites, Antineoplastic; Biological Transport; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Female; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Membrane Transport Proteins; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Reduced Folate Carrier Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2007 |
High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biopsy; Brain Neoplasms; Central Nervous System Neoplasms; Female; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Recurrence; Stereotaxic Techniques | 2007 |
[How I treat: an ectopic pregnancy].
Topics: Abortifacient Agents, Nonsteroidal; Chorionic Gonadotropin; Decision Making; Dilatation and Curettage; Fallopian Tubes; Female; Humans; Intrauterine Devices; Laparoscopy; Methotrexate; Pregnancy; Pregnancy, Ectopic; Pregnancy, Tubal; Recurrence; Retrospective Studies; Risk Factors; Smoking; Ultrasonography, Prenatal | 2006 |
Treatment of vulvovaginal erosive and stenosing lichen planus by surgical dilatation and methotrexate.
Topics: Adrenal Cortex Hormones; Aged; Combined Modality Therapy; Dermatologic Agents; Dilatation; Female; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Ointments; Recurrence; Tacrolimus; Vulvar Lichen Sclerosus | 2007 |
Leflunomide versus methotrexate in Wegener's granulomatosis.
Topics: Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Recurrence; Remission Induction | 2007 |
Conventional dose intensive immunochemotherapy regimen in an adult patient with very late relapse of Burkitt's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child, Preschool; Cyclophosphamide; Doxorubicin; Humans; Male; Methotrexate; Prednisone; Recurrence; Rituximab; Vincristine | 2007 |
Pathogenetic role of myelitis for syringomyelia.
Topics: Adult; Back Pain; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Multiple Sclerosis; Myelitis; Myelitis, Transverse; Neck Pain; Neurologic Examination; Neuromyelitis Optica; Paresthesia; Prednisone; Quadriplegia; Recurrence; Sarcoidosis; Spinal Cord; Syringomyelia | 2007 |
Testicular relapse of primary central nervous system lymphoma.
Topics: Brain; Central Nervous System Neoplasms; Combined Modality Therapy; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Testicular Neoplasms; Treatment Outcome | 2007 |
MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.
Topics: Adolescent; Adult; Aged; Child; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Humans; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Point Mutation; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Rate; Treatment Outcome | 2007 |
[Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 8; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Methotrexate; Recurrence; Remission Induction; Rituximab; Translocation, Genetic; Vincristine | 2007 |
Dose-related reduction in allergen-specific T cells associates with clinical response of atopic dermatitis to methotrexate.
Topics: Adult; Allergens; Dermatitis, Atopic; Dermatologic Agents; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Female; HLA-A Antigens; HLA-DRB1 Chains; Humans; Male; Methotrexate; Recurrence; T-Lymphocytes | 2007 |
Tumour dormancy in breast cancer: an update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm, Residual; Recurrence; Time Factors | 2007 |
Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Electrophoresis, Agar Gel; Epirubicin; Female; Fluorouracil; Genotype; Humans; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Polymorphism, Genetic; Predictive Value of Tests; Recurrence; Retrospective Studies; Thymidylate Synthase | 2007 |
Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Immunotherapy; Infections; Injections, Spinal; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Methotrexate; Methylprednisolone; Recurrence; Retrospective Studies; Treatment Outcome | 2007 |
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
Topics: Adult; Algorithms; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Recurrence; Vasculitis | 2007 |
Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Cyclophosphamide; Female; Follow-Up Studies; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Recurrence; Remission Induction; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 2007 |
Neutrophilic panniculitis in infancy: a cutaneous manifestation of juvenile rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Juvenile; Diagnosis, Differential; Female; Humans; Infant; Methotrexate; Neutrophil Infiltration; Panniculitis; Recurrence; Skin | 2007 |
Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Child; Child, Preschool; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infliximab; Male; Methotrexate; Recurrence; Retrospective Studies; Tumor Necrosis Factor-alpha; Uveitis; Visual Acuity | 2007 |
Acute lymphoblastic leukemia in a patient with chronic cyanoacrylate exposure.
Topics: Adhesives; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyanoacrylates; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Humans; Male; Mercaptopurine; Methotrexate; Mouth Mucosa; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Salvage Therapy; Self Care; Tooth Fractures; Vincristine | 2007 |
Conjunctival involvement in chronic recurrent multifocal osteomyelitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Chronic Disease; Conjunctival Diseases; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methotrexate; Osteomyelitis; Prednisolone; Recurrence; Retrospective Studies; Sulfasalazine | 2008 |
Serpiginous choroiditis treated in a stepladder approach.
Topics: Azathioprine; Choroiditis; Drug Administration Schedule; Drug Therapy, Combination; Folic Acid; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence | 2007 |
[Immunologic problems in allogenic and autologous bone marrow transplantation].
Topics: Antigens, Viral; B-Lymphocytes; Bone Marrow Transplantation; Graft Rejection; Graft vs Host Disease; Herpesvirus 4, Human; Humans; Immune Tolerance; Immunocompetence; Immunoglobulins; Leukemia; Methotrexate; Pokeweed Mitogens; Recurrence; T-Lymphocytes; Transfer Factor; Transplantation Immunology; Transplantation, Autologous; Transplantation, Homologous | 1984 |
Effect on natural killer and antibody-dependent cellular cytotoxicity of adjuvant cytotoxic chemotherapy including melphalan in breast cancer.
Topics: Antibody-Dependent Cell Cytotoxicity; Breast Neoplasms; Cytotoxicity, Immunologic; Drug Therapy, Combination; Female; Humans; Killer Cells, Natural; Long-Term Care; Melphalan; Methotrexate; Recurrence | 1983 |
An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Child; Child, Preschool; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prognosis; Recurrence; Stomatitis; United States | 1984 |
Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Hematologic Diseases; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Prednisone; Recurrence | 1984 |
[Treatment of recurrence in children with acute lymphoblastic leukemias].
Topics: Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Mercaptopurine; Methotrexate; Prednisolone; Prognosis; Recurrence; Vincristine | 1983 |
Intermediate dose methotrexate and recurrent pleural effusions.
Topics: Adult; Humans; Leukemia, Lymphoid; Male; Methotrexate; Pleural Effusion; Recurrence | 1983 |
Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation.
Topics: Acute Disease; Bone Marrow Diseases; Child; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immune Tolerance; Infant; Injections, Spinal; Intelligence Tests; Leukemia, Lymphoid; Male; Meningeal Neoplasms; Methods; Methotrexate; Recurrence | 1984 |
Prolonged methotrexate infusions in children with acute leukemia in relapse and in remission and with medulloblastoma. Pharmacokinetics, toxicity and clinical results.
Topics: Actuarial Analysis; Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Child; Hematologic Diseases; Humans; Infusions, Parenteral; Injections, Spinal; Kinetics; Leukemia, Lymphoid; Medulloblastoma; Methotrexate; Recurrence | 1984 |
Outcome following late marrow relapse in childhood acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Diseases; Brain; Central Nervous System Diseases; Child; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Male; Methotrexate; Recurrence; Spinal Cord; Testicular Neoplasms; Time Factors | 1984 |
[Long-term survival and fatal late relapse in acute leukaemia in adults].
Topics: Acute Disease; Adolescent; Adult; Cyclophosphamide; Female; Humans; Leukemia; Lomustine; Male; Methotrexate; Middle Aged; Recurrence; Thioguanine; Time Factors | 1983 |
Isolated testicular relapse in boys with acute lymphoblastic leukaemia: treatment and outcome.
Topics: Adolescent; Bone Marrow Diseases; Child; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Male; Methotrexate; Prognosis; Recurrence; Testicular Neoplasms | 1982 |
[Treatment of relapse in acute lymphoblastic leukaemia of childhood (author's transl)].
Topics: Bone Marrow; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Infant; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Skull; Vincristine | 1980 |
Favorable response to maintenance therapy of second or subsequent remissions in childhood acute lymphocytic leukemia.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Prednisone; Prognosis; Recurrence; Remission, Spontaneous; Vincristine | 1980 |
The treatment of primary childhood acute lymphocytic leukemia with intermediate dose methotrexate.
Topics: Adolescent; Antineoplastic Agents; Brain; Child; Child, Preschool; Drug Administration Schedule; Evaluation Studies as Topic; Follow-Up Studies; Humans; Infant; Leukemia, Lymphoid; Leukocyte Count; Male; Methotrexate; Recurrence; Risk | 1981 |
Methotrexate absorption in children with acute lymphoblastic leukemia.
Topics: Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Intestinal Absorption; Leukemia, Lymphoid; Male; Methotrexate; Prognosis; Recurrence; Time Factors | 1981 |
Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults.
Topics: Adolescent; Adult; Anaphylaxis; Asparaginase; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Ifosfamide; Leukemia, Lymphoid; Male; Methotrexate; Middle Aged; Recurrence | 1981 |
[An adult case of long-term survivor of acute lymphoblastic leukemia (author's transl)].
Topics: Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Methotrexate; Middle Aged; Prednisolone; Recurrence; Vincristine | 1981 |
Methotrexate and ultraviolet radiation.
Topics: Adult; Arthritis; Coal Tar; Female; Humans; Methotrexate; Psoriasis; Recurrence; Sunburn; Ultraviolet Therapy | 1982 |
Methotrexate levels in the interstitial space and seminiferous tubule of rat testis.
Topics: Animals; Extracellular Space; Infusions, Parenteral; Leukemia, Lymphoid; Male; Methotrexate; Rats; Rats, Inbred Strains; Recurrence; Seminiferous Tubules; Testis | 1982 |
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Inflammation; Lymphoma; Methotrexate; Mucous Membrane; Neutropenia; Podophyllotoxin; Recurrence | 1982 |
Adjuvant therapy for stage II, estrogen receptor negative breast cancer.
Topics: Actuarial Analysis; Antineoplastic Agents; Axilla; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Receptors, Estrogen; Recurrence | 1981 |
Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix: a third look.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Recurrence; Uterine Cervical Neoplasms | 1980 |
[Two cases of multiple myeloma with the successful endoprosthesis of the femoral head showed a satisfactory response to AAAP-therapy for relapse with extramedullary myeloma (author's transl)].
Topics: Antineoplastic Agents; Doxorubicin; Drug Therapy, Combination; Female; Femur Head; Hip Prosthesis; Humans; Methotrexate; Middle Aged; Multiple Myeloma; Prednisolone; Recurrence | 1980 |
Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis.
Topics: Adolescent; Adult; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Female; Humans; Infant; Male; Methotrexate; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 1995 |
[Recurrent tubal pregnancy after a intra-tubal injection of methotrexate. Analysis of an case report with a histological tubal study].
Topics: Adult; Female; Folic Acid Antagonists; Humans; Hysterosalpingography; Laparoscopy; Methotrexate; Pregnancy; Pregnancy, Tubal; Recurrence | 1995 |
Ultraviolet recall associated with etoposide and cyclophosphamide therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Eruptions; Etoposide; Humans; Leucovorin; Male; Methotrexate; Prednisolone; Recurrence; Sunburn; Vincristine | 1993 |
Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Keratins; Lymphatic Metastasis; Methotrexate; Middle Aged; Postmenopause; Premenopause; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Survival Analysis; Tamoxifen; Time Factors | 1994 |
Neuropsychological and neurological outcome after relapse of lymphoblastic leukaemia.
Topics: Age Factors; Brain; Child; Child, Preschool; Cognition Disorders; Cranial Irradiation; Developmental Disabilities; Education; Female; Growth Disorders; Humans; Infant; Intelligence; Leukemia, Lymphoid; Leukemic Infiltration; Male; Methotrexate; Nervous System Diseases; Radiation Injuries; Radiotherapy; Recurrence; Whole-Body Irradiation | 1994 |
Changes in Tc-99m radionuclide bone scan images and peripheralization of marrow hematopoietic activity associated with the administration of granulocyte colony stimulating factor as an adjunct to dose-intensified chemotherapy for breast cancer. A case rep
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Humans; Methotrexate; Radionuclide Imaging; Recurrence; Technetium | 1994 |
Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Erythrocytes; Female; Follow-Up Studies; Guanine Nucleotides; Humans; Infant; Male; Mercaptopurine; Methotrexate; Polyglutamic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Regression Analysis; Remission Induction; Risk; Thionucleotides; Time Factors | 1995 |
Recurrent gestational trophoblastic disease following in-vitro fertilization.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Embryo Transfer; Etoposide; Female; Fertilization in Vitro; Humans; Infertility, Female; Methotrexate; Peptide Fragments; Pregnancy; Recurrence; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1994 |
Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Survival Rate; Time Factors; Transplantation, Autologous | 1995 |
CNS chemoradiotherapy of childhood leukemia: the plot thickens but the ending bodes well.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Injections, Spinal; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Radiotherapy; Recurrence; Sex Factors | 1995 |
Treatment of recalcitrant cardiac allograft rejection with methotrexate. Cardiac Transplant Team.
Topics: Administration, Oral; Azathioprine; Bacterial Infections; Case-Control Studies; Combined Modality Therapy; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Leukocyte Count; Lymphatic Irradiation; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Transplantation, Homologous | 1995 |
Prognosis and treatment of seizures in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Epilepsy; Female; Humans; Incidence; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Retrospective Studies; Seizures; Vincristine | 1995 |
Results of treatment of small non-cleaved cell lymphoma in patients without positive HIV serology.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; HIV Seropositivity; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Recurrence; Survival Rate; Vincristine | 1993 |
Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Platelet Transfusion; Recurrence; Remission Induction; Survival Analysis; Thiotepa; Transplantation, Homologous; Whole-Body Irradiation | 1995 |
[Central nervous system relapses in acute lymphoblastic leukemia and different methods of prophylaxis].
Topics: Adolescent; Adult; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Female; Humans; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Risk Factors; Survival Analysis | 1995 |
An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Critical Care; Female; Humans; Infant; Injections, Intravenous; Injections, Spinal; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Recurrence; Remission Induction; Time Factors | 1995 |
Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate.
Topics: Adolescent; Adult; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Methotrexate; Middle Aged; Pilot Projects; Recurrence; Remission Induction; Takayasu Arteritis | 1994 |
Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Aspartate-Ammonia Ligase; Clinical Trials as Topic; Cytarabine; Dose-Response Relationship, Drug; Humans; Idarubicin; Incidence; Methotrexate; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy | 1994 |
Reactivation of phototoxicity test for psoralens plus ultraviolet A by low-dose methotrexate.
Topics: Aged; Dermatitis, Phototoxic; Humans; Male; Methotrexate; Psoriasis; PUVA Therapy; Recurrence; Sunburn | 1994 |
Successful bone marrow transplant for a patient with T-lymphoblastic lymphoma in second remission preconditioned by total-body irradiation plus melphalan and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Etoposide; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Whole-Body Irradiation | 1994 |
Immunoblastic lymphadenopathy in a five-month-old girl: successful treatment with immunosuppressants.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Infant; Interferon-alpha; Lymph Nodes; Mercaptopurine; Methotrexate; Recurrence; Remission Induction | 1994 |
Relapsing chickenpox in a young man with non-Hodgkin's lymphoma.
Topics: Acyclovir; Adult; Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Herpesvirus 3, Human; Humans; Immunocompromised Host; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Recurrence; Vincristine; Virus Activation | 1994 |
Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Rate; Teniposide; Thioguanine; Vincristine | 1994 |
Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Leucovorin; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Teniposide; Vincristine | 1994 |
[Effective treatment of recurrent keratoacanthoma using methotrexate].
Topics: Aged; Drug Administration Schedule; Ear, External; Female; Forehead; Humans; Keratoacanthoma; Male; Methotrexate; Middle Aged; Nose; Recurrence; Skin Diseases | 1994 |
[Relapse of acute leukemia after allogeneic bone marrow transplantation].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Rate | 1994 |
Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
Topics: Adult; Age Factors; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Family Health; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Retrospective Studies; Surveys and Questionnaires; Survival Rate; Time Factors; Tissue Donors | 1993 |
[Successful oral administration of etoposide therapy for refractory malignant lymphoma treated with frequent combination chemotherapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Salvage Therapy; Vincristine | 1993 |
PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cathepsin D; Chemotherapy, Adjuvant; Cyclophosphamide; Estrogens; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Prognosis; Proteins; Radioimmunoassay; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Survival Analysis; Tamoxifen; Time Factors; Trefoil Factor-1; Tumor Suppressor Proteins | 1993 |
[Glucocorticoid monotherapy for Cogan syndrome?].
Topics: Administration, Oral; Adult; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Female; Hearing Loss, Bilateral; Humans; Iritis; Methotrexate; Optic Neuritis; Prednisolone; Recurrence; Syndrome; Tinnitus; Vestibular Diseases | 1993 |
Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Combined Modality Therapy; Daunorubicin; Humans; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Recurrence; Remission Induction; Time Factors; Transplantation, Homologous; Vincristine | 1993 |
Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Remission Induction; Survival Analysis; Vincristine | 1993 |
Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985.
Topics: Brain Neoplasms; Child; Child, Preschool; Cranial Irradiation; Humans; Infant; Injections, Spinal; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Survival Rate | 1993 |
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Topics: Adult; Aged; Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Histocompatibility; Humans; Leukemia; Male; Methotrexate; Middle Aged; Recombinant Proteins; Recurrence; Survival Rate; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 1995 |
Recurrent recall of sunburn by methotrexate.
Topics: Administration, Oral; Dermatologic Agents; Facial Dermatoses; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Sunburn; Sunlight | 1995 |
Methotrexate-linked ventricular arrhythmias.
Topics: Administration, Oral; Adult; Angina Pectoris; Arrhythmias, Cardiac; Biopsy; Coronary Angiography; Dermatologic Agents; Electrocardiography, Ambulatory; Endocardium; Heart Arrest; Humans; Male; Methotrexate; Myocardial Infarction; Psoriasis; Recurrence; Ventricular Premature Complexes | 1995 |
Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate.
Topics: Administration, Oral; Administration, Topical; Aged; Alanine Transaminase; Aspartate Aminotransferases; Dermatologic Agents; Drug Administration Schedule; Drug Tolerance; Erythrocyte Indices; Evaluation Studies as Topic; Female; gamma-Glutamyltransferase; Humans; Liver; Male; Methotrexate; Middle Aged; Motivation; Platelet Count; Psoriasis; Recurrence; Time Factors | 1995 |
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Female; Humans; Infant; Leukocyte Count; Male; Methotrexate; Netherlands; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Treatment Outcome | 1996 |
Mutations in the gene for human dihydrofolate reductase: an unlikely cause of clinical relapse in pediatric leukemia after therapy with methotrexate.
Topics: Adolescent; Animals; Antimetabolites, Antineoplastic; Base Sequence; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Genes; Genetic Vectors; Humans; Infant; Male; Methotrexate; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retroviridae; Tetrahydrofolate Dehydrogenase | 1996 |
Recurrent cervical pregnancy after assisted reproduction by intrafallopian transfer.
Topics: Adult; Cervix Uteri; Female; Folic Acid Antagonists; Gamete Intrafallopian Transfer; Humans; Methotrexate; Potassium Chloride; Pregnancy; Pregnancy, Ectopic; Recurrence; Zygote Intrafallopian Transfer | 1996 |
Childhood acute lymphoblastic leukemia relapse in the uterine cervix.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Humans; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Ultrasonography; Uterine Cervical Neoplasms; Vaginal Smears; Vincristine | 1996 |
Induction toxicity of a modified Memorial Sloan-Kettering-New York II Protocol in children with relapsed acute lymphoblastic leukemia: a single institution study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Daunorubicin; Female; Humans; Male; Methotrexate; Neutropenia; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Vincristine | 1996 |
Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cerebrospinal Fluid; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Disease-Free Survival; Female; Humans; Hydrocortisone; Injections, Spinal; Leukemia; Leukemic Infiltration; Male; Meninges; Methotrexate; Prospective Studies; Recurrence; Remission Induction; Risk; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 1996 |
Treatment of pyoderma gangrenosum with methotrexate.
Topics: Adult; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Methotrexate; Prednisone; Pyoderma Gangrenosum; Recurrence; Wound Healing | 1996 |
Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 1996 |
Successful treatment of lymphomatoid granulomatosis using cyclosporin-A after failure of intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Doxorubicin; Etoposide; Humans; Immunosuppressive Agents; Lung Diseases; Lymphomatoid Granulomatosis; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Salvage Therapy; Vincristine | 1996 |
Exacerbation of rheumatoid arthritis after termination of chemotherapy for breast carcinoma.
Topics: Adenocarcinoma; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Recurrence | 1996 |
[Obesity as the first manifestation of central nervous system involvement in acute lymphoblastic leukemia].
Topics: Antineoplastic Agents; Body Mass Index; Child; Combined Modality Therapy; Cytarabine; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Methotrexate; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Recurrence | 1996 |
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantatio
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Leukemia; Methotrexate; Middle Aged; Recurrence; Transplantation, Homologous; Treatment Outcome | 1996 |
Successful transvaginal ultrasound-guided puncture and injection of a cervical pregnancy in a patient with simultaneous intrauterine pregnancy and a history of a previous cervical pregnancy.
Topics: Abortion, Legal; Adult; Cervix Uteri; Cesarean Section; Female; Humans; Injections; Methotrexate; Potassium Chloride; Pregnancy; Pregnancy Outcome; Pregnancy Reduction, Multifetal; Pregnancy, Ectopic; Punctures; Recurrence; Twins; Ultrasonography, Doppler, Color; Ultrasonography, Prenatal; Vagina | 1996 |
PUVA-induced phototoxicity: incidence and causes.
Topics: Clinical Protocols; Dermatitis, Phototoxic; Doxycycline; Drug Interactions; Female; Herpes Zoster; Humans; Incidence; Male; Methotrexate; Methoxsalen; Middle Aged; Nausea; Photosensitizing Agents; PUVA Therapy; Radiotherapy Dosage; Recurrence; Retrospective Studies | 1997 |
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Male; Melphalan; Methotrexate; Prednisone; Recurrence; Remission Induction; Retreatment; Salvage Therapy; Stomach Neoplasms; Transplantation Conditioning; Tumor Lysis Syndrome; Vincristine | 1997 |
Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: usefulness of local and regional irradiation and reduced dose chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Recurrence; Survival Rate; Vincristine | 1997 |
Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Survival Rate | 1997 |
Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Topics: Actuarial Analysis; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphatic Irradiation; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome | 1997 |
Malignancy in patients with rheumatoid arthritis treated with methotrexate.
Topics: Arthritis, Rheumatoid; Female; Humans; Lymphoma, B-Cell; Methotrexate; Middle Aged; Recurrence | 1997 |
In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow; Cell Survival; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Life Tables; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Remission Induction; Tumor Cells, Cultured; Vincristine | 1997 |
Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Recurrence; Salvage Therapy; Survival Rate; Time Factors; Vincristine | 1997 |
Effect of resumption of second line drugs in patients with rheumatoid arthritis that flared up after treatment discontinuation.
Topics: Acute Disease; Aged; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Organogold Compounds; Penicillamine; Recurrence; Sulfasalazine; Treatment Outcome | 1997 |
Successful methotrexate treatment of a viable pregnancy within a thin uterine scar.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Cesarean Section; Cicatrix; Female; Humans; Injections, Intramuscular; Methotrexate; Pregnancy; Pregnancy Complications, Cardiovascular; Recurrence; Uterine Hemorrhage; Uterus | 1997 |
Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prognosis; Recurrence; Renal Insufficiency; Tacrolimus; Transplantation, Homologous | 1997 |
On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemia.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Male; Metabolic Clearance Rate; Methotrexate; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Probability; Prognosis; Recurrence; Reproducibility of Results; Risk Assessment | 1997 |
Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blast Crisis; Burkitt Lymphoma; Carrier Proteins; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Leukocyte Count; Male; Methotrexate; Neoplasm Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Tetrahydrofolate Dehydrogenase | 1997 |
Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression.
Topics: Adolescent; Autoimmune Diseases; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Malabsorption Syndromes; Male; Methotrexate; Methylprednisolone; Polyendocrinopathies, Autoimmune; Recurrence | 1997 |
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cranial Irradiation; Daunorubicin; Female; Humans; Infant; Injections, Spinal; Leukemia-Lymphoma, Adult T-Cell; Leukocyte Count; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Survival Rate; Vincristine | 1997 |
High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: pattern of failure and implications for involved-field radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoguazone; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Treatment Failure | 1997 |
Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Female; Humans; Male; Methotrexate; Recurrence; Remission Induction; Retrospective Studies; Time | 1997 |
Salvage therapy for relapsed or refractory childhood acute lymphocytic leukemia by alternative administration a lymphoid- and myeloid-directed chemotherapeutic regimen consisting of dual modulation of ara-C, hydroxyurea, and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Fever; Gastrointestinal Diseases; Humans; Hydrocortisone; Hydroxyurea; Leucovorin; Male; Methotrexate; Mitoxantrone; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Treatment Outcome | 1997 |
Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Recurrence; Retrospective Studies; Vincristine | 1997 |
[Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence].
Topics: Adult; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Recurrence; Respiratory Distress Syndrome; Tacrolimus | 1998 |
Cogan's syndrome with Takayasu's arteritis.
Topics: Angiography; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Aspirin; Cyclophosphamide; Epoprostenol; Female; Hearing Loss, Sensorineural; Humans; Injections, Intravenous; Keratitis; Methotrexate; Middle Aged; Platelet Aggregation Inhibitors; Prednisolone; Recurrence; Subclavian Artery; Takayasu Arteritis | 1998 |
Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Child; Child, Preschool; Cytarabine; Humans; Hydrocortisone; Injections, Spinal; Leukemic Infiltration; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 1998 |
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Recurrence; Tissue Donors; Transplantation, Homologous | 1998 |
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
Topics: Administration, Oral; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Asparaginase; Biological Availability; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; DNA Adducts; Erythrocytes; Female; Guanosine Triphosphate; Humans; Infant; Injections, Spinal; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proportional Hazards Models; Recurrence; Thionucleotides; Treatment Outcome; Vincristine | 1998 |
Interstitial ectopic pregnancy--management with laparoscopically-guided local methotrexate infiltration.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Female; Humans; Methotrexate; Pregnancy; Pregnancy, Ectopic; Progesterone; Recurrence; Ultrasonography, Prenatal | 1998 |
Recurrent interstitial pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Chorionic Gonadotropin; Female; Humans; Laparotomy; Methotrexate; Pregnancy; Pregnancy, Ectopic; Recurrence | 1998 |
Tetraploidy in acute myeloid leukemia secondary to large cell lymphoma.
Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Chromosome Aberrations; Combined Modality Therapy; Cyclophosphamide; Fatal Outcome; Humans; Immunophenotyping; Karyotyping; Leukemia, Myeloid; Leukemia, Radiation-Induced; Lymphoma, Large B-Cell, Diffuse; Male; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Neoplastic Stem Cells; Palliative Care; Polyploidy; Prednisone; Procarbazine; Recurrence; Vincristine | 1998 |
Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Female; Humans; Injections, Intraventricular; Male; Meningeal Neoplasms; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Treatment Outcome | 1999 |
Methotrexate in refractory Crohn's disease.
Topics: Adolescent; Adult; Azathioprine; Crohn Disease; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 1999 |
Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Recurrence; Retrospective Studies | 1999 |
Disseminated Langerhans cell histocytosis in children: treatment outcome.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Male; Mercaptopurine; Methotrexate; Prednisolone; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine | 1999 |
Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Incidence; Logistic Models; Mastectomy, Radical; Methotrexate; Recurrence; Retrospective Studies; Risk Assessment; Survival Analysis; Survival Rate; Time Factors | 1999 |
[The presence of minimal residual disease during induction therapy is a reliable factor for the prognosis of recurrence in children with standard-risk B-cell precursor acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; DNA Primers; Genes, T-Cell Receptor delta; Humans; Mercaptopurine; Methotrexate; Molecular Sequence Data; Neoplasm, Residual; Polymerase Chain Reaction; Prednisone; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Vincristine | 1999 |
The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis.
Topics: Adolescent; Age of Onset; Analysis of Variance; Antirheumatic Agents; Arthritis, Juvenile; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Monitoring; Female; Gastrointestinal Diseases; Humans; Infant; Logistic Models; Male; Methotrexate; Predictive Value of Tests; Recurrence; Remission Induction; Treatment Outcome | 1999 |
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Drug Administration Schedule; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Tacrolimus | 1999 |
Diffuse large-cell lymphoma of the testis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Recurrence; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Treatment Outcome; Vincristine | 1999 |
MVAC-therapy for advanced urothelial carcinoma in an anuric renal transplant recipient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Anuria; Cisplatin; Doxorubicin; Humans; Kidney Transplantation; Lymphatic Metastasis; Male; Methotrexate; Recurrence; Urinary Bladder Neoplasms; Vinblastine | 2000 |
Methotrexate and corticosteroid therapy for pediatric localized scleroderma.
Topics: Administration, Oral; Anti-Inflammatory Agents; Child; Child, Preschool; Confidence Intervals; Dermatologic Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intravenous; Leukopenia; Male; Methotrexate; Methylprednisolone; Placebos; Recurrence; Remission Induction; Scleroderma, Localized | 2000 |
Treatment for repeat tubal ectopic pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Female; Humans; Laparoscopy; Methotrexate; Pregnancy; Pregnancy, Tubal; Recurrence; Salpingostomy | 2000 |
Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric Oncology.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; France; Humans; Infant; Lomustine; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Prednisone; Recurrence; Retrospective Studies; Survival Rate; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine | 2000 |
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Italy; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Recurrence; Survival Rate; Vincristine | 2000 |
Primary T-cell lymphoma of the brain in children: a case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arabinose; Asparaginase; Brain Neoplasms; Child; Combined Modality Therapy; Cytosine; Female; Humans; Lymphoma, T-Cell; Methotrexate; Recurrence; Remission Induction | 2000 |
Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia.
Topics: B-Lymphocytes; Biological Transport; Cell Membrane; Drug Resistance, Neoplasm; gamma-Glutamyl Hydrolase; Humans; Methotrexate; Neoplastic Stem Cells; Peptide Synthases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Thymidylate Synthase; Tumor Cells, Cultured | 2000 |
Treatment of persistent rejection with methotrexate in stable patients submitted to heart transplantation.
Topics: Adolescent; Adult; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Methotrexate; Middle Aged; Recurrence; Treatment Outcome | 2000 |
Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Treatment Outcome; Vindesine | 2000 |
[Treatment and prognosis of children with relapsed non-Hodgkin's lymphoma--a report from CCLSG-NHL 890 Study. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Survival Rate; Vincristine | 2000 |
Methotrexate and the photodermatitis reactivation reaction: a case report and review of the literature.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Female; Humans; Methotrexate; Photosensitivity Disorders; Postoperative Period; Pregnancy; Pregnancy, Tubal; Recurrence; Time Factors | 2000 |
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease.
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Recurrence; Treatment Outcome | 2000 |
The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
Topics: Adult; Aged; Angiogenesis Inducing Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; Doxorubicin; Endothelial Growth Factors; Female; Fibroblast Growth Factor 2; Humans; Immunohistochemistry; In Situ Hybridization; Interleukin-8; Lymphokines; Male; Methotrexate; Microcirculation; Middle Aged; Multivariate Analysis; Muscle Neoplasms; Neoplasm Metastasis; Prognosis; Recurrence; RNA, Messenger; Time Factors; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vinblastine | 2000 |
Three conservative approaches to treatment of interstitial pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Laparoscopy; Methotrexate; Pregnancy; Pregnancy, Tubal; Recurrence; Ultrasonography | 2001 |
Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate.
Topics: Adult; Antibodies, Monoclonal; Chronic Disease; Dermatologic Agents; Drug Therapy, Combination; Humans; Infliximab; Male; Methotrexate; Psoriasis; Recurrence; Tumor Necrosis Factor-alpha | 2001 |
Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.
Topics: Adolescent; Adult; Ambulatory Care; Busulfan; Child; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Neural Tube Defects; Program Evaluation; Recurrence; Survival Analysis; Thalassemia; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |
Late reactivation of spinal tuberculosis by low-dose methotrexate therapy in a patient with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Immunosuppression Therapy; Methotrexate; Middle Aged; Recurrence; Spine; Treatment Outcome; Tuberculosis, Spinal | 2001 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chlorambucil; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferons; Levamisole; Male; Methotrexate; Pentoxifylline; Recombinant Proteins; Recurrence; Sulfasalazine; Thalidomide | 2001 |
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nuclear Family; Recurrence; Retrospective Studies; Survival Rate; Whole-Body Irradiation | 2001 |
[Fertility after laparoscopic treatment of ectopic pregnancy in a series of 138 patients].
Topics: Adolescent; Adult; Chorionic Gonadotropin; Fallopian Tubes; Female; Fertility; Humans; Laparoscopy; Methotrexate; Multivariate Analysis; Pregnancy; Pregnancy, Ectopic; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome | 2001 |
Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, T-Cell; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Recurrence; Red-Cell Aplasia, Pure; Remission Induction; T-Lymphocytes, Cytotoxic | 2001 |
Long-term effects on the intelligence of children treated for acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Follow-Up Studies; Humans; Intelligence; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Recurrence; Survivors; Time Factors; Wechsler Scales | 2001 |
Repeated achilles tendinitis after high dose methotrexate.
Topics: Achilles Tendon; Adolescent; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Factors; Tendinopathy | 2001 |
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Regression Analysis; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous | 2001 |
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antilymphocyte Serum; Bone Marrow; Busulfan; Cell Count; Chromosomes, Human, Pair 7; Cyclophosphamide; Disease-Free Survival; Feasibility Studies; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Histocompatibility; Humans; Infections; Karyotyping; Methotrexate; Middle Aged; Monosomy; Myelodysplastic Syndromes; Recurrence; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |
High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Brain; Brain Neoplasms; Central Nervous System Neoplasms; Disease Progression; Disease-Free Survival; Humans; Injections, Intravenous; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Recurrence; Testicular Neoplasms | 2001 |
Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Lineage; Combined Modality Therapy; Daunorubicin; Disease Progression; Fatal Outcome; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Genes, Immunoglobulin; Glycophorins; HLA-DR Antigens; Humans; Immunophenotyping; Killer Cells, Natural; Leukemia, Lymphoid; Male; Methotrexate; Myeloid Cells; Neoplasm Proteins; Neoplastic Stem Cells; Peroxidase; Prednisolone; Recurrence; Remission Induction; T-Lymphocyte Subsets; Transplantation, Homologous; Vincristine | 2002 |
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recurrence; Remission Induction; Survival Rate; Thiotepa; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mechlorethamine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Taiwan; Treatment Outcome; Vincristine | 2001 |
Burkitt's lymphoma: single-centre experience with modified BFM protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infections; Lymphoma, AIDS-Related; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission Induction; Treatment Outcome; Vincristine | 2002 |
Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implications.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Logistic Models; Longitudinal Studies; Male; Methotrexate; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Proto-Oncogene Proteins c-bcl-2; Recurrence; Retrospective Studies; Survival Analysis; Tumor Suppressor Protein p53; Vincristine | 2002 |
Allogeneic hematopoietic grafts after total-body irradiation in dogs with spontaneous tumors.
Topics: Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Dogs; Female; Graft Rejection; Graft vs Host Reaction; Leukemia, Experimental; Lymphoma; Male; Methotrexate; Neoplasms, Experimental; Radiotherapy Dosage; Recurrence; Remission, Spontaneous; T-Lymphocytes; Transplantation, Autologous; Transplantation, Homologous | 1978 |
The role of chemotherapy in the management of cancer of the head and neck: a review.
Topics: Bleomycin; Dinitrochlorobenzene; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Head and Neck Neoplasms; Humans; Immunotherapy; Infusions, Parenteral; Injections, Intra-Arterial; Leucovorin; Methotrexate; Mouth Neoplasms; Recurrence | 1975 |
Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Topics: alpha-Fetoproteins; Carmustine; Fetal Proteins; Humans; Liver Neoplasms; Methotrexate; Recurrence | 1976 |
Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Methotrexate; Middle Aged; Recurrence; Semustine; Vincristine | 1976 |
Preventive cranial irradiation in the treatment of acute lymphocytic leukemia in children.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Lymphoid; Male; Meningeal Neoplasms; Methotrexate; Radiotherapy, High-Energy; Recurrence; Remission, Spontaneous; Skull | 1978 |
Superior vena caval obstruction due to small-cell anaplastic lung carcinoma. Response to chemotherapy.
Topics: Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Lomustine; Lung Neoplasms; Methotrexate; Nitrosourea Compounds; Recurrence; Vascular Diseases; Vena Cava, Superior | 1976 |
Adult acute leukemia: frequency of central system involvement in long term survivors.
Topics: Adolescent; Adult; Brain Neoplasms; Cytarabine; Female; Follow-Up Studies; Humans; Leukemia; Leukemia, Lymphoid; Male; Meningeal Neoplasms; Methotrexate; Recurrence; Remission, Spontaneous; Time Factors | 1977 |
[Prevention and treatment of neuroleukemia].
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Cytarabine; Humans; Leukemia, Lymphoid; Methotrexate; Neoplasm Metastasis; Recurrence; Spinal Cord Neoplasms | 1977 |
Therapeutic considerations in acute lymphocytic leukemia.
Topics: Antineoplastic Agents; Child; Daunorubicin; Drug Therapy, Combination; Follow-Up Studies; Humans; Leukemia, Lymphoid; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission, Spontaneous; Vincristine | 1978 |
Proliferative kinetics of the leukemic cells in meningeal leukemia.
Topics: Adult; Cell Division; Humans; Kinetics; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Recurrence; Remission, Spontaneous | 1978 |
Pyrimethamine in prevention of relapses of meningeal leukemia: report of two cases.
Topics: Central Nervous System; Child; Cytarabine; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Male; Meningeal Neoplasms; Methotrexate; Pyrimethamine; Recurrence; Remission, Spontaneous | 1978 |
Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission.
Topics: Adolescent; Bone Marrow; Child; Child, Preschool; Cytarabine; Drug Therapy, Combination; Female; Humans; Infant; Kinetics; Leukemia, Lymphoid; Male; Methotrexate; Mitosis; Recurrence; Remission, Spontaneous | 1978 |
A reappraisal of the results of stopping therapy in childhood leukemia.
Topics: Antineoplastic Agents; Bone Marrow Diseases; Central Nervous System; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Male; Meningeal Neoplasms; Methotrexate; Probability; Recurrence; Remission, Spontaneous; Risk; Sex Factors; Testicular Neoplasms; Time Factors | 1979 |
[AAAP therapy for relapse of acute leukemia (author's transl)].
Topics: Adolescent; Adult; Antineoplastic Agents; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Nitrosourea Compounds; Prednisolone; Recurrence | 1978 |
[A case of acute lymphocytic leukemia relapsed with leukemic pleuritis and paraplegia, with special reference to "AAAP"-therapy effect (author's transl)].
Topics: Doxorubicin; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Methotrexate; Middle Aged; Nitrosourea Compounds; Paraplegia; Pleurisy; Prednisolone; Recurrence | 1978 |
Dissimilar courses of twins with leukemia.
Topics: Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Leukemia, Lymphoid; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission, Spontaneous; Vincristine | 1977 |
Acute lymphoblastic leukemia with eosinophilia and basophilia.
Topics: Antineoplastic Agents; Basophils; Central Nervous System Diseases; Child, Preschool; Diagnosis, Differential; Eosinophilia; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocytosis; Male; Methotrexate; Recurrence; Remission, Spontaneous | 1979 |
Serum copper and zinc measurement in patients with osteogenic sarcoma.
Topics: Adolescent; Adult; BCG Vaccine; Copper; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Osteosarcoma; Recurrence; Spectrometry, X-Ray Emission; Time Factors; Zinc | 1978 |
High-dose methotrexate with cyclophosphamide and cis-platinum in treatment of advanced ovarian carcinoma.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Bone Marrow; Cisplatin; Cyclophosphamide; Drug Resistance; Drug Therapy, Combination; Female; Humans; Kidney; Leucovorin; Methotrexate; Ovarian Neoplasms; Recurrence | 1979 |
Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Chlorambucil; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunotherapy; Mastectomy; Methotrexate; Mycobacterium bovis; Prednisone; Recurrence | 1978 |
Dapsone in the treatment of pemphigus vulgaris.
Topics: Adult; Dapsone; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Pemphigus; Prednisone; Recurrence | 1978 |
Combined modality treatment of Burkitt's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents; Burkitt Lymphoma; Central Nervous System Diseases; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Prednisolone; Recurrence; Remission, Spontaneous; Time Factors; Vincristine | 1978 |
Melphalan and methotrexate in advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Bone Marrow; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Melphalan; Methotrexate; Middle Aged; Neoplasm Metastasis; Recurrence | 1978 |
Combination chemotherapy in recurrent medulloblastoma.
Topics: Adolescent; Antineoplastic Agents; Brain Neoplasms; Carmustine; Child; Child, Preschool; Dexamethasone; Drug Therapy, Combination; Female; Humans; Male; Medulloblastoma; Methotrexate; Recurrence; Remission, Spontaneous; Time Factors; Vincristine | 1979 |
Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience.
Topics: Adolescent; Adult; Africa; Age Factors; Antineoplastic Agents; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Female; Follow-Up Studies; Humans; Male; Methotrexate; National Institutes of Health (U.S.); Prednisolone; Recurrence; Remission, Spontaneous; Uganda; United States; Vincristine | 1977 |
Quadruple chemotherapy in the treatment of advanced or recurrent gastrointestinal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Methotrexate; Middle Aged; Recurrence; Remission, Spontaneous; Time Factors; Vincristine | 1977 |
Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pemphigus; Prednisone; Recurrence | 1977 |
[Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Topics: Antigen-Antibody Reactions; BCG Vaccine; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunotherapy; Lectins; Lymphatic Metastasis; Lymphocyte Activation; Lymphocytes; Melanoma; Methotrexate; Recurrence; Remission, Spontaneous; Rosette Formation; Skin Neoplasms; Skin Tests; Tuberculin Test | 1977 |
Preventing central nervous system leukemia.
Topics: Animals; Brain; Central Nervous System Diseases; Child; Child, Preschool; Cytarabine; Humans; Hydrocortisone; Injections, Spinal; Leukemia; Methotrexate; Recurrence; Spine; Time Factors | 1976 |
Combined modality treatment of American Burkitt's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents; BCG Vaccine; Burkitt Lymphoma; Cells, Cultured; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Male; Methotrexate; Recurrence; Remission, Spontaneous; Time Factors; United States; Vincristine | 1976 |
Brain damage after intrathecal methotrexate.
Topics: Adolescent; Adult; Aged; Brain Diseases; Cerebral Cortex; Child; Child, Preschool; Female; Humans; Infant; Injections, Spinal; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Methotrexate; Middle Aged; Recurrence | 1975 |
[Duration of chemotherapy in acute lymphoblastic leukemia of childhood (author's transl)].
Topics: Child; Child, Preschool; Drug Administration Schedule; Humans; Injections, Spinal; Leukemia, Lymphoid; Methotrexate; Recurrence | 1976 |
Combination chemotherapy as an adjuvant treatment in operable breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Recurrence; Time Factors | 1976 |
Relapse in Burkitt's lymphoma.
Topics: Abdominal Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Facial Neoplasms; Follow-Up Studies; Humans; Methotrexate; Recurrence; Remission, Spontaneous; Vincristine | 1976 |
A pilot study of intensive weekly chemotherapy for extensive disease small-cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Pilot Projects; Recurrence; Treatment Outcome; Vincristine | 1992 |
Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty.
Topics: Angioplasty, Balloon; Animals; Carotid Arteries; Carotid Artery Injuries; Carotid Stenosis; Methotrexate; Muscle, Smooth, Vascular; Recurrence; Swine; Tritium | 1992 |
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; DNA, Neoplasm; Drug Therapy, Combination; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Prognosis; Recurrence; RNA, Messenger; Transcription, Genetic | 1992 |
Methotrexate treatment of recalcitrant childhood dermatomyositis.
Topics: Adolescent; Calcium; Child; Child, Preschool; Dermatomyositis; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Prednisone; Recurrence; Remission Induction; Retrospective Studies | 1992 |
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Ifosfamide; Infant; Male; Methotrexate; Prednisone; Prognosis; Recurrence; Remission Induction; Teniposide; Vincristine | 1992 |
Recurrent episodes of pseudoseptic arthritis in rheumatoid arthritis: response to D-penicillamine and methotrexate.
Topics: Arthritis, Infectious; Arthritis, Rheumatoid; Female; Humans; Methotrexate; Middle Aged; Penicillamine; Recurrence | 1992 |
The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate.
Topics: Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Drug Therapy, Combination; Female; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Male; Methotrexate; Middle Aged; Pilot Projects; Prospective Studies; Recurrence; Remission Induction; Treatment Failure | 1992 |
[Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Rate; Vindesine | 1992 |
Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Recurrence | 1992 |
Marrow transplantation in patients with acute myeloid leukemia.
Topics: Acute Disease; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Drug Administration Schedule; Graft vs Host Disease; Humans; Leukemia, Myeloid; Methotrexate; Pentoxifylline; Radiotherapy Dosage; Recurrence; Remission Induction; Transplantation, Autologous; Whole-Body Irradiation | 1992 |
Treatment of low-grade and intermediate-grade lymphoma with intensive combination chemotherapy results in long-term, disease-free survival.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Recurrence; Remission Induction; Survival Rate; Vincristine | 1990 |
Treatment of the eosinophilia-myalgia syndrome.
Topics: Adrenal Cortex Hormones; Adult; Aged; Eosinophilia-Myalgia Syndrome; Female; Humans; Methotrexate; Middle Aged; Recurrence | 1991 |
Skin manifestation of extramedullary relapse in adult with acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Immunotherapy; Leukemic Infiltration; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radiotherapy; Recurrence; Remission Induction; Skin; Vincristine | 1991 |
Weight gain with breast cancer adjuvant treatment.
Topics: Adaptation, Psychological; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Melphalan; Methotrexate; Middle Aged; Prednisone; Recurrence; Regression Analysis; Social Support; Vinblastine; Weight Gain | 1991 |
Cancer chemotherapy: hormonal changes and recurring asthma.
Topics: Adenocarcinoma; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Asthma; Breast Neoplasms; Cyclophosphamide; Drug Hypersensitivity; Female; Fluorouracil; Humans; Methotrexate; Recurrence | 1991 |
Extracorporeal photopheresis in psoriasis vulgaris: clinical and immunologic observations.
Topics: Adolescent; Adult; Chronic Disease; Drug Administration Schedule; Female; Humans; Immunoglobulin E; Immunophenotyping; Interleukin-2; Male; Methotrexate; Photochemotherapy; Psoriasis; Recurrence; Skin Tests | 1990 |
Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Hydrocortisone; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Teniposide; Vincristine | 1990 |
Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporins; Drug Combinations; Graft Rejection; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Middle Aged; Prednisone; Prognosis; Recurrence; Transplantation, Homologous | 1990 |
Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Recurrence; Remission Induction; Risk Factors; Survival Analysis; Xanthine Oxidase | 1990 |
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. The Swedish Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Recurrence; Remission Induction; Retrospective Studies | 1990 |
[The treatment of tubal pregnancy with methotrexate].
Topics: Adult; Combined Modality Therapy; Emergencies; Fallopian Tubes; Female; Humans; Methotrexate; Pregnancy; Pregnancy, Tubal; Recurrence | 1990 |
Adjuvant chemotherapy and scar irradiation in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Prednisone; Prospective Studies; Recurrence; Survival Rate | 1990 |
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Recurrence | 1990 |
Multicentric reticulohistiocytosis and cancer: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arthritis; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cyclophosphamide; Female; Fluorouracil; Histiocytes; Humans; Lymphatic Diseases; Lymphatic Metastasis; Methotrexate; Middle Aged; Paraneoplastic Syndromes; Prednisone; Recurrence; Skin Diseases; Staining and Labeling | 1985 |
Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mouth Mucosa; Prednisone; Radiation Injuries; Recurrence; Stomatitis; Tonsillar Neoplasms; Vincristine | 1989 |
Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Colony-Stimulating Factors; Cyclosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Infant; Leukocytes; Male; Methotrexate; Middle Aged; Recombinant Proteins; Recurrence | 1989 |
[A study of complete responders in cases of metastatic breast cancer treated with combination chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Recurrence; Remission Induction; Tamoxifen; Tegafur; Time Factors | 1989 |
Ascending myelopathy after chemotherapy for central nervous system acute lymphoblastic leukemia: correlation with cerebrospinal fluid myelin basic protein.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined Modality Therapy; Cytarabine; Humans; Hydrocortisone; Injections, Spinal; Leukemia, Lymphoid; Male; Methotrexate; Myelin Basic Protein; Prednisone; Radiotherapy Dosage; Recurrence; Spinal Cord Neoplasms; Testicular Neoplasms; Vincristine | 1985 |
Familial hemophagocytic lymphohistiocytosis: therapy in the German experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Infant, Newborn; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence | 1989 |
Factors affecting survival in allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporins; Graft Rejection; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Middle Aged; Postoperative Complications; Pulmonary Fibrosis; Recurrence; Reoperation | 1989 |
[Treatment with methotrexate for tubal pregnancy].
Topics: Chorionic Gonadotropin; Female; Humans; Laparoscopy; Methotrexate; Pregnancy; Pregnancy, Tubal; Recurrence; Ultrasonography | 1987 |
Bone-marrow transplantation for haematological malignancy in childhood.
Topics: Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytomegalovirus Infections; Evaluation Studies as Topic; Female; Graft vs Host Disease; Humans; Injections, Spinal; Leukemia; Leukemia, Lymphoid; Lymphatic Diseases; Male; Methotrexate; Pneumonia; Premedication; Prognosis; Recurrence; Time Factors; Transplantation, Homologous; Whole-Body Irradiation | 1986 |
Reversal of recalcitrant cardiac allograft rejection with methotrexate.
Topics: Adult; Cardiomyopathy, Dilated; Coronary Disease; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Male; Methotrexate; Middle Aged; Recurrence; Tissue Donors | 1988 |
T-cell depletion versus methotrexate as GvHD-prophylaxis in allogeneic bone marrow transplantation for leukaemia.
Topics: Acute Disease; Adult; Bone Marrow; Bone Marrow Transplantation; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Recurrence; T-Lymphocytes | 1988 |
White cell count during maintenance chemotherapy for standard-risk childhood acute lymphoblastic leukemia: relation to relapse rate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Humans; Leukocyte Count; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Risk Factors | 1988 |
Multifocal eosinophilic granuloma--a case report.
Topics: Eosinophilic Granuloma; Gingiva; Humans; Infant; Lymph Nodes; Male; Methotrexate; Mouth Diseases; Palate; Recurrence | 1988 |
[Lyell's syndrome from the repeat treatment of psoriasis with methotrexate].
Topics: Aged; Female; Humans; Methotrexate; Psoriasis; Recurrence; Remission Induction; Stevens-Johnson Syndrome | 1988 |
CNS relapse in children with acute lymphoblastic leukemia after cranial prophylaxis.
Topics: Adolescent; Brain; Brain Neoplasms; Child; Child, Preschool; Female; Humans; Injections, Spinal; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Spinal Cord Neoplasms | 1988 |
Reactivation of cutaneous radionecrosis associated with methotrexate therapy for psoriasis.
Topics: Humans; Male; Methotrexate; Middle Aged; Necrosis; Radiodermatitis; Recurrence; Scrotum; Skin | 1988 |
High dose intravenous methotrexate with leucovorin rescue in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Drug Therapy, Combination; HLA-DR Antigens; Humans; Injections, Intravenous; Leucovorin; Methotrexate; Pain; Pilot Projects; Recurrence; T-Lymphocytes | 1988 |
Combined chemotherapy and surgery for pulmonary metastases from osteogenic sarcoma. Results of 10 years experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Postoperative Complications; Prospective Studies; Recurrence; Survival Rate | 1988 |
Comments on primary and adjuvant treatments of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Methotrexate; Prognosis; Recurrence | 1988 |
Modified Capizzi maintenance regimen in children with relapsed acute lymphoblastic leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Humans; Leukemia, Lymphoid; Methotrexate; Recurrence; Vincristine | 1986 |
The pharmacology of orally administered chemotherapy. A reappraisal.
Topics: Administration, Oral; Allopurinol; Biological Availability; Child; Circadian Rhythm; Drug Administration Schedule; Drug Interactions; Food; Humans; Infusions, Parenteral; Kinetics; Leukemia, Lymphoid; Mercaptopurine; Methotrexate; Recurrence | 1986 |
The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Brain Diseases; Child; Child, Preschool; Humans; Infant; Leukemia; Leukemia, Lymphoid; Meningeal Neoplasms; Methotrexate; Middle Aged; Recurrence; Risk | 1986 |
Long-term relapse-free survival in adult acute lymphoblastic leukemia.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Combined Modality Therapy; Doxorubicin; Female; Humans; Leukemia, Lymphoid; Male; Methotrexate; Middle Aged; Nervous System Neoplasms; Prednisone; Prognosis; Recurrence; Vincristine | 1985 |
Central nervous system morbidity following an initial isolated central nervous system relapse and its subsequent therapy in childhood acute lymphoblastic leukemia.
Topics: Acute Disease; Central Nervous System Diseases; Child; Combined Modality Therapy; Humans; Intelligence Tests; Leukemia, Lymphoid; Male; Methotrexate; Nervous System Neoplasms; Radiography; Recurrence | 1985 |
Therapy of CNS leukemia with intraventricular chemotherapy and low-dose neuraxis radiotherapy.
Topics: Adolescent; Brain; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Drug Combinations; Female; Humans; Infant; Injections, Intraventricular; Injections, Spinal; Leukemia, Lymphoid; Male; Meningeal Neoplasms; Methotrexate; Prognosis; Radiotherapy Dosage; Recurrence | 1985 |
Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse, and graft-versus-host disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Leukemia, Lymphoid; Male; Methotrexate; Recurrence; Whole-Body Irradiation | 1985 |
Ifosfamide and etoposide as salvage therapy for non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Podophyllotoxin; Recurrence | 1986 |
[Polymyositis and dermatomyositis in the metropolitan hospital complex of the Panama Department of Social Security. 1973. Clinical review and effects of treatment].
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Dermatomyositis; Female; Humans; Male; Methotrexate; Middle Aged; Myositis; Recurrence | 1985 |
[Photochemotherapy combined with low-dose methotrexate in severe forms of psoriasis].
Topics: Adolescent; Adult; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Photochemotherapy; Psoriasis; Recurrence; Time Factors | 1985 |
Treatment of diffuse aggressive non-Hodgkin's lymphomas with an intensive multi-drug regimen including high-dose cytosine arabinoside (F-MACHOP).
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Vincristine | 1985 |
[Immunosuppression of severe dermatomyositis with cytostatic drugs and thymectomy (author's transl)].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Chronic Disease; Dactinomycin; Dermatomyositis; Female; Humans; Mercaptopurine; Methotrexate; Recurrence; Thymectomy | 1974 |
Marrow transplantation for aplastic anemia and acute leukemia.
Topics: Anemia, Aplastic; Animals; Bone Marrow Cells; Bone Marrow Transplantation; Child; Cyclophosphamide; Diseases in Twins; Drug Therapy, Combination; Female; Graft vs Host Reaction; Histocompatibility Antigens; Humans; Infections; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphocyte Culture Test, Mixed; Lymphoma; Methods; Methotrexate; Radiotherapy Dosage; Recurrence; Transplantation, Autologous; Transplantation, Homologous | 1974 |
[Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Castration; Cyclophosphamide; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Fluorouracil; Hormones; Humans; Hypophysectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Ovary; Prednisone; Recurrence; Remission, Spontaneous; Vincristine | 1974 |
[Treatment of acute lymphoblastic leukosis: evaluation of the maintenance and reinduction standards. Analysis of 33 cases].
Topics: Acute Disease; Adult; Child; Daunorubicin; Humans; Leukemia, Lymphoid; Methotrexate; Prednisone; Recurrence; Remission, Spontaneous; Vincristine | 1972 |
Factors that influence the appearance of central nervous system leukemia.
Topics: Central Nervous System Diseases; Cerebrospinal Fluid; Cobalt Radioisotopes; Daunorubicin; Humans; Injections, Spinal; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Mercaptopurine; Methotrexate; Prednisone; Radioisotope Teletherapy; Recurrence; Retrospective Studies; Vincristine | 1973 |
[Meningeal leukaemia in chloroma with later generalized leukaemia (author's transl)].
Topics: Adult; Blood Cell Count; Bone Marrow Examination; Cytarabine; Female; Humans; Injections, Spinal; Leukemia, Myeloid; Lumbar Vertebrae; Methotrexate; Myelography; Recurrence; Remission, Spontaneous; Sciatica; Spinal Neoplasms | 1974 |
Fourteen relapses of acute lymphoblastic leukaemia in a child.
Topics: Agranulocytosis; Asparaginase; Blood Cell Count; Bone Marrow Examination; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Hemoglobins; Humans; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Pneumonia; Prednisone; Recurrence; Vincristine | 1973 |
Intracellular lysozyme in mature neutrophils and blast cells in acute leukemia.
Topics: Adult; Cell Separation; Hematopoietic Stem Cells; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Methotrexate; Muramidase; Neutrophils; Recurrence | 1974 |
The prognosis of acute leukaemia in childhood.
Topics: Acute Disease; Antineoplastic Agents; Bone Marrow Examination; Brain Neoplasms; Child; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Methotrexate; Prednisone; Prognosis; Recurrence; Remission, Spontaneous; Vincristine | 1974 |
Response to combination therapy after relapse in childhood acute lymphocytic leukemia.
Topics: Adolescent; Anemia, Aplastic; Antineoplastic Agents; Central Nervous System; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Diarrhea; Drug Combinations; Female; Follow-Up Studies; Humans; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Nausea; Pneumonia, Pneumocystis; Prednisone; Radiotherapy; Recurrence; Remission, Spontaneous; Stomatitis, Aphthous; Vincristine; Vomiting | 1972 |
Löffler's endomyocardial fibrosis with eosinophilia in association with acute lymphoblastic leukemia.
Topics: Bone Marrow Examination; Child; Chromosome Aberrations; Drug Therapy, Combination; Endomyocardial Fibrosis; Eosinophilia; Heart Murmurs; Humans; Hydrocortisone; Leukemia, Lymphoid; Liver; Lymph Nodes; Male; Mercaptopurine; Methotrexate; Myocardium; Organ Size; Pneumonia, Pneumocystis; Prednisone; Recurrence; Tachycardia; Vincristine | 1974 |
Methotrexate and prednisone in pemphigus vulgaris. Therapeutic results obtained in 36 patients between 1961 and 1970.
Topics: Administration, Oral; Adult; Aged; Antibodies; Female; Fluorescent Antibody Technique; Humans; Injections, Intramuscular; Male; Methotrexate; Middle Aged; Pemphigus; Prednisone; Recurrence; Time Factors | 1972 |
[Pemphigus vulgaris. Recurrence 9 years after sudden interruption of corticotherapy].
Topics: Adrenal Cortex Hormones; Fluorescent Antibody Technique; Humans; Male; Methotrexate; Middle Aged; Mouth Diseases; Pemphigus; Recurrence; Triamcinolone | 1972 |
Allogeneic marrow grafting in acute lymphoid leukemia during marrow remission.
Topics: Adolescent; Blood Cell Count; Bone Marrow Cells; Bone Marrow Transplantation; Child; Cobalt Radioisotopes; Cytogenetics; Female; Graft Rejection; Hematocrit; Histocompatibility Antigens; Humans; Leukemia, Lymphoid; Male; Methotrexate; Pneumonia, Pneumocystis; Postoperative Complications; Prognosis; Recurrence; Remission, Spontaneous; Transplantation, Homologous | 1973 |
Marrow transplantation for the treatment of acute leukemia using HL-A-identical siblings.
Topics: Acute Kidney Injury; Antilymphocyte Serum; Bone Marrow Cells; Bone Marrow Transplantation; Cyclophosphamide; Daunorubicin; Female; Graft Rejection; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppression Therapy; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Methotrexate; Pneumonia; Recurrence; Sepsis; T-Lymphocytes; Transplantation Immunology; Transplantation, Homologous | 1974 |
Clinical evaluation of patients treated for rhabdomyosarcoma.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclophosphamide; Evaluation Studies as Topic; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Postoperative Care; Radiotherapy Dosage; Recurrence; Rhabdomyosarcoma; Thiotepa; Time Factors | 1972 |
Significance of growth rates, cell kinetics, and histology in the irradiation and chemotherapy of squamous cell carcinoma of the mouth.
Topics: Biopsy; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cobalt Isotopes; Humans; Kinetics; Methotrexate; Mitosis; Mouth Neoplasms; Recurrence; Time Factors | 1973 |
[Effectiveness and complications of treating psoriasis with antimetabolites].
Topics: Adrenal Cortex Hormones; Adult; Antimetabolites; Chronic Disease; Drug Combinations; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Psoriasis; Recurrence; Remission, Spontaneous | 1973 |
Pregnancy after hydatidiform mole.
Topics: Abortion, Spontaneous; Abortion, Therapeutic; Congenital Abnormalities; Contraceptives, Oral; Dactinomycin; Delivery, Obstetric; Female; Fetal Death; Humans; Hydatidiform Mole; Infant Mortality; Infant, Newborn; Infant, Premature; Intrauterine Devices; Methotrexate; Pregnancy; Recurrence; Time Factors | 1973 |
[Experience in treating pemphigus with corticosteroids and methotrexate].
Topics: Adrenal Cortex Hormones; Adult; Aged; Female; Humans; Male; Methotrexate; Middle Aged; Pemphigus; Recurrence; Remission, Spontaneous | 1973 |
Meningeal leukaemia.
Topics: Child; Female; Humans; Injections, Spinal; Leukemia; Male; Meningeal Neoplasms; Methotrexate; Prognosis; Recurrence | 1967 |
[Therapy of leukemic meningiosis. I].
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cytarabine; Electroencephalography; Humans; Infant; Injections, Spinal; Leukemia; Meninges; Methotrexate; Neoplasm Metastasis; Neurologic Manifestations; Recurrence | 1971 |
Hyperleukocytosis before the beginning of treatment in acute leukaemia in children and its subsequent repetition at the onset of relapses.
Topics: Acute Disease; Antibiotics, Antineoplastic; Bone Marrow Examination; Child; Cytarabine; Humans; Leukemia; Leukemia, Lymphoid; Leukocytosis; Mercaptopurine; Methotrexate; Prednisone; Prognosis; Recurrence; Vincristine | 1970 |
Psoriasis in childhood.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Dermatologic Agents; Female; Humans; Infant; Infections; Male; Methotrexate; Middle Aged; Psoriasis; Psychophysiologic Disorders; Racial Groups; Recurrence; Sex Factors; Skin; Skin Diseases, Infectious; Sunlight | 1971 |